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Chemokines organize immune cell trafficking by inducing either directed (tactic) or random 
(kinetic) migration and by activating integrins in order to support surface adhesion (haptic). 
Beyond that the same chemokines can establish clearly defined functional areas in 
secondary lymphoid organs. Until now it is unclear how chemokines can fulfill such diverse 
functions. One decisive prerequisite to explain these capacities is to know how chemokines 
are presented in tissue. In theory chemokines could occur either soluble or immobilized, and 
could be distributed either homogenously or as a concentration gradient. To dissect if and 
how the presenting mode of chemokines influences immune cells, I tested the response of 
dendritic cells (DCs) to differentially displayed chemokines. DCs are antigen presenting cells 
that reside in the periphery and migrate into draining lymph nodes (LNs) once exposed to 
inflammatory stimuli to activate naïve T cells. DCs are guided to and within the LN by the 
chemokine receptor CCR7, which has two ligands, the chemokines CCL19 and CCL21. 
Both CCR7 ligands are expressed by fibroblastic reticular cells in the LN, but differ in their 
ability to bind to heparan sulfate residues. CCL21 has a highly charged C-terminal exten-
sion, which mediates binding to anionic surfaces, whereas CCL19 is lacking such residues 
and likely distributes as a soluble molecule. This study shows that surface-bound CCL21 
causes random, haptokinetic DC motility, which is confined to the chemokine coated area by 
inside-out activation of β2 integrins that mediate cell binding to the surface. CCL19 on the 
other hand forms concentration gradients which trigger directional, chemotactic movement, 
but no surface adhesion. In addition DCs can actively manipulate this system by recruiting 
and activating serine proteases on their surfaces, which create - by proteolytically removing 
the adhesive C-terminus - a solubilized variant of CCL21 that functionally resembles CCL19. 
By generating a CCL21 concentration gradient DCs establish a positive feedback loop to 
recruit further DCs from the periphery to the CCL21 coated region. In addition DCs can 
sense chemotactic gradients as well as immobilized haptokinetic fields at the same time and 
integrate these signals. The result is chemotactically biased haptokinesis - directional 
migration confined to a chemokine coated track or area - which could explain the dynamic 
but spatially tightly controlled swarming leukocyte locomotion patterns that have been 
observed in lymphatic organs by intravital microscopists.  
The finding that DCs can approach soluble cues in a non-adhesive manner while they attach 
to surfaces coated with immobilized cues raises the question how these cells transmit 
intracellular forces to the environment, especially in the non-adherent migration mode. In 
order to migrate, cells have to generate and transmit force to the extracellular substrate. 
Force transmission is the prerequisite to procure an expansion of the leading edge and a 
forward motion of the whole cell body. In the current conceptions actin polymerization at the 
leading edge is coupled to extracellular ligands via the integrin family of transmembrane 
receptors, which allows the transmission of intracellular force. Against the paradigm of force 
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transmission during migration, leukocytes, like DCs, are able to migrate in three-dimensional 
environments without using integrin transmembrane receptors (Lämmermann et al., 2008). 
This reflects the biological function of leukocytes, as they can invade almost all tissues, 
whereby their migration has to be independent from the extracellular environment. How the 
cells can achieve this is unclear. For this study I examined DC migration in a defined three-
dimensional environment and highlighted actin-dynamics with the probe Lifeact-GFP. The 
result was that chemotactic DCs can switch between integrin-dependent and integrin-
independent locomotion and can thereby adapt to the adhesive properties of their environ-
ment. If the cells are able to couple their actin cytoskeleton to the substrate, actin polymeri-
zation is entirely converted into protrusion. Without coupling the actin cortex undergoes 
slippage and retrograde actin flow can be observed. But retrograde actin flow can be 
completely compensated by higher actin polymerization rate keeping the migration velocity 
and the shape of the cells unaltered. Mesenchymal cells like fibroblast cannot balance the 
loss of adhesive interaction, cannot protrude into open space and, therefore, strictly depend 
on integrin-mediated force coupling. This leukocyte specific phenomenon of “adaptive force 
transmission” endows these cells with the unique ability to transit and invade almost every 
type of tissue. 
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-/-      knockout 
3D      three-dimensional 
3T3  fibroblast cell line "3-day transfer, inoculum 3x10
5 
cells” 
ACK  ammonium-chloride-potassium 
ADP  adenosine-5'-diphosphate 
ANOVA  analysis of variance 
AOX1  alcohol oxidase promoter 
Apr  aprotinin 
Arp2/3  actin related protein 2/3 
ATP  adenosine-5'-triphosphate 
ATPase  adenosine-5'-triphosphatase 
BMGY  buffer glycerol-complex medium 
BMMY  buffer methanol-complex medium 
Bp/kbp  base pair(s), kilo base pairs 
BSA  bovine serum albumin 
C  cysteine 
C57BL/6  inbred mouse strain "C57 black 6" 
CAP  cyclase associated protein 
CCL  CC- or β-chemokine 
CCX-CKR  CC-X-chemokine receptor 
CCR  CC- or β-chemokine receptor 
CD  cluster of differentiation 
cDC  conventional dendritic cells 
C-terminus,  carboxy-terminus, carboxy-terminal 
C-terminal 
ctrl  control 
CX3CL  CXXXC- or γ-chemokine 
CX3CR  CXXXC- or γ-chemokine receptor  
CXCL  CXC- or α-chemokine 
CXCR  CXC- or α-chemokine receptor 
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Cy  cyanine 
D10  DMEM supplemented with glutamine and 10% FCS 
DAG  diacylglycerol 
DC   dendritic cell 
ddH2O  double distilled water 
ddNTP  dideoxynucleotide -5'-triphosphate 
DMEM  Dulbecco‟s Modified Eagle Medium 
DMSO  dimethyl sulfoxide 
DNA  deoxyribonucleic acid 
dNTP  deoxynucleotide -5'-triphosphate 
DRY-motive  aspartic acid-arginine-tyrosine motive 
ECM  extracellular matrix 
E.coli  bacteria: Escherichia coli 
EDTA  ethylenediaminetetraacetic acid 
ELR-motive  glutamate-leucine-arginine motive 
ER  endoplasmatic reticulum 
FACS  fluorescence-activated cell sorting 
FCS  fetal calf serum 
FDC  follicular dendritic cell 
FITC  fluorescein isothiocyanate 
FRC  fibroblastic reticular cell 
GAG  glycosaminoglycan 
GDP  guanosine-5'-diphosphate 
GEF  guanine nucleotide exchange factor 
GFP  green fluorescent protein 
GM-CSF  granulocyte-macrophage colony-stimulating factor 
gp38  glycoprotein 38 
GPCR  G protein-coupled receptor 
GTP  guanosine-5'-triphosphate 
GTPase  guanosine-5'-triphosphatase 
HBSS  Hank's buffered salt solution 
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HEPES  N-(2-hydroxyethyl)-piperazine-N‟-2-ethanesulfonic acid 
HEV  high endothelial venule 
HRP  horseradish peroxidase 
HS  heparan sulfate 
HSG  half-synthetic, glycerol-based 
ICAM-1  intercellular adhesion molecule 1 
IFN  interferon 
Ig  immunoglobulin 
IL  interleukine 
InsP3  inositol-1,4,5-trisphosphate 
IPTG  isopropyl β-D-1-thiogalactopyranoside 
Itg  gene: integrin 
kDa  kilodaltons 
KO  knockout 
LB  Lysogeny broth, mediium for bacteria 
LFA1  lymphocyte function-associated antigen 1 
LN   lymph node 
LoxP  locus of X-over P1;  site on the bacteriophage P1 genome consisting of an 
asymmetric 8 bp sequence in between with two sets of palindromic se-
quences 
LPS  lipopolysaccharide 
MACS  magnetic-activated cell sorting 
M-CSF  macrophage colony-stimulating factor 
MEF  mouse embryonic fibroblast 
MEM  minimum essential medium 
MHC  major histocompatibility complex 
MOPS  3-(N-morpholino)propanesulfonic acid 
MP  mouse plasma 
MRC  marginal reticular cells 
Mx  promoter: myxovirus resistance 
ns  not significant 
NTA  nitrilotriacetic acid 
N-terminus,  amino-terminus, amino-terminal 
N-terminal 
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OD  optical density  
p19
ARF  
ADP ribosylation factor, 19 kDa protein 
PAMP  pathogen-associated molecular pattern 
PALP  periarteriolar lymphoid sheath 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
pDC  plasmacytoid  dendritic cell 
PDCA-1  plasmacytoid dendritic cell antigen 1 
PE  phycoerythrin 
PEG  polyethylene glycol 
PIP3  phosphotidylinositol-3,4,5-trisphosphate 
PLC  phospholipase C 
Plg  gene: plasminogen 
plt  gene mutations: paucity of lymph node T cells 
PLT  primary lymphoid organs 
PMSF  phenylmethylsulfonyl fluoride, serine protease inhibitor 
Poly(I)∙Poly(C)  polyinosinic-polycytidylic acid 
polySia  polysialic acid 
P.pastoris  yeast: Pichia pastoris 
PSGL-1  P-selectin glycoprotein ligand 1 
PtdIns(4,5)P2  phosphatidylinositol-4,5-bisphosphate 
Ptx  pertussis toxin 
PVDF  polyvinylidene fluoride 
R10/20  RPMI supplemented with glutamine, penicillin/streptomycin and 10% or 
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Rac  ras-related C3 botulinum toxin substrate 
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RPMI  Roswell Park Memorial Institute medium 
RT   room temperature 
SAP  shrimp alkaline phosphatase 
SCS  subcapsular sinus 
SDS  sodium dodecyl sulfate 
SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoresis 
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SEM  standard error of the mean 
SLO  secondary lymphoid organ 
SUMO  small ubiquitin-like modifier 
Sup  supernatant 
TAE  Tris-acetate-EDTA 
TBS  Tris buffered saline 
TD  thoractic duct 
TEMED  N,N,N',N'-tetramethylethylenediamine  
TFB  transformation buffer 
Th cell  T helper cell 
TIRF  total internal reflection fluorescence  
TNF  tumor necrosis factor 
Treg  regulatory T cell 
trunc.  truncated 
TSM  Tris-sucrose-magnesium buffer 
UAA  under-agarose migration assay 
VCAM-1  vascular cell adhesion molecule 1 
VLA4  very late antigen 4 
WT   wild-type 
XCL  C- or δ-chemokine 
XCR  C- or δ-chemokine receptor 
YPDS  yeast extract peptone dextrose medium with sorbitol 




In higher eukaryotes the immune system can be subdivided into the innate and the adaptive 
immune response. Innate immunity defends the host by non-specific mechanisms, whereas 
the adaptive response is specific to an antigen. During adaptive immune response antigens 
must be captured, transported and displayed to specific leukocytes, which leads finally to 
the generation of effector cells and high-affinity antibodies. The initiation of adaptive 
immunity depends on:  
- Dendritic cells (DCs) as the most important antigen-presenting cells  
- Secondary lymphatic organs (SLOs) and their micro-architecture facilitating successful 
DC-T cell encounters – a crucial step during adaptive immune response 
- Chemokines as leukocyte guidance and positioning cues 
I will focus here on the characteristics and tasks of DCs, their maturation process and how 
the infrastructure of lymph node (LN) and spleen can influence the immune response. 
Beyond that, I will give insights into the cytoskeletal organization during leukocyte migration 
and will summarize the current knowledge how chemokines influence leukocyte positioning 
and migration in SLOs. 
 
1.1 Dendritic cells (DCs) 
1.1.1 Functions of DCs 
DCs are specialized antigen-presenting cells that play a dual role in initiating the adaptive 
immune response to foreign antigens and maintaining self-tolerance. Most DCs are 
strategically positioned to sense and respond to invading pathogens. They can be found in 
all organs, which are exposed to the environment, like the skin or the gut, and SLOs. But 
differentiated DCs and their precursors also circulate in the blood from where they can be 
recruited to sites of infection (Alvarez, Vollmann & von Andrian, 2008). 
In mice all DCs express CD11c and major histocompatibility complex class II (MHCII) and 
can be further classified by the expression of CD11b, CD8α, CD4, PDCA-1, Langerin and a 
growing list of other markers. But the most fundamental distinction can be made between 
CD11chigh MHCII+ DCs (conventional DCs, cDCs) and interferon (IFN) producing CD11clow 
MHCII+/low DCs (plasmacytoid DCs, pDCs; Alvarez, Vollmann & von Andrian, 2008). 
Immature cDCs sample the peripheral tissue to collect antigenic material, which leads to cell 
maturation and migration to SLOs where they interact with naïve T cells. Naïve T cells scan 
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these migratory cDCs until they find one which presents MHCII-antigen complexes that 
matches to their individual T cell receptor. Successful encounter induces activation and 
proliferation of the cognate T cell, as well as differentiation into the adequate effector type 
(O´Shea & Paul, 2010). Another subtype of cDCs are lymphoid tissue resident DCs, which 
do not migrate in the lymph. Instead their function is restricted during their whole lifetime to 
one lymphoid organ, where they collect and present foreign as well as self-antigens 
(Shortman & Naik, 2007). pDCs mostly circulate in the blood and also access LNs via high 
endothelial venules (HEVs). These cells are responsible for sensing viruses and the release 
of high amounts of type 1 interferons. pDC-derived interferons modulate strength and quality 
of natural killer cell, T and B cell responses during viral infection (Ito, Wang & Liu, 2005).  
I will focus here on migratory cDCs and in the following text the terms `DC` and `migratory 
cDC` are used synonymously.  
 
1.1.2 DC maturation 
DCs express different cell surface receptors like Toll-like-, C-type-lectins, chemokine and 
cytokine receptors, which allow them to sense pathogen associated molecular patterns 
(PAMPs) and pro-inflammatory cytokines in their environment (Randolph, Angeli & Swartz 
2005). These signals initiate phenotypic changes: The maturating cells transport more 
antigen-MHCII complexes to the cell surfaces, become motile, develop dendrites, small cell 
extensions, and start to migrate into the next draining LN (Bancherau & Steinman, 1998). 
During migration the cells engage ligands, mainly chemokines expressed on the afferent 
lymphatics, which complete the maturation process (Figure 1; Marsland et al., 2005). These 
fully matured cDCs express T cell co-stimulatory molecules like CD80 and CD86 and 
secrete interleukins and type I interferons, which lead to generation of T helper cells (Th; 
Bancherau & Steinman, 1998). When DCs only sense cytokines without microbial signals, 
the cells collect and present self-antigens and remain in a semi-mature stage which leads to 
the induction of regulatory T cells (Treg; Randolph, Angeli & Swartz, 2005). 
Immature DCs express the chemokine receptors CCR1, CCR2, CCR5, CCR6, CXCR1 and 
CXCR2. Their ligands, inflammatory chemokines, guide the cells to pathogens or inflamed 
tissue. During the maturation process these chemokine receptors are down-regulated and 
instead CCR7 is induced. This process is also called `chemokine receptor switch` (Rot & 
von Andrian, 2004). CCR7 and its ligands CCL19 and CCL21 are the central guidance cues 
which direct mature DCs to the draining LN (Figure 1; Randolph, Angeli & Swartz, 2005). 




Figure 1: ´Chemokine receptor switch´. Immature DCs reside in peripheral tissues and express several 
chemokine receptors, which guide the cells to pathogens or inflamed tissue. After contact with pathogen 
associated molecular patterns (PAMPs) DCs undergo a maturation program. During this process these 
chemokine receptors are down-regulated and instead CCR7 is expressed on high levels. The CCR7 
ligands CCL19 and CCL21 guide the DCs to draining LNs, where they can drive naïve T cell activation. 
CCL19, CCL21 and other ligands expressed on afferent lymphatics provide further DC maturation 
signals, which lead to the expression of co-stimulatory molecules and the secretion of cytokines and 
interferons (taken from: Bachmann, Kopf & Marsland, 2006). 
1.2 Secondary lymphoid organs (SLOs) 
SLOs provide a specialized micro-environment to enable efficient encounters between 
different leukocyte subsets. I will focus here on the organization of LNs and the lymphoid 
tissue in the spleen, because here chemokine-dependent cell positioning is best investi-
gated.   
 
1.2.1 Spleen: Structure and Function 
The spleen is the body´s main blood filter and is situated in a prime position to capture 
blood-borne antigens and initiate an adaptive immune response against them. The spleen 
consists mainly of CXCL12 rich red pulp responsible for red blood disposal and discrete 
areas of lymphoid tissue surrounding the central arterioles, the white pulp. The white pulp is 
subdivided into CCL21 expressing T cell areas around central arterioles, also called 
periarteriolar lymphoid sheaths (PALSs), and globular CXCL13 expressing B cell follicles at 
the periphery of the T cell zones. The white pulp is surrounded by the marginal zone, where 
branches of central arterioles terminate. Therefore, the marginal zone forms an interface 
between the white pulp, the red pulp and the blood circulation  For that reason the marginal 
zone is an important site of antigen capture, where marginal zone macrophages and tissue 
resident splenic DCs encounter blood-borne antigens, apoptotic cells and microorganisms 
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(Figure 2; Mebius & Kraal 2005). Also incoming B and T cells enter the spleen at the 
marginal zone from where they migrate along bridging channels formed by stromal cells into 
the white pulp  Activated lymphocytes leave the spleen by entering the blood circulation 
again in the marginal zone (Villadangos & Schnorrer, 2007; Turley, Fletcher & Elpek, 2010). 
 
 
Figure 2: Structure of the spleen. The afferent splenic artery splits into several central arterioles. Each 
arteriole is surrounded by white pulp, which consists of a T cell zone (also called periarteriolar lymphoid 
sheath; PALS) and B cell follicles. The white pulp is surrounded by the so-called marginal zone, the 
interface between blood coagulation, red and white pulp, where tissue resident macrophages and DCs 
encounter blood-derived microorganisms and antigens. The arterioles end in the red pulp cords, which 
transport the blood to the venous sinus and subsequently into the collecting vein (adapted from: Mebius 
& Kraal, 2003).  
1.2.2 Lymph node: Structure and function 
To initiate the adaptive immune response an antigen-loaded DC must physically interact 
with a matching naïve T cell. The success rate of such interactions is extremely low, 
because the frequency of a naïve T cell recognizing a specific antigen is 1: 105 - 106 (Moon 
et al., 2007; Lämmermann & Sixt, 2008). SLOs, especially LNs, enhance the feasibility of 
this rare stochastic event. In LNs cell associated and soluble antigens from the periphery 
encounter circulating lymphocytes. Thus, LNs are a compact projection of the peripheral 
patch of tissue they drain. Besides that, LNs function as fluid filters inhibiting the systemic 
spread of pathogens and acting as the central regulators of fluid equilibration between 
interstitium and blood.  
Two main zones can be distinguished histologically in the LN: The cortex and the medulla. 
The medullary sinus consists of a labyrinth of lymph drainage vessels, which collect lymph 
and drain it into the efferent lymph vessel. Besides that, lymphocytes exit LNs through the 
medullary sinus. The surrounding medullary cords contains plasma cells, memory T cells 
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and to a smaller amount macrophages. The cortex can be further divided into the CCL21 
expressing paracortex or T cell area as well as the CXCL13 rich B cell zone, which consists 
of primary B cell follicles and after successful antigen engagement of germinal centers 
(Figure 3). The B cell areas are the centre of the humoral immune response, whereas in the 
T cell area DC-T cell-encounters take place (von Andrian & Mempel, 2003). DCs enter the 
LN via the afferent lymphatics and migrate around the B cell follicles into the deep T cell 
zone, where they position near high endothelial venules (HEVs) (Lämmermann et al., 2008; 
Miyasaka & Tanaka, 2004). The entry side of the afferent lymphatics in the LN is called 
subcapsular sinus (SCS) and is populated by resident cells, for example SCS macrophages 
(Lämmermann & Sixt, 2008). Via the afferent lymphatics not only cells, but the whole 
interstitial fluid including soluble antigens, intact microbes, particles of pathogens and 
extracellular signaling molecules like chemokines and cytokines enter the LN. In the blood 
stream circulating naïve T and B cells enter the paracortex via HEVs. The areas in proximity 
to HEVs therefore facilitate quick and efficient encounters between incoming T cells and 
waiting mature DCs (Miyasaka & Tanaka, 2004). HEVs are specialized postcapillary venules 
lined by high endothelial cells and are mostly located in the T cell area near the B cell 
follicles, an area also called cortical ridge (Figure 3; Katakai et al., 2004). The entry of DCs 
as well as of T cells is CCR7-dependent (Debes et al., 2005, Bromley et al., 2005).  
 
 
Figure 3: Lymph node (LN) organization. (A): LNs can be divided into the medulla (yellow) and the cortex, 
which consists of the T cell area (blue) and B cell follicles (purple). The blind-ending afferent lymph 
vessels collect the interstitial fluid and transport it to the subcapsular sinus (SCS) from where it can 
circulate directly to the efferent lymph vessel or enter the conduit system. The lymph flow is indicated 
with black arrows. (B)  Magnified picture detail of the T cell area: T and B cells enter LNs via high 
endothelial venules (HEVs), specialized blood vessels. HEVs are surrounded by a layer of fibroblastic 
reticular cells (FRCs). Besides that, FRCs form a network of reticular fibers and conduits, which channel 
lymph from the sinus into the HEVs (taken from: von Andrian & Mempel, 2003). 
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1.2.3 Stroma cell networks in SLOs 
Stroma cells in SLOs contribute to the immune response by providing chemokines, 
presenting antigen as well as adhesion molecules and acting as scaffold for leukocyte 
trafficking.  
The T cell zone of LNs consists to 95% of densely packed T cells. The residual space is 
captured by resident DCs and stroma cells. The stroma, the only non-hematopoietic, 
immobile component of this area, is formed by fibroblastic reticular cells (FRCs). The T cell 
stroma constitutes a filigree three-dimensional network that is reminiscent of the skeleton of 
a sponge. The FRCs secrete extracellular matrix (ECM) which associates to so-called 
conduits. These structures, varying in diameter from 200 nm and 3 µm, channel small 
molecules (<70 kDa, 20-200 nm in diameter (Manolova et al., 2008)) from the sinus through 
the T cell area into HEVs. Conduits persist of a loosely packed bundle of collagen (I, III) 
fibrils stabilized by molecules like fibromodulin and decarin which provide spaces between 
the fibrills to allow the passage of fluid and small soluble molecules. The collagen bundle is 
sheathed by various layers of microfibrills consisting of fibrillin and fibronectin. Finally, the 
fibrillar core is enwrapped by a basal membrane. FRCs produce these structures and at the 
same time sit on the basal membrane to seal 95% of it by close cell-cell-contacts (Figure 3 
B; Figure 4; Lämmermann & Sixt, 2008). On the remaining 5% resident DCs are closely 
associated with the FRC network scanning the fluid in the conduits for antigens thereby 
rapidly informed about the periphery (Figure 4; Hayakawa, Kobayashi & Hoshino, 1988).  
 
Figure 4: Composition and 
function of conduits in the 
LN. Lymph enters the LN 
via the afferent lymphatics 
and is transported via the 
sinus and conduits to 
HEVs. The conduits form a 
network and are partly 
decorated by resident DCs. 
The conduits consist of a 
loosely packed collagen 
core exhibiting space for 
lymph flow. The core is 
surrounded by a microfi-
brillar zone and a base-
ment membrane. This 
structure is enlaced by 
FRCs, which also secret 
the ECM components to 
build the inner conduit 
(taken from: Sixt et al., 
2005). 
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FRCs are the main producers of the chemokines CCL19 and CCL21, which bind to the 
chemokine receptor CCR7 (Luther et al., 2001; Carlsen et al., 2005; Link et al., 2007).  
CCL21 also seems to be associated with the surfaces of FRCs (Katakai et al., 2004). One 
potential CCL21 binding partner on FRCs is the proteoglycan podoplanin (Bekiaris et al., 
2007). Both FRC organization and CCL21 secretion are induced by interstitial lymph flow in 
the LN (Tomei et al., 2009). Additionally FRCs express the integrin ligands intercellular 
adhesion molecule 1 (ICAM1) and vascular cell adhesion molecule 1 (VCAM1) (Ma et al., 
1994, Xu et al., 2001). But the corresponding ligands lymphocyte function-associated 
antigen 1 (LFA1, αLβ2 integrin) and very late antigen 1 (VLA4, α4β1 integrin) on DCs or T 
cells, respectively, are not essential for their movement within the LN (Woolf et al., 2007; 
Lämmermann et al., 2008). Nevertheless, CCL21 influences the migration speed of T cells 
in the LN (Worbs et al., 2007; Okada & Cyster 2007; 1.3.3.3, p.25).  
Current data emphasize further immunological functions of FRCs: These stroma cells can 
also directly present antigens to naïve T cells and induce proliferation (Fletcher et al., 2010). 
Moreover, the FRCs regulate naive CD4+ and CD8+ T cell homeostasis by secreting 
interleukine (IL)-7 and CCL19 (Link et al., 2007; Turley, Fletcher & Elpek, 2010). Beyond 
that FRCs act as guidance structures for T cell migration, thus organizing random T cell 
swarming within the T cell zone (Bajenoff et al., 2006). DCs are also closely associated with 
FRCs network and might also use the stromal network for movement (Hayakawa, Kobayashi 
& Hoshino, 1988).  
The composition and organization of the FRC network in the splenic PALSs resembles the 
LN T cell area stroma very closely. Splenic conduits connect the central arteriole with the 
marginal zone. The splenic conduit system seems to distribute blood-borne and locally 
produced molecules to the PALSs. In contrast to LN conduits, the splenic conduits can 
channel larger molecules. Beyond that the homeostatic chemokines CCL21 and CXCL13 
can be found within the tubular system as well as on the fiber network (Nolte et al., 2003). 
In B cell follicles CXCL13 expressing follicular dendritic cells (FDCs) form a network in the 
center of the follicles in LNs, spleen and other lymphoid organs. FDCs appear morphologi-
cally similar to DCs due to numerous, thin dendrites, but are of non-hematopoietic, 
mesenchymal origin (Mueller & Germain, 2009). FDCs can directly capture antigens and 
present them to naïve B cells (Allen & Cyster, 2008). Beyond that, B cell migration was 
observed to be FDC guided, but also freely moving B cells without stromal association could 
be detected (Bajenoff et al., 2006; Suzuki et al., 2009). There is also a conduit system 
described in B cell follicles, which is less dense and shows reduced branching compared to 
T cell area conduits. These B cell follicle conduits channel antigens directly to naïve B cells 
(Pape et al., 2007; Roozendaal et al., 2009; Bajenoff & Germain, 2009). The origin of these 
conduits, if they are formed by FDCs or by remaining FRCs in the B cell areas, is not 
clarified yet (Roozendaal et al., 2009; Bajenoff & Germain, 2009). 
Beyond that, similar stromal cell networks are described in the splenic PALSs, the marginal 
zones in the spleen and underneath the SCS in LNs especially at the edges of B cell follicles 
(Nolte et al., 2003; Bajenoff et al., 2008). These stromal networks are formed by another 
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mesenchymal cell subset called marginal reticular cells (MRCs). MRCs express like FDCs 
CXCR13 and are able to form conduits delivering antigens directly from the SCS to B cells 
and FDCs (Katakai et al., 2008; Balogh et al., 2004; Roozendaal et al., 2009). 
 
1.3 Chemokines 
Chemokines (from „chemotactic cytokines“) are secreted proteins, 8 to 17 kDa in size, that 
function as the most important communication system of immune cells. Their main task is 
the regulation of leukocyte migration and positioning. But chemokines are also participating 
in processes like cell adhesion, cell differentiation as well as apoptosis and influence the 
proliferation and maturation of immune cells. Currently 43 chemokines are known in humans 
and mice. 
 
1.3.1 Chemokine classifications 
The protein family of chemokines is not defined by a common function, but by structural 
similarities. Nearly all chemokines exhibit four invariant cysteine residues, that form two 
cysteine bridges, one in between the first and the third residue, the second bridge in 
between the second and the forth cystein. The classification of chemokines in different 
subgroups depends on the relative position of the first two cysteins.  
Chemokines with a non-conserved amino acid in between the first two cysteins are known 
as CXC- or α-chemokines. This subgroup comprises 16 chemokines (systematic nomencla-
ture: CXCL1 to CXCL16). The second big subgroup are the CC- or β-chemokines, where 
the first two cystein residues succeed directly (CCL1 to CCL28, CCL9 and CCL10 are 
identical). CC-chemokines partly possess six cysteins, which can form three cysteine 
bridges (C6-CC: CCL1, 15, 21, 23, 28). The third subgroup consists of only one member, 
which is known as CX3C- or γ-chemokine, because it exhibits three amino acids between 
the first two cysteins (CX3CL1). The trivial name of this chemokine is fractalkine and in the 
chemokine family it is the only surface receptor with a transmembrane domain. There are 
two exceptions of the ´4-cysteine paradigm´, XCL1 and XCL2, which have only two cysteins 
and belong to the fourth subgroup of C- or δ-chemokines (Figure 5; Rot & von Andrian, 
2004). 
For chemokines a special folding structure was described, consisting of three anti-parallel β-
sheets and a carboxy (C)-terminal α-helix. A further structural similarity is the very flexible 
amino (N)-terminus, which lacks a fixed structure and is responsible for the receptor binding 
and activation (Figure 5; Figure 7; Frederick & Clayman, 2001).  
Chemokines can be further classified according to their expression pattern. Homeostatic 
chemokines are constitutively secreted and among other tasks guide leukocytes to 
Introduction   
23 
 
lymphatic organs. Moreover, homeostatic chemokines segregate lymphoid organ compart-
ments through spatially restricted expression. The expression of inflammatory chemokines 
on the other hand is limited to infections or pro-inflammatory situations, where they direct 
leukocytes to inflamed or injured tissue (Rot & von Andrian, 2004).  
 
 
Figure 5: Schematic depiction of the four chemokine subtypes. The flexible N- and C-termini are 
illustrated in irregular lines. The first three chemokine groups have an α-helix (purple jagged line) 
followed by three β-sheets (pink arrows), which are connected by loops. Green dashed lines indicate 
cysteine bridges. The CX3C-chemokine fractalkine is the only one with a mucin and a transmembrane 
domain. The structure of the C-chemokines is widely unknown and is therefore only indicated with a 
pointed line (taken from: Frederick & Clayman, 2001). 
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1.3.2 Inflammatory chemokines 
Inflammatory chemokines can be secreted by a great diversity of cells as a response to 
viruses, bacteria and physically damaging agents like silica or urate crystals. The secretion 
of inflammatory chemokines can be triggered by PAMPs, as well as endogenous molecules 
that are associated with infection and injuries, like elastase, defensines and fibrinogen. The 
expression of these chemokines can further be stimulated by inflammatory or immunomodu-
latory cytokines like IL-1, tumor necrosis factor (TNF)-α, INF-γ, IL-4, IL-5, IL-6, IL-13 and IL-
17. Inflammatory chemokines are typically ligands of the chemokine receptors CCR1, 
CCR2, CCR3, CCR5, CXCR2 and CXCR3. Besides the recruitment of DCs residing in the 
tissue, inflammatory chemokines also recruit monocytes, neutrophils and other effector cells 
from the blood to sites of infections (Rot & von Andrian, 2004). 
 
1.3.3 Homeostatic chemokines 
Homeostatic chemokines are constitutively produced in the healthy individual by specialized 
stroma cells and control homing, retention and motility of lymphocytes and DCs. During 
immune response lymphatic tissues transiently down-regulate the transcription of homeos-
tatic chemokines to regulate overall cellularity in SLOs (Mueller et al., 2007). Moreover, 
homeostatic chemokines, like CXCL12, CXCL13 and CCL21, are indispensable for SLO 
formation and organization. 
 
1.3.3.1 CXCL12 : Precursor retention in the bone marrow and localization of 
plasma cells in SLOs  
CXCL12 (also: stromal cell derived factor 1, SDF-1) is broadly expressed by stroma cells 
within bone marrow and many epithelial tissues. Six different isoforms of CXCL12 are 
described in humans, three in mice, which differ in their affinity towards proteoglycans. The 
exact organ specific expression patterns of the different CXCL12 splice variants are unclear 
(Rueda et al., 2008; Lortat-Jacob, 2009; Torres & Ramirez, 2009). Generally high CXCL12 
concentrations can be observed in splenic red pulp, LN medullary cords and the subepi-
thelial region of tonsils, but also in non-lymphatic tissues like gut, heart and brain (Har-
greaves et al., 2001; Casamayor-Palleja et al., 2001; Egawa et al., 2001). Deficiency in 
either receptor or ligand causes perinatal lethality because of severe defects in bone 
marrow homeostasis, gut vasculogenisis, heart and brain development (Egawa et al., 2001). 
CXCL12 serves as a chemoattractant and cell positioning guidance cue for naive B cells 
and T cells, special DC subsets, like Langerhans cells, and plasma cells, which all express 
the corresponding chemokine receptor CXCR4 (Hargreaves et al., 2001, Egawa et al., 2001, 
Kabashima et al., 2007). CXCR4-/- plasma cells transferred to wild-type (WT) recipients 
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accumulate adjacent to the white pulp or within the marginal zone (Hargreaves et al., 2001). 
In the LN CXCR4-/- plasma cells localize adjacent to follicles, at the perimeter of the medulla 
(Cyster, 2003). Furthermore, CXCL12-dependent cell sorting is responsible for the 
establishment of the dark zone of germinal centers, where maturating B cells and antibody-
producing plasma cells accumulate. In the bone marrow CXCL12 seems to function as a 
retention signal for precursor cells to avoid too early cell egress and thereby regulate 
hematopoietic cell homeostasis (Nagasawa et al., 1996). Besides that, CXCL12 is ex-
pressed on HEVs and promotes together with CCR7 ligands B cell attachment to HEVs 
(Okada et al., 2002).  
 
1.3.3.2 CXCL13: Organization of B cell areas in SLOs 
The main task of the homeostatic chemokine CXCL13 (also: B cell chemoattractant, BLC) is 
the guidance of naïve B cells into the B cell follicles of SLOs as convincingly shown with B 
cells deficient in the corresponding chemokine receptor CXCR5 transferred to WT reci-
pients. These CXCR5-/- B cells are detained in homing to B cell follicles in spleen and 
peyer`s patches and instead they are trapped in T cell zones (Okada et al., 2002; Förster et 
al., 1996). CXCR5 is also expressed on mature re-circulating B cells, subsets of CD4+ and 
CD8+ T cells and skin derived migratory DCs (Förster et al., 1994; Saeki et al., 2000).  
CXCL13 is produced by MRCs in the subcapsular region of the follicle and in the centre of 
the follicle by FDCs (Cyster et al., 2000; Katakai et al., 2008). In addition to that, the 
formation of the germinal center light zone, where activated B cells undergo affinity-
maturation, depends on CXCL13 expression by FDCs (Cozine, Wolniak & Waldschmidt, 
2005). The motility of GC B cells is significantly reduced in CXCR13-/- mice (Allen et al., 
2007). CXCL13 can bind to heparin sulfates and collagen and is therefore found to be 
concentrated on collagen fibers and stromal cells like FDCs (de Paz et al., 2007; Yang et al., 
2007; Nolte et al., 2003). In CXCR5-/- and CXCL13-/- mice up to 95% of all peripheral LNs 
and peyer´s patches are lacking. In the residual SLOs the characteristic highly organized B 
cell follicles are missing. The resulting rudimentary B cell enriched areas exhibit only poorly 
demarked borders between B cell rich areas and T cell zone and lack the typical FDC 
network. Therefore, in these organs B cells are located in the outer regions of lymphoid 
tissue forming a ring around the T cell areas (Förster et al., 1996; Ansel et al., 2000).  
 
1.3.3.3 CCL19 and CCL21: Organization of T cell areas in SLOs 
CCL19 (also: ELC, MIP-3 , CK 11, Exodus3) and CCL21 (also: SLC, 6Ckine, Exodus 2, 
TCA-4) are both ligands of the chemokine receptor CCR7. They are likely of similar structure 
and have comparable binding constants towards CCR7 (Frederick & Clayman, 2001; 
Yoshida et al., 1998; Pilkington et al., 2004). The two CCR7 ligands also bind to CC-X-
chemokine receptor (CCX-CKR), a so-called interceptor (Gosling et al., 2000). Interceptors 
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show no chemokine receptor signaling, but instead scavenge chemokines from extracellular 
spaces (Comerford et al., 2006; Heinzel, Benz & Bleul, 2007). Both chemokines stimulate 
endocytosis and antigen presentation by DCs and induce a pro-inflammatory differentiation 
program in semi-mature DCs on their way to draining LNs (Yanagawa & Onoe, 2003; 
Marsland et al., 2005; 1.1.2, p.16). However, these two homeostatic chemokines also exhibit 
considerable differences. 
CCL21 is produced by FRCs and in mice also by HEVs (Link et al., 2007; Carlsen et al., 
2005). Additionally FRCs express CCL19, but at a 100-fold lower level (Luther et al., 2001; 
Link et al., 2007). Beyond that, monocytes, macrophages as well as several maturated DC 
subsets are an accessory source of CCL19 (Figure 6 A; Sallusto et al., 1999; Cyster, 1999; 
Luther et al., 2000). In mice the gene locus encoding the two CCR7 ligands was duplicated 
during evolution. By point mutation two functional CCL21 variants developed out of two 
CCL21 genes, which only differ in amino acid 65, where one CCL21 exhibit a serine 
(CCL21-Ser), the other one a leucine (CCL21-Leu). CCL21-Ser is expressed in lymphoid 
organs, CCL21-Leu in lymphatic vessels and also in non-lymphatic organs like lung, colon, 
stomach, heart and skin (Gunn et al., 1998). In contrast to that, only one CCL21 variant 
persists in humans (Vassileva et al., 1999). Even though the whole gene locus encoding 
both CCR7 ligands was duplicated, only one functional CCL19 gene exists. The duplicated 
CCL19 gene exhibits a mutated stop codon which prevents protein expression (Nakano & 
Gunn, 2001).  
In a naturally occurring strain of mutant mice the locus coding for CCL21-Ser and the active 
copy of CCL19 is deleted. The mutation called ´paucity of lymph node T cell´ (plt) results in a 
loss of CCL21 and CCL19 expression in SLOs (Vassileva et al., 1999; Mori et al., 2001; 
Nakano & Gunn 2001; Figure 6 B). In plt/plt mice the homing of DCs as well as naïve T cells 
to SLOs and thymus is impaired. Only a few maturated DCs accumulate in the SCS of LNs 
without reaching the T cell area (Gunn et al., 1999; Marsland et al., 2005). Therefore, T and 
B cell priming occurres in plt/plt mice mainly in superficial cortical areas of LNs (Junt et al., 
2002). Due to impaired T cell homing to the thymus as well as to all SLOs T cell numbers 
are impaired and no clear T cell zones are detectable (Misslitz et al., 2004; Nakano et al., 
1997; Nakano et al., 1998). Due to these defects T cell development is disturbed, especially 
the establishment of self-tolerance is impaired. Plt/plt mice have therefore a delayed 
adaptive immune response and develop multi-organ autoimmunity (Kurobe et at., 2006; 
Nitta et al., 2009; Förster, Davalos-Misslitz & Rot, 2008). 
 





Figure 6: Expression pattern of CCR7 ligands in LNs. (A) CCL21-Leu is expressed in the initial 
lymphatics. Whereas the second CCL21 variant CCL21-Ser can be found in the terminal subcapsular 
sinus (SCS) lymphatics as well as in the LN T cell area. The CCL21 variant expressed in collecting 
vessels is not identified yet. CCL19 is like CCL21-Ser secreted by the stromal cells in the T cell zone but 
in much lower amounts. In addition to that, many hematopoietic cells like mature DCs produce CCL19. 
(B) In plt/plt mice only CCL21-Leu is expressed in the initial lymphatics. Mature DCs are not able 
anymore to enter the T cell area, instead the cells accumulate in the SCS (taken from: Randolph, Angeli 
& Swartz, 2006).  
A unique feature of CCL21 is its elongated C-terminus consisting of 32 amino acids 12 of 
which are basic. The CCL21 C-terminus facilitates binding to negatively charged proteins, 
like glycosaminoglycans (GAGs) of the heparan and chondroitin sulfate subgroups (Hirose 
et al., 2001; Hirose et al., 2002; Ueno et al., 2002; Uchimura et al., 2006). In contrast to that, 
CCL19 interacts only weakly with GAGs and remains therefore predominantly soluble (de 
Paz et al., 2007). CCL21 immobilization might be required for efficient chemokine presenta-
tion on endothelial cells and potentially FRCs to DCs and T cells (Yoshida et al., 1998; Gunn 
et al., 1998; Stein et al., 2000; Ueno et al., 2002; Bao et al., 2010; 1.3.4, p. 28). CCL21 
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expressed by FRCs influences the migration speed of T cells in the LN. In plt/plt mice a 30% 
reduction in velocity could be measured (Worbs et al., 2007; Okada & Cyster 2007). By 
intravenous application of CCL21 the migration velocity can be restored. CCL19 was not 
tested in this experimental setup (Worbs et al., 2007). Thus, continuous CCL21-signaling 
seems to drive T cell motility. It is still under discussion if immobilized CCL21 covers the T 
cell area homogenously or exhibits a higher concentration in the center of the T cell zone. 
Okada et al. (2005) observed a CCL21 gradient extending from the T cell zone into the B 
cell follicle.  
Beyond that CCL21 is very efficient in the induction of tertiary lymphoid organs. When 
CCL21 is artificially introduced into tumor tissue or pancreatic islets, the chemokine entails 
large, highly organized infiltrates including HEVs and a complex stromal cell network. The 
infiltrates recapitulate the architecture of SLOs. CCL19 is less capable in recruiting cells in 
these experimental setups; the infiltrates are less organized and DCs, T and B cells are 
frequently interspersed (Nomura et al., 2001; Luther et al., 2001). Apart from these features 
CCL21 also increases T cell interactions with DCs and promotes immune responses by co-
stimulating T cell activation and proliferation (Friedmann, Jacobelli & Krummel, 2006; 
Flanagan et al., 2004).  
Surprisingly CCL19-/- mice have no gross abnormalities in T cell migration and positioning 
(Link et al., 2007). Furthermore, DC migration, maturation and function occur normally in the 
absence of CCL19. CCL21 alone is sufficient to fulfill these functions (Britschgi et al., 2010). 
After CCR7 binding both chemokines induce signaling, but only CCL19 also effectively 
stimulates CCR7 phosphorylation and internalization subsequently leading to receptor 
desensitization and degradation. Following receptor binding almost 4 times more CCL19 
than CCL21 is internalized. When the endocytosis of CCL19 is blocked, DCs cannot migrate 
towards a CCL19 source anymore (Otero, Groettrup & Legler, 2006; Byers et al., 2008). 
Beyond that also the interceptor CCX-CKR, which scavenges the CCR7 ligands from 
extracellular spaces, internalizes CCL19 much more efficiently than CCL21 (Comerford et 
al., 2006, Heinzel et al., 2007). Another unique feature of CCL19 is that it transforms the 
morphology of mature DCs. The chemokine evokes extension and probing of dendrites of 
DCs thereby potentially leading to a more efficient interaction of DCs with naïve T cells 
(Yanagawa & Onoe, 2002). Moreover, CCL19 promotes much more efficient T cell 
emigration from explanted thymus slices compared to CCL21. But by removing the C-
terminal tail of CCL21 the chemokine gains this function of CCL19 and T cell egress could 
be restored (Ueno et al., 2002). 
 
1.3.4 Chemokine immobilization on proteoglycans 
The structure of chemokines influences their mode of presentation and distribution within 
tissues or extracellular matrix. Chemokines are secreted proteins, but many of them can 
Introduction   
29 
 
bind to proteoglycans (also: glycoproteins). Proteoglycans consist of a core protein with one 
or more covalently attached GAG chains. GAGs are long unbranched polysaccharides 
consisting of a repeating disaccharide unit and can be divided into six subgroups: Chondroi-
tin sulfates, dermatan sulfates, keratin sulfates, heparan sulfates, heparin and hyaluronan. A 
common feature of GAGs is their negative charge due to the high amount of sulfate- and 
carboxyl-groups, so they can interact with basic proteins, as for example chemokines. But 
chemokine-GAG interactions do not exclusively depend on overall electrostatic interactions; 
chemokines selectively bind specifically functional domains of GAGs (Kuschert et al., 1999; 
Witt et al., 1994; Patel et al., 2001). Most chemokines exhibit heparan sulfate (HS) binding 
sites (Amara et al., 1999; Santiago et al., 2006). HS comprise 95% of the proteoglycans and 
are composed of alternating α-linked N-acetyl- or N-sulfo-glucosamine and α/β-linked 
hexuronic acid. The predominant heparan sulfate proteoglycans on cell membranes are 
transmembrane syndecans and GPI-anchored glypicans (Handel et al., 2005). Many 
homeostatic chemokines interact with GAGs: CCL21 immobilize with its C-terminus on 
heparan and chondroitin sulfates (Hirose et al., 2001; Hirose et al., 2002; Uchimura et al., 
2006; Rot und von Andrian, 2004; Miyasaka und Tanaka, 2004). Binding to these GAGs 
mediate for example the CCL21 immobilization on the proteoglycans P-selectin glycoprotein 
ligand-1 (PSGL-1), which is expressed on white blood cells and endothelial cells (Veerman 
et al., 2007). Beyond that CCL21 immobilizes to podoplanin (also: gp38), which is ex-
pressed on lymphatic endothelial cells as well as on FRCs and potentially presents CCL21 
to DCs (Breiteneder-Geleff et al., 1999; Kriehuber et al., 2001; Pegu et al., 2007; Bekiaris et 
al., 2007). CCL21 binds furthermore to ECM proteins like collagen IV, MAC25 and to 
basement membranes of HEVs (Miyasaka und Tanaka, 2004). CXCL13 binds to heparin 
sulfates as well as to collagen fibers. Potentially these interactions facilitate the immobiliza-
tion of CXCL13 on FDCs in B cell follicles in vivo (Cyster et al., 2000, Nolte et al., 2003). For 
the germinal center chemokine CXCL12 three different isoforms with widely divergent HS 
binding capacities are published. CXCL12γ for example can form one of the most stable 
GAG-chemokine complexes (Rueda et al., 2008; Lortat-Jacob, 2009). In vitro many 
chemokines can also be immobilized on artificial substrates like polycarbonate membranes 
(Kohrgruber et al., 2004).  
The immobilization of chemokines on GAGs has several functions: Through binding GAGs 
can store, protect from degradation or limit the distribution of chemokines. GAGs enhance 
for example the local chemokine concentration on endothelial cells that line the interior of 
blood and lymph vessels; without such a mechanism chemokine accumulation would be 
disrupted by the shear forces of blood or lymph flow (Ali et al., 2000). Immobilized chemo-
kines on endothelial cells are a prerequisite for leukocyte extravasation, the movement from 
blood capillaries into the surrounding tissue. Before the cells can squeeze through the 
endothelial cell layer, integrins on the leukocyte´s surface must be activated by surface-
bound chemokines to allow tight adhesion to capillaries‟ walls (Ley et al., 2007; Shamri et 
al., 2005). Immobilized CCL21 on vascular and lymphatic endothelia is for example a 
prerequisite for efficient B and T cell recruitment to SLOs (Bao et al., 2010; Shamri et al., 
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2005). Hirose et al. (2002) showed that immobilization of CCL21 on heparan sulfates 
supports integrin activation, whereas CCL21 binding to chondroitin sulfates prevents integrin 
activation and signaling. Proudfoot et al. (2003) further sustained the in vivo relevance of 
chemokine immobilization followed by chemokine oligomerization with an elegant in vivo 
peritoneal recruitment assay. Non-GAG binding chemokine mutants were unable to induce 
cell recruitment. The same result was observed with mutants that were not able to form 
higher-order oligomers. It is unclear if GAG-bound chemokines can signal through G 
protein-coupled receptors (GPCRs) or if they first have to dissociate from the receptor 
(Proudfoot et al., 2003). In vitro chemokine function is independent of chemokine binding to 
or oligomerization on GAGs (Paavola et al., 1998, Proudfoot et al., 2003). 
Therefore, chemokine immobilization in particular microenvironments can be influenced by 
the expression pattern of GAGs. In interstitial spaces GAG binding may create immobilized 
chemokine gradients. But evidence for the existence of continuous chemokine gradients in 
vivo is scarce, due to difficulties of visualizing chemokines in vivo (McDonald et al., 2010). 
Another possibility is that GAG-binding supports the establishment of immobilized chemo-
kines shape fields (Pelletier et al., 2000). Also the release of GAG-bound chemokines for 
example by proteolytic shedding is possible. But the system is even more complex because 
also GAGs can be soluble, surface bound or be degraded to soluble ectodomains (Handel 
et al., 2005). Thus, chemokines can also be immobilized on soluble GAGs. The binding of 
chemokines to GAGs is maybe another level of regulation and may result in fine-tuning 
migration, localization and activation of leukocytes (Hoogewerf et al., 1997; Rot, 1993; 
Middleton et al., 1997). 
 
 
1.3.5 Chemokine receptors  
Chemokines bind to G-protein coupled receptors (GPCRs) with seven transmembrane 
domains, which transmit the signal into the cell. Chemokine receptors consist of a single 
polypeptide chain with three extra and three intracellular domains, an acidic N-terminal, 
extracellular domain as well as a serine/threonine-rich intracellular C-terminus. Together the 
extracellular protein domains specify the ligand recognition. The cytoplasmic protein loops 
and the C-terminal domain are responsible for signaling and receptor internalization (Figure 
7). Ligand binding induces allosteric changes in the tertiary structure of the chemokine 
receptor, which then allows binding and activation of heterotrimeric G-Proteins, consisting of 
an α- β- and γ-subunit, on the intracellular domains. Activated G-proteins exchange 
guanosine-5'-diphosphate (GDP) for guanosine-5'-triphosphate (GTP) followed by the 
dissociation into an α- and a βγ-subunit. The βγ-subunit activates phosphoinositide-3 kinase 
(PI3K) which in turn produces phosphotidylinositol-3,4,5-trisphosphate (PIP3). PIP3 induces 
the activation of the small GTPase Rac that subsequently leads to the activation of the actin 
nucleating and elongating factor actin related protein 2/3 (Arp2/3) thereby enhancing actin 
polymerization (Rot & von Andrian, 2004; Thelen & Stein, 2008). Chemokine receptors can 
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couple to different Gα subunits, but the most significant are pertussis toxin sensitive Gαi 
subunits (Rot & von Andrian, 2004). Gαi subunits inhibit adenylate cyclase, activate a variety 
of phospholipases and phosphodiesterases, and promote the opening of several ion 
channels (Birnbaumer, 2007). Pertussis toxin keeps Gαi in a GDP-bound, inactive state, 
prevents binding to the chemokine receptor and thereby inhibits GPCR-dependent signaling 
(Smrcka, 2008). 
 
Figure 7: Chemokine-chemokine receptor interac-
tion. Chemokines can bind as soluble molecules to 
the chemokine receptor or be presented by glyco-
saminoglycans (GAGs) to the receptor as shown 
here. Chemokines posses a glutamate-leucine-
arginine motif (ELR) in their flexible N-terminus, 
which interacts with the N-terminus of the recep-
tor. Chemokine receptors exhibit seven transmem-
brane domains and three conserved sequence 
motifs that are important for signal transmission: 
An aspartate-residue followed by a threonine-X-
proline-motif (TXP, X: any amino acid) in the 
second transmembrane domain and between the 
second intracellular loop and the third transmem-
brane domain a aspartic acid-arginine-tyrosine 
motif (DRY; taken from: Mantovani, Bonecchi & 





Currently 19 chemokine receptors are known: 11 CC-chemokine receptors (CCR1 to 
CCR11), 6 CXC-chemokine receptors (CXCR1 to CXCR6), one C-chemokine receptor 
(XCR1) and finally one CXC3-chemokine receptor (CX3CR1). 
 
1.3.6 CCR7: Guidance of mature DCs 
The chemokine receptor CCR7 is expressed in semi-mature and mature DCs, thymocytes 
during defined development stages, naïve B and T cells, Treg cells, central memory T cells 
(TCM) and also in non-lymphoid cell types for example in various malignancies (Ohl et al., 
2004; Misslitz et al., 2004; Reif et al., 2002; Sallusto et al., 1999; Szanya et al., 2002; 
Schneider et al., 2007; Shields et al., 2007).  
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The CCR7-/- mice exhibit only a weak and delayed adaptive immune response due to 
alterations in the micro-architecture of the thymus as well as of SLOs: In the paracortical 
areas of LNs, Peyer´s patches and the white pulp of the spleen T and B cell areas are not 
clearly separated. The medullary areas of the thymus are smaller, but more numerous and 
located to the outer rim of the organ. Instead the mice develop ecotopic lymphoid aggre-
gates in mucosal sites like lungs, stomach and intestine with well segregated B and T cell 
zones as well as HEVs. These morphological changes are due to impaired cell homing and 
positioning in SLOs. CCR7-/- mice show impaired migration of DCs form the skin, lung and 
the intestine to draining LNs. LN homing and positioning of naïve T cells, TCM and Treg cells 
is also strongly impaired, which results in LNs and Peyer´s patches that are largely devoid of 
T cells, which accumulate instead in the red pulp of the spleen. Due to the disturbed thymic 
architecture T cell development and maturation is hindered  which leads on one hand to a 
delayed adaptive immune response and on the other hand to impaired central and 
peripheral tolerance. Ineffective tolerance to self antigens causes the development of multi-
organ autoimmunity in CCR7-/- mice (Förster et al., 1999; Förster, Davalos-Misslitz & Rot, 
2008). 
 
1.4 Chemokine guided migration in the immune system 
Leukocyte trafficking is indispensable for innate and especially adaptive immunity. Chemo-
kines are the main guidance cues in the immune system and responsible for leukocyte 
migration and positioning. Here, I will discuss how the presentation mode of chemokines 
influences cells and the current knowledge about chemokine-dependent directional and non-
directional migration in vivo. 
 
1.4.1 Leukocyte trafficking 
A number of discrete migration processes can be described for leukocytes: The exit of 
progenitors, committed and differentiated cells from the primary lymphoid organs, thymus 
and bone marrow, into the blood circulation; the extravasation from the blood vasculature 
into target tissues or SLOs; crawling within interstitial tissues to scan for antigens; the entry 
into lymph vessels after antigen encounter to reach draining LNs and the exit from SLO by 
entering the blood circulation again (Figure 8; Alvarez, Vollmann & von Andrian, 2008).  
All these processes depend to certain extends on chemokines. Some of these migration 
events like the directional migration towards LNs implicate the existence of chemokine 
concentration gradients (Lämmermann et al., 2008; Pflicke et al., 2009). Whether these 
gradients are soluble or immobilized is indistinct till now. The extravasation of leukocytes on 
the other hand is controlled by immobilized chemokines, as mentioned before. But in most of 
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Figure 8: Trafficking routes of leukocytes. Leuko-
cytes originate from precursors in primary lympho-
id tissues (PLTs) like the bone marrow or the thy-
mus. Precursor or committed cells enter the blood 
circulation to migrate to peripheral tissues and 
SLOs. After antigen encounter in the periphery DCs 
migrate via afferent lymphatics to draining LNs. B 
and T cells enter SLOs directly from the blood 
stream. Leukocytes leave SLOs via efferent lym-
phatics followed by entering the blood circulation 
again via the thoractic duct (TD; taken from: Alva-




1.4.2 Cell migration modes 
How cells migrate, random or directed, adhesive or non-adhesive, depends on the activation 
state of its integrins and in which form chemokines are presented to the cell. Activated 
integrins on cell surfaces define the cells` capability to position and migrate in specific 
environments. This migration mode has been termed haptic. Haptic movement is strictly 
confined to a preformed path because the immobilized integrin-ligands act as mechanical 
anchor. The best characterized stimuli for integrin activation on leukocytes are GAG-bound 
chemokines (Ley et al., 2007; Shamri et al., 2005; Bao et al., 2010). If chemokine immobili-
zation is always a prerequisite for integrin activation on leukocytes is unclear. Random 
adhesive migration in a homogenous chemokine field is termed haptokinesis. Haptotaxis 
describes the migration along concentration gradients of extracellular ligands. Leukocytes 
have the unique capability to migrate within confined three-dimensional environments like 
the interstitium of mesenchymal tissues without using transmembrane force coupling via 
integrins. Such integrin-independent movement can be triggered in vitro by soluble 
chemokines. In a homogenous, soluble chemokine field the cells show chemokinesis, 
random migration, whereas the cells perform chemotaxis, directional migration, in a soluble 
chemokine concentration gradient (Lämmermann et al., 2008).  
Available experimental data from SLOs only allow the distinction between random, kinetic 
and directional, tactic motility. If haptic interactions with other cells or the ECM take place, 
cannot be distinguishes in these experiments due to technical limitations like microscopically 
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resolution or experimental design, which often does not visualize the surrounding cells or 
ECM.  
 
1.4.3 Evidence for kinesis 
A homogenous chemokine distribution results in a random locomotion pattern. The 
corresponding in vivo cell migration pattern is also often described as cell “swarming”, 
because the cells scan their environment, especially other immune cells, in a non-directional 
way (“stochastic model”) (Asperti-Boursin et al., 2007; Okada and Cyster, 2007; Worbs et 
al., 2007). Chemokine dependent, kinetic swarming behavior is described for many 
leukocytes. Dermal DCs for example continuously crawl through interstitial spaces in the 
skin in a Gαi dependent manner, the responsible chemokines are not determined yet (Ng et 
al., 2005). Another example are double-negative as well as double-positive CXCR4 
expressing thymocytes, which are confined to thymic cortex where they move slowly without 
directional bias (Witt et al., 2005; Ehrlich et al., 2009). Furthermore, after entry into lymphoid 
organs T and B cells localize to their distinct areas and show a random migration pattern 
within their specific zone (Miller et al., 2002; Miller et al., 2003; Wei et al., 2005). But the 
random migration is still organized. The three-dimensional scaffolds of T cell area FRCs and 
the B cell area FDCs represent tracks along which T and B cells migrate, a phenomenon 
that has been described as “guided randomness” (Bajenoff et al., 2006; Mempel et al., 
2006). Mechanistically, it was suggested that CCL21 and CXCL13 immobilized on the 
stroma surface might form a kinetic scaffold that keeps the cells motile (Bajenoff et al., 2006; 
Bajenoff et al., 2008; Roozendaal et al., 2009).  
 
1.4.4 Evidence for taxis 
During adaptive immune response leukocyte subsets accumulate in distinct regions within B 
or T cell areas or perform directed migration to converge and interact with each other. These 
observations can only be explained with the assumption of graded guidance cues which 
direct the cells. It is possible to correlate chemokine receptor levels with accurate cell 
positioning in lymphoid organs. Here, the cells show responsiveness to two chemokines and 
distinct thresholds of chemokine receptors which guide the cells to positions where the 
attraction to both chemokines is balanced. These experiments were mainly carried out either 
in static tissue sections or in engineered two-dimensional microenvironments (Randolph et 
al., 1999; Ansel et al., 1999; Hardtke et al., 2005; Ricart et al., 2010). Until now it was not 
possible to visualize chemokine gradients in lymphatic tissue. Thus, it remains speculative if 
long range chemotactic gradients in vivo exist, but it would be a plausible explanation for the 
experimental data I will discuss here. I focus here on data derived from spleen and LNs, 
because they have been most extensively studied, harbor similar cell subsets and feature 
matching basic structures. 
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Activated T cells differentiate into cytokine secreting effector cells for example into diverse 
Th cell subtypes. Th1 cells maximize the killing efficiency of macrophages and the prolifera-
tion of cytotoxic CD8+ T cells, whereas Th2 cells mainly stimulate B cell class switching and 
antibody maturation (Zhu & Paul 2010; Paul & Zhu, 2010). In the spleen CCR7 expressing 
naïve T cells and Th1 cells localize to the deep T cell areas, whereas Th2 cells which lack 
CCR7 home in close proximity to B cell follicles, where they can get into contact with naïve 
B cells (Randolph et al., 1999). To finally enter CXCL13 producing B cell follicles activated T 
cells further upregulate CXCR5 (Ansel et al., 1999; Hardtke et al., 2005). Simultaneously, 
after antigen-binding B cells upregulate CCR7 followed by migration to the B cell-T cell area 
edge to gain T cell help (Reif et al., 2002). After successful B cell stimulation germinal 
centers are established within the B cell follicle. Germinal center organization is based upon 
sorting CXCL12 sensitive maturating B cells and antibody-producing plasma cells into the 
so-called dark zone and B cells, which carry already their specific antibody on their surface, 
into the CXCL13 expressing light zone to undergo affinity maturation (Allen et al., 2004; 
Hargreaves et al., 2001). Moreover, it was demonstrated that also DC subsets are spatial 
separated by graded chemokine receptor expression in the LN: Dermis derived DCs express 
CXCR5 and localize in proximity to B cell follicles. On the other hand only CCR7 expressing 
epidermal DCs settle strictly in the deep T cell area (Kissenpfennig et al., 2005; Saeki et al., 
2000; Wu & Hwang, 2002).  
With the help of confocal or two-photon intravital microscopy directional cell migration could 
be observed in unfixed tissue slices and living animals. For example during maturation DCs 
migrate directionally towards efferent lymphatics followed by directed movement towards the 
T cell area (Pflicke and Sixt, 2009; Sen et al., 2010). Furthermore, activated B cells start to 
upregulate CCR7 and move then directionally towards the boundary between T and B cell 
area (Okada et al., 2005). Leukocytes also perform directional migration in vivo when they 
are exposed to artificially applied soluble gradients (Worbs et al., 2007; Khandoga et al., 
2009). T cells for example can glide into the SCS when exposed to artificial CCL19 
gradients (Worbs et al., 2007). Besides that, microinjection of chemoattractants into the 
murine cremaster muscle induces polarization and directional interstitial migration of 
neutrophils and monocytes towards the locally administered stimuli (Khandoga et al., 2009).  
 
1.4.5 Leukocytes as chemotactic organizers  
Leukocytes are not only guided by chemotactic gradients; recent studies have provided 
evidence that they can actively manipulate or generate chemotactic gradients during 
inflammatory conditions. For instance skin-derived DCs secrete CCL22 and can thereby 
attract recently activated CD4+ T cells to promote further stimulation (Tang and Cyster 
1999). Furthermore, neutrophil-derived CCL3 is essential for the rapid recruitment of 
immature DCs to the site of Leishmania major inoculation to induce adaptive immunity 
(Charmoy et al., 2010). Such a behavior could also be monitored in vivo via two photon 
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microscopy. In with Toxoplasma gondii infected LNs neutrophil swarms could be observed 
initiated by cooperative action of neutrophils. The correlation between size and persistence 
of the swarms suggests that the neutrophils themselves generate a gradient for swarm 
formation, which is likely mediated by CXCL8 and CXCL1 (Chtanova et al., 2008). Moreo-
ver, the chemokines CCL3 and CCL4 are released following productive interactions 
between CD4+ T cells and DCs in the reactive LN to recruit CD8+ naïve T cells and rapidly 
induce cytotoxic immune response (Castellino et al., 2006).  
 
1.5 Cytoskeleton of migrating leukocytes 
The migratory properties of leukocytes are indispensable for innate and adaptive immune 
responses. The migration speed of leukocytes lies in the range of 10 - 40 μm per minute 
which is for example more than ten times faster as the migration of fibroblasts (Friedl, 
Borgmann & Bröcker, 2001; Friedl & Weiglin, 2008). On their way leukocytes encounter a 
multitude of different environments as they can invade almost all tissues. These features 
imply unique properties of the cytoskeleton in rapid migrating leukocytes in comparison to 
slowly migrating cells of epithelial or mesenchymal origin which are restricted to distinct 
tissues. In these slow cell types the force of the actomyosin system has to be mechanically 
transduced to the extracellular environment via transmembrane receptors of the integrin 
family. Thus migration always relies on cell adhesions. But a number of recent studies 
demonstrated that in leukocytes, adhesion and migration can occur independently 
(Lämmermann et al., 2008).  
 
1.5.1 Basal mechanisms of leukocyte migration 
The course of events during mesenchymal and epithelial cell migration is normally described 
as followed: First, the leading edge of the cell expands generating a protrusion. The front 
side of this protrusion attaches to the extracellular substrate subsequently followed by 
contraction of the actin-myosin network resulting in the movement of the whole cell body. 
Finally adhesion sites in the rear of the cell are weakened leading together with the actin-
myosin contraction to the detachment of the cell back. The transmission of intracellular 
forces to the environment, also called traction, by adhesive interaction is a prerequisite for 
locomotion in these cell types. 
Leukocytes, as amoeboid cells, are independent of adhesive interactions in three-
dimensional environments, potentially because the can convey traction by inserting 
protrusion into the fibrillar ECM network, which provides physical foothold (Lämmermann et 
al., 2008). This migration mode is also called ´chimneying` (Figure 11). Amoeboid cells 
(termed after the protozoon Amoeba proteus: amoibe after the Greek word for „change‟ and 
Proteus after the Greek `god of change`) have in common that they undergo rapid shape 
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changes during migration at which cell deformation is generated by the actin-myosin 
cytoskeleton. The proportion of myosin and actin can widely diverge during amoeboid 
motility. This morphological term integrates different biophysical migration modes from 
contraction-dependent blebbing motility to complete actin polymerization-based gliding 
(Lämmermann & Sixt, 2009).   
 
1.5.2 Force generation: Actin-myosin interactions 
The movement of the actin cortex as well as the intracellular force generation strictly 
depends on actin polymerization and the action of myosin II. 
 
 
Figure 9: Actin treadmilling. Actin monomers assemble into polar filaments with a (+) and a (-) end which 
consists of two parallel protofilaments twisted in a right-handed helix. ATP-actin binds to the barbed (+) 
end and subsequently hydrolyzes by its ATPase function the bound ATP and releases phosphate. The 
remaining ADP-actin has a lower affinity to the filament and is subsequently released from the slower 
growing pointed (-) end. ADP is substituted against ATP supported by the cyclase associated protein 
(CAP) complex to generate again ATP-actin monomers. The transport of ATP-actin to the (+) end and the 
release of ADP-actin from the (-) end is assisted by profilin and cofilin, respectively (taken from: Baum et 
al., 2006). 
The 43 kDa protein actin is one of the most abundant proteins in eukaryotic non-muscle 
cells. Actin can assemble to filaments, also called microfilaments, and operates besides 
microtubuli and intermediate filaments as the main cytoskeletal structure. Actin monomers 
always assemble head-to-tail resulting in a polar filament with a (+) and a (-) end which 
consists of two parallel protofilaments twisted in a right-handed helix. The subsequent 
addition of actin monomers is feasible on both ends of the filament, but in most cases the 
binding of adenosine-5'-triphosphate (ATP)-actin monomers at the (+) end is favored. The 
ATPase function of actin subsequently hydrolyzes ATP and releases the phosphate-group. 
Hydrolysis does not occur directly, but rather with a lag of time after integration of the 
monomer into the filament. The generated adenosine-5'-diphosphate (ADP)-actin monomers 
disassemble from the slower growing ´pointed´ (-) end of the microfilament. Afterwards ADP 
is replaced by ATP preparing the monomers for another round of polymerization. These 
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features together with the lower affinity of ADP-actin to filament ends than ATP-actin result in 
the so-called ´actin treadmilling´. Treadmilling is the balanced process of actin assembly at 
the (+) and disassembly at the (-) end (Figure 9; Baum et al., 2006). Actin filaments are 
polarized in lamellipodia with their (+) oriented towards the plasma membrane (Small, 
Isenberg & Celis, 1978). Therefore, elongating actin filaments push against the leading cell 
membrane thereby extending the lamellipodium (Renkawitz & Sixt, 2010).  
Myosins are actin-dependent motors which convert chemical energy stored in ATP into 
mechanical force. 24 different myosin classes are described, but myosin II class proteins are 
the mayor motor proteins that regulate actomyosin contractility in both muscle and non-
muscle cells. Myosins II function as actin cross-linkers and contractile motors and are mainly 
located at the back of the cell. Myosin II self-assembles into bipolar filaments through their 
C-termini (Figure 10 A). The motor domains at the N-termini associate with actin filaments. 
By pulling the actin filaments together myosin II generates by ATP consumption cortical 
tension (Figure 10 B; Clark et al., 2007). 
 
Figure 10: Myosin II filament assembly 
and interaction with actin. (A) Myosin II 
monomers consist of two regulatory 
light chains, two essential light chains 
and two heavy chains. Two regions 
can be distinguished the C-terminal 
coiled-coil region and the N-terminal 
motor domain. (B) Two myosin II mo-
nomers assemble to one bipolar myo-
sin II filament through interactions 
facilitated via their coiled-coil regions. 
The N-terminal motor regions bind to 
actin filaments and pull on them upon 
activation (adapted from: Clark et al., 
2007). 
 
Actin-myosin contraction has several functions: It detaches the trailing edge of the cell by 
the inactivation and removing of integrins. Beyond that hydrostatic pressure can be created 
by contractility in the back to push out the membrane at the front. Contractility is not 
essential for leukocyte migration when the pores in the interstitium are large enough. But the 
passage through narrow pores depends on the actomyosin-mediated squeezing and 
deforming of the rigid nucleus (Figure 11; Nourshargh, Hordijk & Sixt, 2010). 
 




Figure 11: Leukocyte migrating through interstitial tissue by actin-myosin interactions. (A) Polymerizing 
actin pushes against the membrane to generate a protrusion. Actin filaments thereby experience a 
counter force that leads to backwards sliding of the filaments. By successful interactions between 
integrins and ECM molecules this retrograde actin flow can be transformed into traction, which leads to 
a forward movement of the cell. Integrins in the tail of the cell are detached by actin-myosin contraction 
at the same time. (B) To squeeze through narrow pores the nucleus has to be deformed by actin-myosin 
contraction. These contractions can also generate hydrostatic pressure, which also protrudes the 
membrane that can intercalate into matrix pores (taken from: Nourshargh, Hordijk & Sixt, 2010). 
 
1.5.3 Force transduction: Integrins 
The actin-myosin system is essential to generate forces to transform the cell shape. But in 
order to cause locomotion the created intracellular forces have to be transmitted to the 
extracellular environment. Only in this case the forces are converted into retrograde traction 
forces. 
Integrins are transmembrane receptors that bind to ECM molecules while the cytoplasmic 
tail interacts with the actin-myosin cytoskeleton to provide mechanical anchorage and 
structural integrity in the cell. Integrins are composed of an α- and a β-subunit. Eight 
different β- and 16 α-chains are known, which can form 24 different integrin dimers. Ligand 
specificity and affinity are defined by the composition of the dimers. Ligands are mostly ECM 
molecules, but also cell surface proteins or soluble proteins can interact with integrins 
(Figure 12). Integrins are the central component of focal adhesions. Focal adhesions are 
large, dynamic protein complexes that transmit mechanical force and regulatory signals at 
sites of integrin clustering and activation. Focal adhesions assemble in a hierarchical order: 
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First, the actin filament binding-protein α-actinin is recruited, followed by proteins of the main 
linkage complex like vinculin and talin and finally integrins appear in the focal adhesions 
(Brown et al., 2006; Hu et al., 2007). Disconnection of the complex facilitated via actin-
myosin contraction is assumed to occur within the linkage complex or between integrins and 
linkage complex (Brown et al., 2006).  
 
 
Figure 12: The integrin family of transmembrane receptors. Integrins are heterodimers consisting of an 
α- and a β- subunit. The composition of the dimers defines the ligand specificity. The expression of β2- 
and β7-subunits is restricted to leukocytes (taken from: Hynes, 2002).  
The described phenomenon of integrin-mediated force transduction is extensively described 
for adherent cells like fibroblasts, which carry active integrins on their surface (Hynes, 2002). 
Leukocytes except of macrophages and activated lymphocytes are non-adherent cells that 
carry mainly inactive integrins on their surfaces which can be activated for example by 
chemokines (Kinashi, 2005). Besides transmitting signals from the exterior to the interior of 
the cell after ligand binding like classical transmembrane receptors (outside-in signaling), 
function and activation state of integrin is also controlled from the inside of the cell (inside-
out signaling) leading to bidirectional intercommunication. Inactive integrins are in a low 
affinity state and interact weakly with ligands. Upon stimulation a conformational change in 
the cytoplasmic tail is induced that propagates to the exterior part of the receptor. Thereby 
the integrin is transformed to a high affinity ligand binding state (Figure 13 A; Hynes, 2002). 
Chemokine-dependent inside-out activation of integrins is for example indispensable for 
tight sticking of leukocytes to the endothelium during extravasation from the bloodstream, 
whereupon the chemokine must be immobilized on the endothelium (Ley et al., 2007; 
Shamri et al., 2005; Grabovsky et al., 2000). However, activated, high-affinity integrins slow 
migrating leukocytes down or even immobilize them the completely (Imai et al., 2008, 
Stanley et al., 2008). The inside-out activation of integrins allows the accurate regulation of 
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leukocyte adhesiveness and on the same time protects cells by limited activation from too 




Figure 13: Chemokine dependent integrin activation. (A) Leukocytes carry inactive integrins on their 
surfaces that can be activated for example by chemokines. Once integrins are in an active state they 
establish adhesive interactions with the environment (adapted from: Böttcher, Lange & Fässler 2009). (B) 
G-protein coupled receptor (GPCR) signaling. After chemokine receptor activation the heterotrimeric G-
proteins dissociate into an α- and a βγ-subunit. The βγ-subunit activates phospholipase C (PLC), which 
cleaves phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) into inositol-1,4,5-trisphosphate (InsP3) 
and diacylglycerol (DAG). InsP3 triggers Ca
2+
 release from the endoplasmatic reticulum (ER), which leads 
to Ca
2+




 (CRAC) channels. DAG, Ca
2+
 and 
calmodulin trigger integrin activation by progressive activation of guanine exchange factors (GEFs), 
GTPases and intermediate effectors. Finally, integrin activator proteins like talin are recruited to the 
integrin tails and lead to integrin activation (taken from: Ley et al., 2007). 
The signaling cascade which leads to integrin activation upon chemokine binding is only 
partly characterized. Upon chemokine receptor activation the coupled G-protein dissociates 
into and α- and a βγ-subunit which in turn activates phospholipase C (PLC). PLC cleaves 
phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) into inositol-1,4,5-trisphosphate (InsP3) 
and diacylglycerol (DAG) are generated. DAG leads to Ca2+-influx from the endoplasmatic 
reticulum into the cytosol which in turn leads to Ca2+ influx from the extracellular space. Ca2+, 
Ca2+-activated calmodulin and DAG subsequently lead to the activation of guanine exchange 
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factors (GEFs), which in turn activate GTPases like RhoA. Together with intermediate 
effectors, that are not well characterized yet, these GTPases lead to the recruitment of 
integrin activator proteins like α-actinin and talin to the focal adhesion site, which finally 
convert the integrin heterodimers into an activated state (Figure 13 B; Ley et al., 2007).  
 
1.5.4 Actin dynamics in the lamellipodium: Retrograde actin flow 
For leukocyte locomotion the actin polymerization-driven deformation of the leading edge is 
of great relevance. As mentioned before the myosin II-dependent contractility is dispensable 
in three-dimensional networks with large pore sizes. In this case actin polymerization alone 
is sufficient for cell deformation and leukocyte locomotion.  
The extending actin network directly pushes against the cell membrane thereby generating 
a lamellipodium. The lamellipodium includes the first 1-3 µm of the leading edge and is a 
thin, sheet-like structure with a thickness of 100-150 nm. Lamellipodia are only weakly 
adherent and devoid of organelles. The area directly affiliated to this structure is the so-
called lamella, which is thicker and more adherent. Both structures also differ in the 
composition of their actin network: the actin filaments of the lamellipodium are highly 
dynamic and orientated with the barbed ends towards the membrane. Actin dynamics in the 
lamella are less pronounced. At the border between lamellipodium and lamellum the first 
focal adhesions are located stabilizing the actin network. In three-dimensional environments 
the leading edge is more roundish and can intercalate into matrix pores (Figure 11 B). 
These cell extensions are also called ´lobopodia´ (Friedl et al., 2001). 
When actin filaments push against the membrane, they experience a counter force by the 
stiffness of the plasma membrane: The actin filaments slide backwards and retrograde actin 
flow can be observed. The contractility of the myosin network enhances this actin movement 
by pulling the cortex backwards. Retrograde flow can be coupled to the external environ-
ment via integrins thereby stopping the backwards flow and, moreover, generating parallel 
to the membrane traction forces (Figure 12). By force coupling the backward orientated flow 
can be turned into forward movement. This mechanism is called `molecular clutch` (Cramer 
1997; Giannone, Mège & Thoumine, 2007). Retrograde actin flow was observed in neural 
growth cones, as well as in fast moving keratocytes (Medeiros et al., 2006, Valloton et al., 
2006). Besides that, it could be shown that the retrograde actin flow is inversely related to 
the protrusion speed in keratocytes (Jurado et al., 2005). In contrast to these observations 
the retrograde actin flow in stationary and migratory fibroblast with their adherent lamellipo-
dia is not correlated with the speed of protrusion (Theriot and Mitchison 1992, Cramer et al., 
1997). Until now it was not analyzed how retrograde actin flow is regulated in low-adhesive 
leukocytes. 
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2 Aims of this thesis 
 
Project 1:  
Chemokines are indispensable for the establishment of functional areas with specialized 
assignments and sharp boundaries in lymphoid organs. At the same time these chemokines 
act as guidance cues for leukocytes to these organs. Furthermore, chemokines can lead to 
cell adhesion via integrin activation or to cytoskeletal polarization which results in directional 
migration. How can chemokines execute such diverse functions? And what determines 
whether a cell adheres, migrates or accomplishes both responses?  
To answer these questions I used dendritic cells (DCs) as a model system and focused on 
their chemokine receptor CCR7-dependent migration to and within LN. Besides that, CCR7 
is indispensable to establish T cell areas in secondary lymphatic organs. CCR7 has two 
ligands, the homeostatic chemokines CCL19 and CCL21. But why does CCR7 require two 
ligands? CCL19 and CCL21 exhibit many similarities like their affinity towards CCR7 and 
their expression pattern (Yoshida et al., 1998, Pilkington et al., 2004; Bachmann, Kopf & 
Marsland 2006). But only CCL21 carries a highly charged C-terminal extension that 
mediates linkage to anionic surfaces, whereas CCL19 is soluble (Ueno et al., 2002). How 
does the presenting mode of the CCR7 ligands influence the DC response? Chemokines 
can be immobilized or soluble, form a gradient or show a uniform, homogenous distribution 
(Miyasaka and Tanaka, 2004). Theoretically these presenting modes can be freely 
combined, but most likely are soluble gradients and immobilized, homogenous fields. If and 
how the presentation form of a chemokine affects the migratory response has not been 
systematically investigated. I used reductionistic in vitro approach to gradually dissect 
different chemokine response patterns of DCs. 
 
Project 2:  
It was shown that the adhesive and migratory properties of cells are not urgently connected: 
DCs can use an integrin-independent amoeboid mode of migration, which is based on actin 
polymerization at the leading edge and myosin II controlled contraction in the rear of the cell 
to squeeze through narrow pores (Lämmermann et al., 2008). These results are contradicto-
ry to the paradigm of integrin-dependent transmission of traction force during mesenchymal 
cell migration. According to this model, cells must transmit forces generated by the 
actomyosin system via integrins to the environment in order to migrate. Till now it is unclear 
how the actin cytoskeleton in DCs adapts to the loss of adhesive interactions and supports 
integrin-independent migration. To answer these questions I examined the migration of DCs 
in a defined pseudo-three-dimensional environment. The actin flow was visualized with the 
probe Lifeact-green fluorescent protein (GFP). This second project was a collaboration with 
a master student in the lab, Jörg Renkawitz. 
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3 Material and Methods 
3.1 Mice 
Itgb2-/- (Wilson et al., 1993), Ccr7-/- (Förster et al., 1999), Lifeact-GFP (Riedl et al., 2008), 
plt/plt (Nakano et al., 1998) and Itgαv
flox/flox Itgβ1flox/flox Itgβ2-/- Itgβ7-/- Mx1Cre+/-  [here called 
Itg-/-; described in Lämmermann et al., 2008; following integrins were targeted/deleted: 
Itgαv
flox/flox (Lämmermann et al., 2008), Itgβ1flox/flox (Potocnik, Brakebusch & Fässler, 2000), 
Itgβ2-/- (Wilson et al., 1993), Itgβ7-/- (Wagner et al., 1996), Mx1Cre+/- (Kühn et al., 1995)] 
mice were kept on a 129SV/C57BL/6 genetic mixed background. The mice were bred in a 
conventional animal facility at the Max Planck Institute of Biochemistry, Martinsried, 
according to the local regulations. 
 
3.2 Chemicals 
If not separately mentioned CCL21, CCL19 and ICAM-1 were purchased from R&D Systems 
and bovine serum albumin (BSA) from PAA. 
 
3.3 Cell culture 
3.3.1 General 
All cells were kept at 37°C, 5% CO2 and a humidity of 100%. DCs, macrophages, growth 
factor producing hybridoma cell lines, B and T cells were cultured in R10 medium. LN 
derived p19ARF-/- fibroblasts (provided by S. Luther) and mouse embryonic fibroblasts (MEFs) 
were cultured in D10 medium in cell culture flasks (Falcon). Cells were centrifuged at 270 g 
for 5 min if not separately mentioned. 
R10 medium  RPMI (Gibco) with 10% fetal calf serum (FCS; Gibco), 5% penicillin/streptomycin 
(PAA), 5 % glutamine (PAA) 
D10 medium  DMEM medium with 10% FCS (Gibco), 5% penicillin/streptomycin (PAA) 
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3.3.2 Cell passaging 
Macrophages, growth factor producing hybridoma cell lines, MEFs and p19ARF-/- LN-
fibroblasts were detached from 10 cm petri dish (Greiner) by trypsination. Therefore, 
adherent cells were washed with phosphate buffered saline (PBS) prior to incubation with 2 
ml trypsin-ethylenediaminetetraacetic acid (EDTA) solution (Gibco; 0.25% Trypsin) for 2 min 
at room temperature (RT). The digestion was stopped by adding 10 ml R10 medium. 
Macrophages were directly used for experiments; fibroblasts were applied to experimental 
procedures or pelleted, resuspended and transferred to new cell culture flasks. 
PBS 1.4 M NaCl (Merck), 20 mM KCl (Merck), 80 mM Na2HPO4 · 2 H2O (Merck),  
15 mM KH2PO4  (Merck) 
 
 
3.3.3 GM-CSF and M-CSF production 
To differentiate bone marrow cells in DCs or macrophages depends on growth factors, 
granulocyte-macrophage colony-stimulating factor (GM-CSF; Lutz et al., 1999) and 
macrophage colony-stimulating factor (M-CSF; LeContel et al. 1993), respectively. Both 
growth factors were produced by hybridoma cell lines. The GM-CSF (provided by B. 
Stockinger) and M-CSF (provided by M. Lutz) producing hybridoma cells were cultivated in 
R10 medium in cell culture flasks (BD Falcon). When the cells reached a confluency of 90 to 
100%, the cells were cultivated in the same medium for two additional days. Afterwards the 
cell supernatant was collected, centrifuged to remove remaining cells and finally filtered 
(Corning vacuum filter/storage bottle system, 0.45 µm pore size) before added to bone 
marrow cells. After two rounds of growth factor enrichment in the cell supernatant the cells 
were trypsinized, splitted and transferred to new flasks. Growth factor containing cell 
supernatants were stored at 4°C. 
 
3.3.4 Generation of bone marrow derived DCs 
DCs were generated from flushed bone marrow as described by Lutz et al. (1999). Mice 
were sacrificed via CO2 aspiration and the femurs removed. The bones were disinfected 
with 70% ethanol for 30 s. Afterwards the bones were opened with sterile scissors and the 
bone marrow flushed with 4°C cold phosphate buffered saline (PBS). After thoroughly 
pipetting to separate the cells from each other, the cell suspension was centrifuged and 
resuspended in R10 medium supplemented with 10% GM-CSF to a final concentration of 
2.5x105 cells/ml. 10 ml of this cell suspension was transferred to one 10 cm petri dish 
(Greiner). On day 3 of culture 10 ml of R10 medium containing 20% GM-CSF were added. 
On day 6 and 8 of culture 10 ml medium were removed and replaced with 10 ml R10 
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medium supplemented with 20% GM-CSF. DCs were cryo-preserved at day 8 to 11 of 
culture and used at day 9 to 12 for experiments after maturation (3.3.5, p.46).  
 
3.3.5 Maturation of DCs 
Immature DCs on day 9 to 11 of culture were used for overnight maturation. DCs of one 
petri dish were pelleted, resuspended in 10 ml R10 medium supplemented with 10% GM-
CSF and transferred to a 5 cm cell culture dish (Falcon). To induce DC maturation 200 ng/ml 
lipopolysaccharide (LPS; Sigma-Aldrich; E.coli; 0127:B8) were added. On the next day the 
non-adherent, maturated DCs were used for experiments. 
 
3.3.6 Cryo-preservation and thawing of DCs 
DCs of one petri dish were pelleted and resuspended in 4°C cold 1 ml freezing medium and 
transferred to cryo vials (Corning). The cells were stored at -80°C or for long-term storage (> 
3 months) transferred into liquid nitrogen. 
For recovering the cryo vials were placed in a 37°C water-bath. The thawed cell suspension 
was rapidly added to 20 ml R10 medium, pelleted and directly used for overnight maturation 
(3.3.5, p.46). 
Freezing medium  FCS (Gibco) supplemented with 10% DMSO (Sigma-Aldrich) 
 
3.3.7 Transfection of DCs 
For DC transfection with vinculin-GFP- (provided by S. Schmidt), CCR7-GFP- (provided by 
D. Legler) or Lifeact-GFP (provided by J. Riedl) plasmids the Mouse T Cell Nucleofector® 
Kit (Lonza) was used. 5x106 immature DCs were pelleted (150 g, 5min) and the supernatant 
discarded completely. The DCs were resuspended in 100 µl room temperate Mouse T Cell 
Nucleofector solution mixed with the supplement solution. Subsequently, 4 µg deoxyribonu-
cleic acid (DNA) were added. After exhaustively mixing the cell suspension was transferred 
to an electroporation cuvette (Lonza) and transfected using the Amaxa Nucleofector with the 
Nucleofector program X-001 (Lonza). Directly after transfection the DC suspension was 
transferred into 3 ml R10 medium supplemented with 10% GM-CSF. 4 hr after transfection 
200 ng/ml LPS (Sigma-Aldrich; E. coli 0127:B8) were added for overnight maturation (3.3.5, 
p.46).  
Before usage in chemotaxis assays, the cells were sorted for GFP-positive cells with a 
FACSAria (Beckton Dickinson; GFP: excitation 488 nm; emission 575 nm; cells sorted > 
5x102 fluorescence intensity). 




3.3.8 Generation of Itg-/- DCs  
In Itg-/- mice (Lämmermann et al., 2008) Itgβ2-/- (Wilson et al., 1993) and Itgβ7-/- (Wagner et 
al., 1996) were constitutively deleted. Itgαvflox/flox (Lämmermann et al., 2008) and Itgβ1flox/flox 
(Potocnik, Brakebusch & Fässler, 2000) genes were flanked by LoxP sites (´flox´).  The mice 
genomes encoded the heterogenic transgene Mx1Cre+/- (Kühn et al., 1995) to induce the 
knockout of the Itgαv and Itgβ1 in hematopoietic cells. In the MxCre system the Cre 
recombinase gene is under control of the Mx promoter, which can be activated by type I 
interferons. Administration of a synthetic double-stranded RNAs or synthetic homologous, 
like polyinosinic-polycytidylic acid (Poly(I)∙Poly(C)) induces the production of interferons and 
subsequently leads to activation of the Mx promoter in hematopoietic precursors. For 
induction mice at an age between 8 and 12 weeks obtained a single intraperitoneal injection 
of 250 µg Poly(I)∙Poly(C) (AmershamBiosciences) in 0.5 ml PBS. Mice were sacrificed via 
CO2 aspiration 10 to 14 days after injection. The knockout efficiency of hematopoietic 
precursors was estimated by fluorescence-activated cell sorting (FACS) analysis of 
peripheral blood platelets, which corresponds with knockout efficiencies in DC precursors (T. 
Lämmermann, personal communication; β1 integrin staining as described below). Bone 
marrow of mice with at least 90% knockout efficiency was processed for DC generation 
(3.3.4, p. 45).  
Because the knockout efficiency after Poly(I)∙Poly(C) injection is always below 100%, 
knockout cells were isolated by FACS sorting. Therefore, after transfection with Lifeact-GFP 
(3.3.7, p.46) and subsequent overnight maturation (3.3.5, p.46), the mature DCs were 
stained with α-integrinβ1-phycoerythrin (PE) antibody (hamster IgG, Biolegends) and GFP-
positive PE-negative cells isolated with a FACSAria (Beckton Dickinson; PE: excitation 488 
nm; emission 518 nm; cells sorted: < 2x102 fluorescence intensity; GFP: excitation 488nm; 
emission 575 nm; cells sorted: > 5x102 fluorescence intensity). For the staining Itg-/- DCs of 
one transfection were resuspended in 1 ml PBS with 5 µl of the antibody for 20 min at 4°C. 
Because the integrin β1 knockout is always correlated with the knockout of integrin αv, the 
staining of Itgβ1-/- DCs is sufficient to identify Itg-/- DCs (T. Lämmermann, personal commu-
nication). 
 
3.3.9 Generation of bone marrow derived macrophages 
To generate bone-marrow derived macrophages a procedure analogue to the DC differen-
tiation protocol was executed (modified after: Le Contel et al., 1993; 3.3.4, p.45). Mouse 
femurs were isolated and the bone marrow flushed. The cells were pelleted and resus-
pended in R10 medium supplemented with 10% M-CSF to a final cell concentration of 2 
x105 cells/ml. 10 ml of the cell suspension was transferred to a 10 cm petri dish (Greiner). 
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On day 3 of culture 10 ml of R10 medium containing 20% M-CSF were added. On day 6 and 
8 of culture 10 ml medium were removed and replaced with10 ml R10 medium supple-
mented with 20% M-CSF. Macrophages were cryo-preserved at day 8 to 9 of culture and 
used at day 8 to 10 for experiments. Macrophages are already activated by attaching to the 
petri dish. 
 
3.3.10 Isolation of CD4+ T cells from the spleen 
To isolate CD4+ T cells from spleen cell suspension the magnetic-activated cell sorting 
(MACS) CD4+ T cell isolation kit (MiltenyiBiotec) was used. The basic principle of this kit is 
to incubate the cell suspension first with an Biotin antibody cocktail that labels all unwanted 
cell (αCd8a: macrophages, mast cells, αCd11b: granulocytes, monocytes, αCd45R: B-
lymphocytes, αDX5: NK-cells, αTer119: erythrocytes). In a second step these selected cells 
are magnetically labeled via Streptavidin MicroBeads. The final cell separation is carried via 
a column in a strong magnetic field, where the labeled cells are retained and the unlabeled 
cells can be easily eluted. 
Mice were sacrificed via CO2 aspiration and the spleen isolated under sterile conditions. The 
spleen was homogenized with a 70 µM cell strainer (BD Biosciences) in 20 ml PBS. After a 
centrifugation step the cell pellet was resuspended in 5 ml ammonium-chloride-potassium 
(ACK) lysis buffer to remove erythrocytes. The lysis reaction was stopped after 5 min at RT 
with 10 ml R10 medium. The cell suspension was pelleted again and the cell number 
determined after resuspension in 10 ml MACS buffer. 
For labelling 1x107 cells were resuspended in 40 µl MACS buffer and mixed with 10 µl 
Biotin-Antibody cocktail. After 10 min at 4°C 30 µl MACS buffer and 20 µl Anti-Biotin 
MicroBeads were added and incubated for additional 15 min at 4°C. The cells were washed 
with 20 ml MACS buffer and subsequently resuspended in 1 ml MACS buffer. The cells were 
transferred to MACS LS column (MiltenyiBiotec) equilibrated with 3 ml MACS buffer and 
fixed in a MACS separator (MiltenyiBiotec). The column was washed three times with 4 ml 
MACS buffer to eluated the CD4+ T cells. 
 
ACK lysis buffer  0.15 M NH4Cl (Merck), 1 mM KHCO3 (Merck), 0.1 M Na2EDTA (Merck) 
 
MACS buffer   PBS containing 0.5 % BSA (PAA), 2 mM EDTA (Merck) 
 
3.3.11 Isolation of B cells from the spleen 
To isolate mature B cells with CD43(Ly-48)-MicroBeads (MiltenyiBiotec) out of spleen a cell 
suspension was prepared as described before (3.3.10, p.48). CD43 is expressed on all 
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leukocytes expect mature B cells. 1x107 cells were resuspended in 90 µl MACS buffer and 
incubated with 10 µl CD43 MicroBead suspension at 4°C for 15 min to label the unwanted 
cells magnetically. The labeling reaction was stopped by adding 20 ml MACS buffer. The 
final separation of the non-labeled B cells with a LS MACS column (MiltenyiBiotec) was 
carried out as described in 3.3.10, p.48. 
 
3.4 Molecular biology techniques 
3.4.1 DNA agarose gel electrophoresis 
Agarose gels are used to separate DNA fragment of different sizes by applying an electric 
field. Shorter fragments move faster and farther than longer ones through an agarose 
meshwork.  
1 to 2% agarose suspension in Tris-acetate-EDTA (TAE) buffer was boiled up in a micro-
wave till the agarose was completely solved. After the agarose solution was cooled down to 
50 °C ethidium bromide (Roth), a fluorescent DNA intercalating agent, was added to a final 
concentration of 1 µg/ml. The agarose/ethidium bromide solution was filled in a custom made 
gel chamber. After the agarose solidified the chamber was filled with TAE buffer. To the DNA 
samples the appropriate amount of 6xOrangeG loading buffer (Sigma-Aldrich) was added. 
The size of the DNA fragments was determined with the DNA markers O´GeneRulerTM DNA 
Ladder Mix (Fermentas) and O´GeneRulerTM 100 bp DNA Ladder (Fermentas). The 
electrophoresis was carried out at a constant voltage of 80 V. DNA fragment bands were 
visualized by the use of UV-light of 366 nm wavelength.  
 
TAE (50x)  2 M Tris (Sigma-Aldrich), 1 M acetic acid (Merck), 50 mM Na2EDTA (Merck), pH 8 
 
3.4.2 PCR 
Polymerase chain reaction (PCR) is a method to amplify a piece of DNA by several orders of 
magnitude by using DNA polymerase enzymes under controlled conditions. 
Recombinant CCL21 with an N-terminal Flag- and a C-terminal His-tag was produced using 
the Pichia pastoris yeast expression system (Invitrogen) and the expression vector pPICZαC 
(Invitrogen). To the coding sequence for CCL21 (amino acids 24 - 133, without signal 
sequence) restriction sites for EcoRI and an XbaI were introduced. 
The coding sequence of mature full-length (amino acids 24 - 133, without signal sequence) 
and C-terminally truncated (amino acids 24 - 98, without signal sequence) CCL21 for the 
E.coli B834(DE3)pLysS (Novagen) expression system was amplified introducing a stop 
codon as well as flanking restriction sites for BsaI and XhoI and subsequently cloned into 
the expression vector pET-6his- SUMO (small ubiquitin-like modifier; Invitrogen). 
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All primers were purchased from Metabion (stock: 100 µM in ddH2O). As DNA template the 
plasmid pET52 (EMBL expression vector for E.coli) with the full CCL21 sequence was used. 
Each PCR reaction contained 5 µl 10xcomplete PCR buffer (Metabion), 1 µl 10 mM dNTPs 
(Fermentas), 0.5 µl 100 µM primer forward, 0.5 µl 100 µM primer reverse, 0.2 µl Taq-
Polymerase (Metabion), 2 µl Template-DNA (pET52 + CCL21; provided by T. Lämmermann) 
and 38.8 µl ddH2O. The sequences of the primers are specified in Error! Reference source 
not found., the PCR program in Error! Reference source not found.. 
Table 1: Primer sequences used to generate CCL21 expression plasmids for the Pichia pastoris yeast 
(Invitrogen) and the E.coli B834(DE3)pLysS (Novagen) expression system. 
Primer Primer sequence 
pPICZαC CCL21 forward 
5´- ACG TAG AAT TCC GAC TAC AAG GAC GAC GAT GAC 
AAG  AGT GAT GGA GGG GGT CAG GAC -3´ 
pPICZαC CCL21 reverse 




5`- CAA GGT CTC AGG TGG TAG TGA TGG AGG GGG TCA 
G -3´ 
pET-6his-SUMO-1 full-
length CCL21 reverse 
5`- CAG CTC GAG TCA TCC TCT TGA GGG CTG TGT CTG 
-3´ 
pET-6his-SUMO-1 trun-
cated CCL21 reverse 
5`-AAT CTC GAG TCA TTT CCC TGG GGC TGG AGG -3´ 
 
Table 2: PCR program used to generate CCL21-inserts. 
t  T [°C] repeats 
10´ 95 1x 
30´´ 95 
32x 1´ 58 
1 ´ 72 
15´ 72 - 
- 4 - 
 
The PCR products were separated on 2% agarose gels, the DNA band of correct size cut 
out and eluated with the QIAquick® Gel Extraction Kit  (Qiagen) according to the manufac-
turer‟s protocol. The CCL21 inserts were eluated with 30 µl ddH2O. 
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3.4.3 Plasmid preparation 
To isolate different amounts of plasmid DNA the Plasmid Mini or Midi Kit from Qiagen were 
used, respectively. The Plasmid Mini Kit was used according to the manufacturer‟s protocol. 
The protocol for the Plasmid Midi Kit was slightly modified:   
50 ml LB-ampicillin medium was inoculated with a single E.coli colony and incubated 
overnight at 37°C under shaking (200 rpm). On the next day the bacteria suspension was 
centrifuged for 10 min at 6000 g. The resulting bacteria pellet was resuspended in 5 ml P1 
buffer and 5 ml P2 buffer were added subsequently. After 2 min incubation at RT 5 ml 4°C 
cold neutralizing buffer P3 were added and thoroughly mixed. Next, the mixture was 
centrifuged for 15 min at 20,000 g and the resulting supernatant transferred on a with QBT 
buffer equilibrated Qiagen tip100 column, where it passed through by gravity flow. The 
column with bound DNA was washed extensively with QC buffer before eluation with 5 ml 
QF buffer. For DNA precipitation 3.5 ml isopropanole were added and the DNA spun down 
for 30 min at 20,000 g. The DNA pellet was resolved in 200 µl ddH2O. 
 
3.4.4 DNA restriction digest 
Restriction enzymes recognize and cut special palindromic DNA sequences hydrolyzing a 
phosphodiester bond. Each vector or insert, respectively, was cut with two different 
restriction enzymes to generate varying 3´- and 5´- sticky ends to minimize re-ligation. 
Each digest contained 20 µl PCR agarose gel eluate (3.4.2, p.49) or 5 µg plasmid DNA, 0.5 
µl BSA (NEB, 10 mg/ml), 5 µl of the accordant 10xNEB buffer, 10 U of each restriction 
enzyme (NEB) and ddH2O to final volume of 50 µl. The digest was carried out for 3 hr at 
37°C.  
The plasmids were de-phosphorylated directly after the restriction digest (3.4.5, p.51). 
Subsequently DNA fragments were separated on an agarose gel, the fragment of the 
correct size cut out and the DNA eluated in 30 µl ddH2O with the QIAquick® Gel Extraction 
Kit (Qiagen) according to the manufacturer´s recommendations. 
 
3.4.5 Plasmid de-phosphorylation 
Following the restriction digest the reactive 5´prime of the linearized plasmid was dephos-
phorylated with shrimp alkaline phosphatase (SAP) to avoid self-ligation. To the DNA 
restriction digest (3.4.4, p.51) the adequate amount of 10xSAP buffer and 1 U of SAP 
(Roche Applied Science) was added and incubated for 1 hr at 37°C. Finally the enzyme was 
heat-inactivated for 15 min at 65°C.  
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3.4.6 DNA ligation 
The ligation reaction forms a phosphodiester bond between the 5´-phospho and the 3`-
hydroxyl group of two DNA fragments which have been cut with the same restriction 
enzyme.  
In this study the Fast-Link DNA Ligation Kit (Epicentre) was used. Each ligation sample 
consisted of 1.5 µl 10xFast-Link ligation buffer, 1.5 µl 10 mM ATP, 1 µl Fast-Link DNA ligase 
(2 U/ml) and a total of 200 ng plasmid- and insert-DNA in a molecular ratio of 1:3. ddH2O 
was added to a final volume of 15 µl. After 30 min incubation at RT the ligase was heat-
inactivated for 15 min at 75°C. The ligation reaction was transformed into heat-competent 
E.colis. 
3.4.7 Preparation of heat-competent Escherichia coli (E.coli) XL1 blue 
5 ml of LB Tetracyclin medium were inoculated with a single E.colis XL1 blue colony and 
incubated overnight at 37°C under shaking (200 rpm). Next, 150 ml of 37 °C warm LB 
Tetracyclin medium were inoculated with 1 ml of the overnight culture and incubated at 37°C 
under shaking (200 rpm) till an optical density of 0.4 at 600 nm (OD600) was reached. After 
10 min cool-down on ice the bacteria suspension was divided on four 50 ml conical tubes 
(Falcon) and centrifuged for 10 min at 4000 g. Each bacteria pellet was resuspended in 37.5 
ml 4°C cold transformation buffer I (TFBI) buffer and incubated for 10 min on ice. The 
resulting suspensions were centrifuged again for 10 min at 4000 g before each bacteria 
pellet was resuspended in 3 ml 4°C cold TFBII buffer. The final suspension was snap-frozen 
in liquid nitrogen in 100 µl aliquots. Competent E.coli XL1 blue aliquots were stored at -
80°C.  
LB medium    1% tryptone (Roth), 0.5% yeast extract (Roth), 1% NaCl (Merck), 
autoclaved 
LB Tetracyclin medium LB medium containing sterile filtered 5 ng/ml Tetracyclin (Sigma-Aldrich),  
20 mM MgSO4 (Merck), 10 mM KCl (Merck) 
TFBI 25 mM potassium acetate (Merck), 50 mM MnCl2 (Merck), 100 mM RbCl 
(Merck), 10 mM CaCl2 (Merck), 15% glycerol (Merck), autoclaved 
TFBII  10 mM 3-(N-morpholino)propanesulfonic acid (MOPS; Biomol), 75 mM 
CaCl2 (Merck), 10 mM RbCl (Merck), 15% glycerol (Merck), sterile filtered 
 
3.4.8 Transformation of heat-competent Escherichia coli 
The complete ligation reaction was added to one on ice thawed 100 µl aliquot of heat-
competent E.coli XL1 blue or one aliquot of E.coli B834(DE3)pLysS (Novagen). The mixture 
was intermingled carefully and incubated for 30 min on ice. Next, a heat-shock of 30 s at 
42°C was performed to promote the uptake of DNA. After 2 min incubation on ice 500 µl LB 
Material and Methods   
53 
 
medium was added and the bacteria incubated for 30 min at 37°C under shaking (400 rpm). 
Finally, the bacteria were spun down, resuspended in 50 µl LB medium and dispensed on 
LB agar plates containing the respective selection antibiotic. The plates were incubated 
overnight at 37°C.  
LB agar plates   1% tryptone (Roth), 0.5 % yeast extract (Roth), 1% NaCl (Merck), 
2% agar (Roth), autoclaved, after cool down to approximately 50°C addi-
tion of 50 ng/ml ampicillin, 50 ng/ml kanamycine, respectively 
 
3.4.9 DNA sequencing 
Plasmids, which showed the expected results in test restriction digests, were subsequently 
sequenced with the Sanger method (also: chain-termination method; Sanger, Nickler & 
Coulson, 1977). The key principle of this method is a modified PCR reaction with dideox-
ynucleotide triphosphates (ddNTPs) in addition to the normally applied deoxynucleotide 
triphosphates (dNTPs), which function as DNA chain terminators, and subsequent sequenc-
ing of the fragments. 
For each plasmid two sequencing reaction, one with a forward primer, the other one with a 
reverse primer, were performed. All primers were purchased from Metabion (stock: 100 µM 
in ddH2O). Each PCR reaction contained 200 ng plasmid DNA, 3 Big Dye 3.1 (ABI 
sequencing chemistry), 1 µl primer and ddH2O to a final volume of 20 µl. The PCR program 
is described in Error! Reference source not found.. The DNA sequencing was carried out 
with an ABI 3730 sequencing machine from the sequencing core facility of the Max Planck 
Institute of Biochemistry, Martinsried. 
Table 3: PCR program for DNA sequencing. 
t  T [°C] repeats 
30´´ 95 25x 
15´´ 50 
4´ 60 
- 4 - 




3.5 Production and purification of recombinant chemokine 
3.5.1 Production of recombinant CCL21 in the yeast Pichia pastoris 
To use Pichia pastoris (P.pastoris) as a protein expression system the desired gene has to 
be stable integrated into the genome by homologous recombination. The gen is placed 
under the control of the alcohol oxidase promoter (AOX1). Thus, by adding methanol the 
protein production can be started.  
In this study we used the P.pastoris strain KM71H (ZeocinTM resistance; Invitrogen) 
according to the instructions of the EasySelectTM Pichia Expression Kit (Invitrogen). The 
applied plasmid pPICZαC contains α-factor-signaling sequence that induces the secretion of 
the recombinant protein into the cell supernatant.  
After transfection with the expression vector different P.pastoris colonies were tested upon 
CCL21 expression levels. The His- and Flag-tagged protein was purified using Ni+ metal 
affinity chromatography and subsequently tested with western-blot detection and coomassie 
staining (Instant Blue, Novexin) of SDS-PAGEs. Afterwards large scale expression with the 
most productive colony was established. 
 
3.5.1.1 Preparation of electro-competent Pichia pastoris 
100 µl of the thawed glycerol stock of P.pastoris KM71H were dispensed on an YPDS plate 
and incubated for three days at 30°C. 5 ml YPDS medium were inoculated with a single 
colony and incubated overnight under shaking. 0.5 ml of the overnight pre-culture were used 
to inoculate 500 ml YPDS medium and incubated again overnight till an OD600 of approx-
imately 1.3 was obtained. The cell suspension was filled into 50 ml conical tubes (Falcon) 
and spun down for 5 min at 1500 g and 4°C. The pellets were resuspended in 100 ml 4°C 
cold ddH2O and centrifuged again for 5 min at 1500 g and 4°C. This step was repeated with 
50 ml 4°C cold ddH2O and 4 ml 4°C cold 1 M sorbitol (Sigma-Aldrich) for resuspension. 
Finally, the cell pellets were resuspended in 0.2 ml 4°C cold 1 M sorbitol. 
YPDS    2% tryptone (Roth), 1% yeast extract (Roth), 2% dextrose (Merck), 
1 M sorbitol (Sigma-Aldrich), autoclaved 
YPDS agar plate      2% tryptone (Roth), 1% yeast extract (Roth), 2% dextrose (Sigma-Aldrich), 
2% agar (Roth), 1 M sorbitol (Sigma-Aldrich), autoclaved  
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3.5.1.2 Electroporation of Pichia pastoris 
A mixture of 80 µl of electro-competent P.pastoris (3.5.1.1) and 10 µg with ScaI linearized 
expression vector (restriction digest: 3.4.4, p.51) in 20 µl ddH2O was filled into an electropo-
ration curette (Biorad). After 5 min reposing on ice the cells were electroporated with a 
Biorad gene pulsor (1.5 kV, 200 Ω, 25 µF). Directly afterwards 1 ml 4°C cold 1 M sorbitol 
was added and the cells transferred into a 15 ml conical tube (Falcon). For recovery the 
cells were incubated for 2.5 hr at 30°C without shaking. Next, 50, 100 and 700 µl of the cell 
suspension was dispensed on YPDS-Zeocin (Invitrogen, selection antibiotic) agar plates, 
respectively, and incubated for 5 days at 30°C. The grown colonies were used for CCL21 
test expression. 
YPDS Zeocin agar plates  2% tryptone (Roth), 1% yeast extract (Roth), 2% dextrose (Sigma-Aldrich), 
2% agar (Roth), 1 M sorbitol (Sigma-Aldrich), autoclaved, after cooled 
down to approximately 50°C 100 µg/ml Zeocin
TM 
(Invitrogen) were added 
 
3.5.1.3 CCL21 test expression in Pichia pastoris 
To test different colonies for their level of CCL21 production each 2 ml buffer glycerol-
complex medium (BMGY) medium in a 24 well-plate were inoculated with a single P.pastoris 
colony. The 24 well-plate with the different test colonies was sealed with air pore tape sheet 
(Qiagen) and incubated overnight at 30°C under shaking (220 rpm). 20 µl of each of these 
pre-cultures were used to inoculate for each test colony 2 ml buffer methanol-complex 
medium (BMMY) medium in a new 24 well-plate sealed again with air pore tape sheet. The 
plate was incubated for three days under shaking (220 rpm) at 20°C. Every day 10 µl 
methanol were added to each test expression to induce protein expression. On day 3 the 
cell supernatant was isolated and the CCL21 purificated using MagneHisTM Ni beads 
(3.5.1.5, p.56). 
BMGY   1% yeast extract (Roth), 2% peptone (Roth), 1.34% YNB (BIO 101), 
100 mM potassium phosphate buffer, 4x10
-5
 % Biotin (Sigma-Aldrich),  
1% glycerol (Merck) 
BMMY   1% yeast extract (Roth), 2% peptone (Roth), 1.34% YNB (BIO 101), 
100 mM potassium phosphate buffer, 4x10
-5
 % biotin (Sigma-Aldrich),  
1% glycerol (Merck) 
1M potassium phosphate buffer   132 mM K2HPO4 (Merck), 868 mM KH2PO4 (Merck) 
 
3.5.1.4 CCL21 large scale expression in Pichia pastoris 
CCL21 large scale expression was performed analog to the test expression protocol 
(3.5.1.3, p.55). 500 ml BMMY medium inoculated with 5 ml of a BMGY overnight pre-culture 
were incubated for 5 days at 30°C under shaking. Each day 2.5 ml methanol were added to 
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induce protein expression. The protein was purificated using Ni-nitrilotriacetic acid (NTA) 
agarose (3.5.1.6, p.56). 
 
3.5.1.5 CCL21 purification with MagneHisTM Ni beads 
For the protein purification the His-tag added to the N-terminus of the P.pastoris CCL21 
construct was used. The basic principle of the enrichment is immobilized metal ion affinity 
chromatography with MagneHisTM Ni beads. Ni2+ ions are bound over chelating ligands to a 
matrix and can interact with the side chains of histidins. Bound proteins can be eluted with 
buffer of high ionic strength. The whole purification was carried out at 4°C. 
30 µl MagneHisTM bead slurry (Promega, 1 mg/ml Ni2+ particles) were washed three times 
with 200 µl washing buffer by resuspending the beads in the buffer and subsequent 
separation of the beads with a magnet. 
To 1 ml P.pastoris supernatant 110 µl 10xbinding buffer as well as the washed MagneHisTM 
beads were added and incubated for 2 hr on a rotating wheel. Next, the beads were 
separated with a magnet and again washed three times with 200 µl washing buffer. To 
eluate the protein the beads were resuspended in 30 µl elution buffer and incubated for 1 hr 
under shaking (1400 rpm). 
 
binding buffer (10x)   1 M N-(2-hydroxyethyl)-piperazine-N’-2-ethanesulfonic acid  
(HEPES; Biomol), 100 mM imidazole (Merck), 3 M NaCl (Merck), pH 7.5 
washing buffer  100 mM HEPES (Biomol), 10 mM imidazole (Merck), 300 mM NaCl 
(Merck), pH 7.5 
elution buffer 100 M HEPES (Biomol), 500 mM imidazole (Merck), 300 mM NaCl 
(Merck), pH 7.5 
 
3.5.1.6 CCL21 purification with Ni-NTA agarose 
To isolate CCL21 out of larger supernatant amounts the Ni-nitrilotriacetic acid (NTA) 
agarose RAQ007.2 (Qiagen, 10 mg/ml) is better suited, perhaps because of the more 
voluminous structure. All purification steps were performed at 4°C with the same buffers as 
for the MagneHisTM purification (3.5.1.5, p.56). 
50 ml P.pastoris supernatant were mixed with 5.5 ml 10xbinding buffer and the pH adjusted 
to 7.8 with 6 M NaOH. 250 µl bead slurry were washed three times with 600 µl washing 
buffer before the beads were resuspended in the supernatant. To enable protein binding the 
supernatant bead mixture was incubated overnight on a rotating wheel. The beads were 
separated by centrifugation and washed three times with 600 µl washing buffer. Finally, 250 
µl elution buffer were added and the suspension incubated for 1.5 hr under shaking (800 
rpm). 
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3.5.2 Expression and purification of full-length and C-terminal 
truncated CCL21 in Escherichia coli B834(DE3)pLysS 
Plasmids were transformed into E.coli B834(DE3)pLysS (Novagen). Bacteria were grown at 
37°C in a half-synthetic, glycerol-based (HSG) medium to an OD600 of 0.5, cooled to RT for 
one hr prior to the addition of Isopropyl-β-d-thiogalactopyranoside (IPTG) to a final 
concentration of 0.5 mM. 6 hr after induction with IPTG at RT, bacteria were pelleted at 
10,000 g and resuspended in 5 ml lysis buffer/g pellet. The resuspended bacteria were 
sonicated and subjected to a cell disruptor to open the bacteria at 2.5 kbar (Constant 
Systems Ltd.). Subsequently 1 mM phenylmethylsulfonyl fluoride (PMSF; Sigma-Aldrich), an 
irreversible serine protease inhibitor, was added and soluble chemokine-containing 
supernatants subsequently collected by centrifugation at 30,000 g. The supernatant was 
filtrated though two cellulose acetate membrane based filters, Whatman FP30/1.2 CA (GE 
Healthcare) and Whatman FP30/0.45 CA (GE Healthcare). The filtered supernatant was 
filled into a 50 ml syringe and manually loaded on a with binding buffer pre-washed HisTrap 
HP column (GE Healthcare), extensively washed with washing buffer and bound proteins 
were eluted with elution buffer using an AKTA Explorer chromatography system (Amersham 
Biosciences, flow rate: 1-2 ml/min). Buffer of eluted fractions with protein of interest was 
replaced with PBS in a with binding buffer equilibrated HighPrep Desalting column (GE 
Healthcare, 4 ml/ml, 0.5 Pa). The protein containing fractions were combined in a 50 ml 
conical tube (Falcon) and overnight digested with 4 µg C-terminal his-tagged Ubl-specific 
protease 1 (ULP1)/mg protein at 4°C on a roller. The digested chemokines were first filtered 
through a Whatman FP30/0.45 CA (GE Healthcare) and then loaded on a Zn2+ charged 
HiTrap IMAC FF column equilibrated with binding buffer (GE Healthcare flow rate: 1-2 
ml/min). Optionally the chemokine containing fractions were applied to an additional gel-
filtration step to achieve a higher purity (HiPrep Sephacryl S-200, GE Healthcare, flow rate: 
1-2 ml/min).  
 
HSG medium  1.49% glycerol (Merck), 0.7% yeast extract (Roth), 1.35% peptone (Roth),  
43 mM NaCl (Merck), 14 mM K2HPO4 (Merck), 11 mM KH2PO4 (Merck),  
568 nM MgSO4 (Merck), pH 6.8, autoclaved 
lysis buffer/  20 mM Na2HPO4 (Merck), 0.5 M NaCl (Merck), 40 mM imidazole (Merck),  
binding buffer  2 mM 2-mercaptoethanol (Sigma-Aldrich), pH 7.4 
washing buffer 20 mM Na2HPO4 (Merck), 0.7 M NaCl (Merck), 40 mM imidazole (Merck),  
      2 mM 2-mercaptoethanol (Sigma-Aldrich), 0.5% Triton (Merck), pH 7.4 
elution buffer  20 mM Na2HPO4 (Merck), 0.5 M NaCl (Merck), 0.5 M imidazole (Merck),  
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3.6 Biochemical methods 
3.6.1 In vitro CCL21 cleavage  
To characterize the cleavage of CCL21 DCs were incubated with the chemokine in either 
RPMI medium supplemented with fetal calf serum (FCS), mouse plasma (MP) or enzymes 
to imitate plasma. The products of CCL21 cleavage in the cell supernatants were separated 
by SDS/PAGE on 15 % Tris-glycine-gels and blotted on polyvinylidene fluoride (PVDF) 
membrane. All cleavage assays were incubated at 37 °C, 5% CO2. 
- 150 ng of untagged CCL21 (R&D Systems) or 75 ng tagged CCL21 (expressed in 
P.pastoris) were incubated with 6x105 DCs in 100 µl R10 medium for 4 to 12 hr. The serine 
protease inhibitor aprotinin (Calbiochem) was applied at 150 mM.  
- The described assay was slightly modified by replacing the 10% FCS-supplement (heat 
inactivated for 20 min at 57 °C) in the R10 medium by not heat inactivated FCS, complete 
heat inactivated FCS (for 5 min at 90°C) or not heat inactivated MP. The assays were 
incubated for 15 hr.  
- 150 ng CCL21 were incubated with 8x105 B cells, 8x105 T cells or 4x104 MEFs in 100 µl 
R10 medium for 12 hr. 
- 150 ng CCL21 were incubated with 6x105 DCs in 100 µl RPMI containing 5% penicil-
lin/streptomycin and 10% not heat inactivated MP for 15 hr with different amounts of the 
plasmin inhibitor VFKck (Calbiochem). 
- 150 ng CCL21 were incubated with 4x104  LN-derived p19ARF-/- LN-fibroblasts in 100 µl 
RPMI containing 5% penicillin/streptomycin and 10% not heat inactivated MP for 15 hr 
- 150 ng CCL21 were incubated with 6x105 DCs in 100 µl RPMI containing 5% penicil-
lin/streptomycin as well as different amounts of plasminogen (mouse, Biopur) for 15 hr. 
 
Cell free cleavage assays: 
- 120 ng CCL21 were incubated with 50 nM plasmin (human, Sigma-Aldrich) in PBS with 
0.1% Tween-20. The reaction was stopped by heat-inactivation at 75°C for 15 min after 
different time points. 
- Different amounts of plasmin (mouse, LOXO) were incubated with 60 ng CCL21 in PBS. 
The reaction was stopped after 1 hr at 37°C by heat-inactivation at 75°C for 15 min. 
 
3.6.2 CCL21 pull-down from LN-lysate 
Mice were sacrificed by CO2 aspiration and popliteal, inguinal and axillary LNs harvested. 
The LNs were mechanically disrupted with the pistil of a syringe in 500 µl 4°C cold tissue 
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lysis-buffer. After 10 min incubation on ice the remaining tissue was completely disrupted by 
sonication and remaining tissue residues removed by centrifugation for 15 min at 15 g in a 
benchtop centrifuge. The supernatant was transferred to a new tube. 50 µl magnetic 
ProteinG Dynabeads (Invitrogen) were washed three times with 200 µl Dynabeads washing 
buffer by repeated resuspension followed by removal of the buffer with a magnet. The 
supernatant was incubated with washed Dynabeads to reduce protein background binding 
for 30 min under shaking (650 rpm). For antibody binding 50 µl washed ProteinG Dyna-
beads were resuspended in 200 µl washing buffer containing 10 µg of rabbit anti-mouse 
Exodus2 (PeproTech) and incubated for 30 min under shaking (650 rpm). After three 
washing steps the beads were resuspended in the pre-treated LN-lysate and incubated for 
30 min under shaking (650 rpm). Afterwards the beads were washed and resuspended in 30 
µl 6xSDS-PAGE sample buffer, heated at 95°C for 10 min and the in SDS-PAGE sample 
buffer eluted proteins analyzed by SDS-PAGE.  
To test for in vivo CCL21-cleavage under inflammatory conditions 5x105 mature DCs in a 
volume of 20 l PBS were injected into the hind footpads of a mouse. The popliteal LNs 
were harvested after 36 hr. The LN-lysate and CCL21 pull-down was carried out as 
described.  
 
tissue lysis buffer 50 mM Tris pH 8 (Sigma-Aldrich), 150 mM NaCl (Merck), 10 mM Na2EDTA 
(Merck), 0.05% desoxycholate, 1% Triton (Merck) + protease inhibitor 
cocktail (complete Mini EDTA-free, Roche, one tablet diluted in 10 ml buffer 
Dynabeads washing       PBS containing 1% Triton (Merck), pH 7.4 
buffer  
 
3.6.3 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE is the most commonly used method to separate proteins under denaturizing 
conditions. The negatively charged detergent sodium dodecyl sulfate (SDS) becomes 
associated with the proteins and promotes their solubilisation. Thus, the proteins become 
negatively charged and can be electrophoretically separated in the meshwork of a poly-
acrylamide-gel according to their individual molecular size and shape. All SDS-PAGE 
protein separations in this study were performed with the so-called discontinuous method, 
where a stacking gel is poured on top of a resolving gel, combined with a BisTris buffer 
system.  
The stacking gels had an acrylamide concentration of 5% and the resolving gels of 15%. 
The gels were prepared in a Biorad Mini gel casting device. The polymerized gels were fixed 
in a BioRad Mini Protean III electrophoresis module that was subsequently filled with 
running buffer.  
The protein samples were mixed with the appropriate amount of 6xSDS sample buffer and 
boiled for 5 min at 95°C and subsequently cooled down to RT before loading on the stacking 
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gel. As a protein standard the Precision Plus ProteinTM Strandards Kaleidoskope (Biorad) 
was applied. 
The electrophoresis was carried out at 80 V (stacking gel) to 120 V (resolving gel), 
respectively. 
 
5% SDS-stacking gel   6.8 ml ddH2O, 1.7 ml acrylamide mix (Serva), 
(10 ml):     1.25 ml 1 M Tris pH 6.8 (Sigma-Aldrich), 100 µl 10% SDS (Merck),  
100 µl 10% APS (Sigma-Aldrich), 10 µl N,N,N',N'-
tetramethylethylenediamine (TEMED; Serva) 
15% SDS-resolving gel 4.6 ml ddH2O, 10 ml acrylamide mix (Serva), 
(20 ml)     5 ml  1,5 M Tris pH 8.8 (Sigma-Aldrich), 200 µl 10% SDS (Merck), 
       200 µl 10% APS (Sigma-Aldrich), 8 µl TEMED (Serva) 
SDS-running buffer (10x) 250 mM Tris (Sigma-Aldrich), 2 M glycine (Riedel-de Haen),  
35 mM SDS (Roth) 
SDS-loading buffer (6x) 300 mM Tris (Sigma-Aldrich), pH 6.8, 0.2% bromphenol blue  
(Sigma-Aldrich), 50% glycerol (Merck), 5% 2-mercaptoethanol   
  (Sigma-Aldrich) 
 
3.6.4 Western-Blot 
Western blotting is a very sensitive method to detect and quantify specific proteins by 
means of antibodies. The proteins are firstly separated on a SDS-PAGE and subsequently 
electrophoretically transferred on a membrane. Here, a tank-blotting system war used for the 
electrophoretic transfer. On the membrane the proteins can be visualized by horseradish 
peroxidase (HRP)-coupled antibodies in combination with chemiluminescence immu-
nodetection reagents. The enzyme HRP catalyzes the release of light by oxidizing the 
chemiluminescent substrate with hydrogen peroxides.  
The polyvinylidene fluoride (PVDF) membrane (Immobilon, 0.2 µm, Millipore) was first 
incubated for 1 min in methanol and ddH2O, respectively, and finally for 10 min in blotting 
buffer. The blotting sandwich was composed of a sponge, one layer of Whatman paper, the 
SDS-PAGE, the pre-incubated PVDF-membrane, a second layer of Whatman paper and 
another sponge. All components were soaked with blotting buffer and layered bubble-free in 
the described order. The blot-sandwich was employed in a Mini Trans-Blot Cell (Biorad) with 
the membrane side of the blot-sandwich orientated toward the anode. The Trans-Blot Cell 
was filled with 4°C cold blotting-buffer. Blotting took place overnight at 4°C with a constant 
voltage of 25 V.  
For the immune detection the membranes were blocked with Tris buffered saline (TBS) + 
0.1% Tween20 (Sigma--Aldrich) containing 5% BSA for 1 hr at RT and incubated with the 
respective first antibody diluted in TBS + 0.1% Tween20 containing 5% BSA for 1.5 hr at 
RT. After washing the membrane three times for 15 min with TBS + 0.1% Tween20, the 
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membrane was incubated with HRP-conjugated secondary antibody diluted in TBS + 0.1% 
Tween20 containing 5% BSA for 1.5 hr at RT. The membrane was washed as described 
before followed by the antibody detection using Western LightningTM Chemiluminescence 
Reagent Plus (PerkinElmer). For chemiluminescence detection the PVDF membrane was 
incubated for 1 min with a mixture of 1 ml Solution A and 1 ml Solution B. All incubation 
steps were carried out under continuous shaking. The chemiluminescent signal was 
detected with an Image Reader LAS-4000 (Fuji Film).  
 
Table 4: Antibodies used for western-blot detection. 
Protein/tag First antibody Dilution Secondary antibody Dilution 
CCL21 Exodus 2 (PeproTech, 200 ng/µl) 1:1500 α-rabbit-HRP (Bio-
rad) 
1:10.000 





Flag-Tag α-Flag M2-Peroxidase HRP  
(Sigma-Aldrich) 
1:15.000 - - 
 
blotting buffer (10x)  250 mM Tris (Sigma-Aldrich) 2 M glycine (Riedel-de Haen) 
blotting buffer (1x)  200 ml methanol (Fisher Scientific), 100 ml 10x blotting buffer,  
700 ml ddH2O 
TBS (10x)    200 mM Tris (Sigma-Aldrich), 1.4 M NaCl (Merck), pH 7.5 
 
3.7 Immunostainings 
3.7.1 Immunostaining of LN cryosections 
Mice were sacrificed via CO2 aspiration, LNs isolated and the surrounding fat tissue carefully 
removed. Afterwards the LNs were embedded in tissue freezing medium (Thermo). With a 
cryostat 8 µm thick sections were cut and collected on glass slides. The sections were 
encircled with PapPen (Kisker) and subsequently fixed in pre-cooled methanol at -20° for 10 
min. After the slides completely dried the tissue was blocked with 1% BSA for 30 min at RT. 
Thenceforward the tissue sections were kept constantly wet with the help of a humidifying 
chamber. Primary antibodies were diluted in 1% BSA in PBS and incubated on the slides for 
45 min at RT followed by three PBS washing steps each 10 min at RT. Next, the sections 
were incubated with secondary antibody diluted in 1% BSA in PBS for additional 45 min at 
RT. Finally, the sections were washed as described before three times with PBS and 
mounted with Elvanol. Stained sections were examined using either a Zeiss Axiophot 
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fluorescence microscope and documented with the Openlab software version 3.1.2 
(Improvision) or an inverted confocal microscope (Leica, SP2). 
The following antibodies were used for immunofluorescence: Rabbit anti-mouse pan-laminin 
1 (rabbit anti-mouse, Sigma), ICAM-1 (hamster anti-mouse, BD Biosciences), anti-mouse 
Exodus2 (rabbit anti-mouse, PeproTech). Primary antibodies were detected using fluo-
rescein isothiocyanate (FITC)- or cyanine3 (Cy3)-conjugated goat anti-hamster or goat anti-
rabbit IgG secondary antibodies (Dianova), respectively.  
Elvanol     12 g Mowiol 4 – 88 (Roth) dissolved in 30 ml 87% glycerol (Merck),  
60 ml Tris-HCl pH 8.5 (Sigma-Aldrich) and 30 ml H2O  
 
3.7.2 Quantification of immobilized CCL21 and CCL19 by 
immunofluorescence 
Microscope slides were incubated for 1 min in a plasma cleaner (Harrick) to enhance protein 
loading capacity by charging the surface. Compartments were demarcated with PapPen 
(Kisker). Within the compartments drops of either 22.5 µg/ml CCL21 or 22.5 µg/ml CCL19 
mixed with 10 µg/ ml ICAM-1 were applied, the contour of the drops marked and incubated 
for 30 min. All incubation steps were carried out in a humidifying chamber at RT. Spots were 
washed with PBS and subsequently incubated with either 1 µg/ml anti-CCL21 (Exodus2; 
rabbit; Peprotech) or 1 µg/ml anti-CCL19 (goat; R&D Systems) in PBS with 1% BSA for 30 
min. After washing the coated areas were incubated with 7.5 µg/ml anti-rabbit Cy3 (donkey; 
Jackson ImmunoResearch) or anti-goat Cy3 (donkey; Jackson ImmunoResearch) in PBS 
with 1% BSA. After thoroughly rinsing with PBS the slides were embedded in Elvanol. The 
stainings were evaluated with a Zeiss Imager Z1 (40x objective) operated via AxioVision 
Rel.4.6.3 software. Fluorescence intensities were quantified using Image J software 
(http://rsbweb.nih.gov/ij/). 
 
3.8 Cell migration and spreading assays 
3.8.1 Time lapse video microscopy 
Experiments were performed at 37°C and 5% CO2 in a humidified and climatized chamber 
using a Zeiss Axiovert 40 CFL microscope operated via FireWire Recorder software (custom 
made, SVS-Vistek).  
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3.8.2 In vitro migration on LN-cryosections 
For migration on cryosections mouse inguinal LNs were snap-frozen in liquid nitrogen. 8-10 
m thick sections were collected on glass slides. The slides with the section were then 
immobilized on the bottom of a custom-built migration chamber, covered with 1 106 DC/ml 
DCs in R10 medium and observed by time-lapse video microscopy. 
Colour-coded composites were generated by superimposing background-subtracted binary 
layers using Openlab software version 3.1.2 (Improvision; Figure 16 C, Figure 17 C). 
Automated cell counting was done by creating background subtracted binary layers and 
subsequent automated pixel density measurements in the marked areas using Openlab 
software (Figure 16 B, Figure 17 A). 
 
3.8.3 In vivo migration of DCs 
Mature DCs were fluorescently labelled with 5 M 5-, 6-carboxyfluorescein diacetate 
succiniminidyl ester (CFSE, Molecular Probes). The DCs were washed with PBS and 
resuspended to a final cell concentration of 1 108 in PBS. 4 µM CFSE was added to the cell 
suspension. After 10 min incubation at RT the labelling reaction was stopped by adding the 
tenfold amount of R10 medium.  
After labelling and extensive washing in PBS, 5 105 DC in a volume of 20 l PBS were 
injected into mouse hind footpads. Draining popliteal LNs were harvested after 24 hr and 
snap-frozen in liquid nitrogen. 
 
3.8.4 Chemokine spot migration assay 
Custom-made glass bottom cell culture dishes were applied for this assay and partially 
incubated for 1 min in a plasma cleaner (Harrick) before use. Afterwards a solution of 22.5 
µg/ml CCL21 or 22.5 µg/ml CCL19 mixed with 5 µg/ml ICAM-1 were dropped onto the cover 
slip and the contour of the drops marked. The drop had in average a diameter of 1 mm. 
After 30 min at 37 °C the drop was washed three times with PBS and covered with 1 106 
DC/ml. The cell behavior was followed by time-lapse video microscopy. 2D projected cell 
surface areas were determined with Metamorph software (Zeiss) after 1, 5, 10 and 15 min. 
 
3.8.5 DC spreading on with polysialic acid (polySia)-coated surfaces 
5 cm cell culture dishes (Falcon) were coated overnight at 4°C with 10 µg/ml polySia 
(Sigma-Aldrich) in PBS. After two washing steps with PBS the dishes were blocked for 30 
min at 37°C with Tris-sucrose-magnesium (TSM) buffer containing 1% BSA. After rinsing 
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with PBS the dishes were let dry before a drop of either 22.5 µg/ml CCL21 or 22.5 µg/ml 
CCL19 in PBS containing 0.1% BSA mixed with 10 µg/ ml ICAM-1 was applied. For controls, 
spots of 0.1 % BSA in PBS mixed with 10 µg/ml ICAM-1 were applied. The contours of the 
drops were marked and the dishes incubated for 30 min at 37°C. After washing the 
chemokine/ICAM-1 coated area was covered with 1x106 DCs/ml. The surface area of the 
cells was determined microscopically after 1, 5, 10 and 15 min. 
TSM buffer     20 mM Tris-HCl (Merck), 150 mM NaCl (Merck), 1 mM CaCl2 (Merck),  
1 mM MgCl2 (Merck) 
 
3.8.6 DC adherence on CCL21-coated fibroblasts 
5x104 p19ARF-/- LN-fibroblasts in 500 µl R10 medium were filled into a dish with a diameter of 
2 cm. After two days the cells were washed two times with R10 medium followed by 
incubation with 200 µl of 1.25 µg/ml CCL21 in R10 medium. After 30 min at 37°C, 5% CO2 
the fibroblasts were rinsed twice with R10 medium and subsequently covered with 200 µl of 
1x106 DCs/ml resuspended in R10 medium for 5 min. Afterwards the dishes were washed 
three times with medium and the remaining, adherent cells counted. 
 
3.8.7 Under-agarose migration assay (UAA) 
UAAs allow the separation of migrating cells from diverse chemotactic sources and to 
determine the chemotactic potential of different chemoattractants (adapted from: Heit & 
Kubes, 2003). In a solid agarose/medium layer three holes were punched. The hole in the 
middle, the “responder hole”, was filled with DCs, the neighboring attractor holes with 
chemokines, inhibitors and/or DCs. The “attractor holes” allow the establishment of a 
concentration gradient and potential chemoattraction of the DCs. The DCs can react and 
migrate between the agarose layer and the underlying bottom of the cell culture dish 
towards the “attractor holes” (Figure 16).  
 
 
Figure 14: Scheme of an under-agarose assay (UAA). In a 
solid agarose/medium layer three holes were punched. In 
the responder hole in the middle DCs were filled. In the 
attractor holes to the left and the right potential chemoat-
tractants were applied. When a chemotactic concentration 
gradient is formed the cells in the middle can react and 
migrate towards the chemotactic source. 
 




10 ml of 4% Agarose (UltraPureTM, Invitrogen) resuspended in ddH2O were heated up until 
the agarose was solved. The agarose solution was then mixed with an on 55°C preheated 
mixture of 10 ml 2x Hank's buffered salt solution (HBSS) with 20 ml R20 medium. 2 ml of the 
final solution was filled into a dish with a diameter of 3 cm. After the agarose solidified three 
holes with a diameter of 3 mm were punched into the agarose. The holes were arranged in 
on line with a distance of 6 mm in-between. After the assay equilibrated for 30 min at 37°C, 
5% CO2 the holes (volume approximately 7 l) were filled with 6x10
4 DCs and/or 625 ng/ml 
CCL19, CCL21 or truncated CCL21 expressed in E.coli B834(DE3)pLysS (3.5.2, p.57). 
Pertussis toxin (List Biochemicals) was applied at 20 µg/ml and aprotinin (Calbiochem) at 
150 µM. After 15 hr at 37°C, 5% CO2 cells, which migrated out of the “responder” hole in the 
middle towards the “attractor holes” to the left and the right, were imaged using a Zeiss 
Axiovert 40 CFL microscope (20x objective) operated via custom-made software (Firewire 
recorder, SVS Vistek). Cells migrated out of the responder hole were counted in a defined 
area.  
HBSS (2x)   0,975 g/l Hanks’ balanced salts (Sigma-Aldrich), 7 mM Na2CO3 (Merck),  
      pH 7.2 
R20 medium   RPMI (Gibco) with 20% FCS (Gibco), 5% penicillin/streptomycin (PAA),  
5% glutamine (PAA) 
 
 
3.8.8 Modified UAA for TIRF microscopy 
To analyze the actin cytoskeleton and the localization pattern of different GFP-tagged 
proteins during DC migration a modified variant of the described UAA was used in combina-
tion with total internal reflexion fluorescence (TIRF) microscopy. TIRF microscopy uses an 
evanescent wave to selectively illuminate and excite fluorophores in a restricted 200 nm 
thick region adjacent to the cell membrane. The basic principal of TIRF microscopy is the 
excitation at a critical angle that generates an evanescent field when light passes from a 
medium of high refractive index (e.g. glass) to one of low refractive index (e.g. the cell). The 
field of excitation decays rapidly with distance from the coverslip, thereby limiting the depth 
of excitation to a small distance. 
For all TIRF-UAAs custom made glass bottom dishes were used. The glass slides were 
untreated, coated with CCL21 and ICAM-1 after plasma-treatment or coated with polyethy-
lene glycol (PEG). For chemokine coating the glass bottom dishes were plasma-treated for 1 
min in a plasma cleaner (Harrick) and afterwards covered with 22.5 µg/ml CCL21 and 10 
µg/ml ICAM-1 in PBS. After 30 min at 37°C the slides were rinsed three times with PBS. 
PEG coated slides were kindly provided by Julien Polleux. Shortly, glass coverslips were 
immersed in a 1 mmol solution of a linear PEG, CH3-(O-CH2-CH2)43-NH-CO-NH-CH2-CH2-
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CH2-Si(OEt)3 dissolved in dry toluene under nitrogen atmosphere for 20 hr. Finally, the 
substrates were rinsed intensively with ethyl acetate, methanol and ddH2O, and dried with 
nitrogen. 
For this variant of UAA, 5 ml of 5% Agarose (UltraPureTM, Invitrogen) dissolved in ddH2O 
was heated up until the agarose was completely solubilized. The agarose solution was 
subsequently mixed with 55°C warm solution of 5 ml 2xHBSS and 10 ml R20 medium. 400 
µl of the final solution was filled into a custom made gas bottom dish with a diameter of 2 cm 
and equilibrated at 37°C for 30 min. A hole was stamped into the agarose layer and filled 
with 600 ng/ml CCL19. Within a distance of approximately 5 mm 10.000 DCs were injected 
between the glass coverslip and the agarose layer. Lifeact-GFP macrophages or Lifeact-
GFP 3T3 fibroblasts were directly injected under the agarose layer without additional 
chemoattraction. TIRF microscopy was performed with an Axiovert 200 (Zeiss) microscope, 
a TIRF 488 nm laser system (Visitron systems) and a Cool-Snap-HQ camera (Roper 
scientific) triggered by Metamorph software (Molecular Devices).  
 
3.8.9 Carbon fiber migration assay  
To simulate the DC migration in the LN along fibroblastic reticular cells in vitro a modified 
variant of a 3D collagen migration assay (Lämmermann et al., 2008) with incorporated 
protein coated carbon fibers providing a haptokinetic scaffold was performed. At the same 
time the cells can sense an applied chemotactic concentration gradient (Figure 17).  
For the collagen gels 750 µl PureCol (stock: 3 mg/ml, bovine Collagen I, Nutacon) were 
carefully mixed with 100 µl 10xMEM (Sigma-Aldrich) and 50 µl NaHCO3-solution (Sigma-
Aldrich, 7.5%) to avoid bubbles. 600 µl of the collagen mix was subsequently added to 300 
µl of 3x106 DC/ml cell suspension in R10 medium and again mixed gently resulting in a final 
collagen concentration of 1.6 mg/ml. The final cell concentration in the gel was 1x106 DC/ml. 
The gels were casted into a custom-made chamber (thickness 2 mm) with protein-coated 
carbon fibers (BALTIC, BP 2308) with a diameter of 5 µm. For coating, carbon fibers were 
incubated with 5 µg/ml ICAM-1 and either 0.1% BSA or 5 µg/ml CCL21/CCL19 for 30 min. 
Polymerized gels were covered with R10-medium or R10-medium containing 0.17 µg/ml 
CCL19 or 0.54 µg/ml truncated CCL21, respectively, and observed via time-lapse video 
microscopy. Manual cell tracking was carried out using the software ImageJ with the 
„Manual Tracking Plugin‟ (http://rsbweb.nih.gov/ij/). 





Figure 15: Scheme of the carbon fiber migration 
assay.  A DC-collagen mixture was casted into 
a custom made chamber. Into the collagen gel 
chemokine-coated carbon fibers were incorpo-
rated. On top of the gel medium with chemoat-
tractant was filled to establish a chemotactic 




3.9 Statistical analysis 
Student‟s t-tests and analysis of variance (ANOVA) were performed after data were 
confirmed to fulfil the criteria of normal distribution and equal variance. Student´s t-test is 
used to compare the means of two samples and ANOVA to compare the means of three or 
more groups. Kruskal-Wallis tests or Mann-Whitney U-test were applied for data which does 
not fulfill the criteria of t-test and ANOVA (normal distribution and equal variance). The 
Mann–Whitney U test is a non-parametric statistical hypothesis test for assessing whether 
two independent samples of observations have equally large values. The Kruskal–Wallis 
one-way analysis of variance by ranks is an extension of the Mann–Whitney U test to three 
or more groups. For posthoc test of Kruskal-Wallis tests data were pairwise compared with 
Dunn´s method. Dunn´s method is used when the number of comparisons is small 









4.1 Chemotactically biased haptokinesis 
Most of the here presented data are published in Schumann et al., 2010 Immunity. 2010 May 
28;32(5):703-13. 
4.1.1 A reductionist in vitro system to study chemokine-driven DC migration 
Two-photon microscopy allows intravital observation of migrating leukocytes in vivo, but 
living tissues are notoriously complex and the multitude of cellular cross-talks makes it 
difficult to investigate molecular mechanisms that are non cell-autonomous. Thus, I chose a 
reductionist in vitro setup to analyze the chemokine-driven migration of DCs within LNs. 
CCL21 and CCL19 are both expressed by fibroblastic reticular cells (FRCs) in the T cell 
area of LNs. As mature DCs carry the CCL21-receptor CCR7 on their surface, I tested 
whether DCs could be used as environmental sensors of the chemokine distribution on LN 
cryosections. I layered mature bone-marrow derived DCs on unfixed, native cryosections of 
peripheral mouse LNs that were immobilized on a glass slide. Hence, the cells of the tissue 
substrate were not alive anymore, but proteins were unfixed and mainly in their natural 
conformation. The cell behavior was analyzed via time-lapse video microscopy over a period 
of 18 hr.  
When mature DCs were applied to these assays, cells that directly settled on the tissue, 
showed a random migration pattern. After 20 min also cells that were not in direct contact 
but in proximity to the tissue showed directed migration towards the cryosection. This 
resulted in a highly synchronized wave of directed migration from the periphery towards the 
inner part of the LN section (Figure 16 A-C; Movie S1). 12-18 hr after the onset of migration, 
DCs accumulated in the centre of the LN, the T cell area. After 18 hr almost no DCs could 
be detected on the glass control area [C] and only 20% of the overall cell density were 
locate at the rim of the section which represents the SCS. Migration was only observed 
when mature DCs were employed and not immature DCs (Figure 16 B; Movie S2) or other 
cell types, like macrophages, mast cells, B or T cells (personal communication M. Sixt). 
Mature DCs are the only cells that show directional migration towards LN cryosections. 
Surprisingly, DCs entered cryosections via special entry routes, suggesting migration along 
preformed tracks (Figure 16 A, red arrows). To investigate whether this reflects the 
physiological process, in vivo and in vitro migration assays were combined. Mice were 
injected subcutaneously with CFSE, a green fluorescent dye, labelled mature DCs into the 
foot pads and the draining popliteal LNs were excised after 10 hr. Histological analysis 
revealed immigrating CFSE positive cells in the interfollicular areas as shown by laminin co-
staining of the stromal infrastructure. Consecutive sections were then used as substrates for 
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the described in vitro migration assay (Figure 16 D, right panel). The applied DCs showed 
directed motility in regions that also contained the CFSE-labelled DCs that had migrated in 
vivo. DCs localised on the B cell areas showed almost no motility. These results demon-
strate that DC migration on tissue cryosections resembles the in vivo process as the cells 
still stick to their interfollicular entry routes migrating around B cell follicles and accumulate 
in the T cell area (Figure 16 D, right panel) as also described by Lämmermann et al. (2008). 
 
 
Figure 16: Organized DC migration on LN cryosections. (A) Contrast enhanced serial images of mature 
DCs on a section. Margins of the section are highlighted by the dotted line. Areas of high DC density are 
outlined (black line). Red arrows indicate entry sites of DCs. Small insert: brightfield image of the LN 
cryosection. Black boxes mark T cell area (T), sinus area (S), control area (C) used for quantification in 
(B). Scale bar represents 200 µm. (B) DCs were quantified in the areas C, S and T by automated density 
measurement. The upper diagram represents mature, the lower immature DCs. Data represent one out of 
>30 independent experiments. (C) Composite picture of serial images of (A). Different time points were 
colorized in graded wavelengths from yellow (1 hr) to red (18 hr) to show migratory fractions of DCs on 
the section. Dotted line: Outline of the section. (D) Left panel: section of a LN showing fluorescently 
labelled DCs (green) entering the LN via interfollicular areas 10 hr after subcutaneous injection. Laminin 
staining (red) highlights the reticular fibers surrounding the B cell follicle. Right panel: single cell 
tracking of DCs migrating on a consecutive section of the one shown left. Each track represents the 
pathway of a single cell. Dotted line: outline of the section. Scale bar represents 50 µm (taken from: 
Schumann et al., 2010).  
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Next, I wanted to define the guidance cues which establish these preformed migration 
pathways. As already mentioned, the predominant chemokines in the T cell area are the 
CCR7 ligands, CCL21 and CCL19. To test if the observed migration patterns on LN 
cyosection are CCR7-dependent, too, I applied mature Ccr7-/- DCs to the cryosection 
assays. Ccr7-/- DCs showed no directional migration toward the center of the LN cryosec-
tions (Figure 17 A). The same result was achieved by employing wild-type (WT) DCs to LN 
sections obtained from plt/plt mice, which lack the expression of both CCR7 ligands in the 
LN (Nakano et al., 1998). However, plt/plt DCs accumulated on WT LN cryosections (Figure 
17 A). These findings suggest that the observed DC migration patterns depend on the 
chemokine receptor CCR7 expressed on DCs and CCR7-ligands present on the LN 
cryosections.  
 
4.1.2 Soluble chemotactic gradient guides DCs on cryosection 
I could clearly observe directional DC migration on LN cryosections. Thus, an either 
immobilized or soluble gradient must persist in the in vitro LN migration assays and direct 
the cells. I immunostained LN cryosections for CCL21 and CCL19 in order to visualize a 
potential graded chemokine distribution. In conformity with previous studies (Luther et al., 
2000) CCL19 was not detectable on LN cryosection by this histological technique; probably 
because of the lower expression level of CCL19 and the marginal binding efficiency of 
CCL19 towards GAGs (Luther et al., 2001; Link et al., 2007; de Paz et al., 2007). By 
contrast the CCL21 signal highlighted the FRC network in the T cell area and left B cell 
follicles unstained (Luther et al., 2000; Woolf et al., 2007 and Figure 17 B). As previously 
described by Okada et al. (2005) the overall LN staining pattern was suggestive of a higher 
CCL21 concentration in the centre of the LN and a CCL21 gradient extending into the B cell 
follicles (Figure 17 B). 
To challenge the possibility of DC migration along an immobilized CCL21 gradient, a 
peripheral part of a LN cryosection was removed, inverted by 180° and repositioned next to 
the remaining tissue section (Figure 17 C, left panel). Also in this setup DCs showed a wave 
of directed migration, but the migration on the inverted small tissue segment was still 
directed towards the centre of the larger segment (Figure 17 C, right panel; Movie S3). The 
DCs migrating towards the big LN segment stopped at the margin of the inverted section, 
because DCs migrate poorly on glass surfaces and prefer to stay in contact with the tissue. 
Because the direction of migration had changed relatively to the tissue, the reason for 
directional DC migration cannot be an immobilized chemokine gradient. The DCs migrated 
towards a soluble chemotactic gradient emanating from the T cell area. Also the fact that 
DCs which are dislodged from the tissue show directed migration toward the cryosection 
support the idea of a soluble gradient (Figure 16 A, Figure 17 C). 
 




Figure 17: DCs are directed by soluble gradients. (A) Accumulation of wild type (WT), Ccr7
-/-
 and plt/plt 
DCs on either WT or plt/plt LN sections. Bars represent mean ± SEM, n = 3. (B) Fluorescent staining of a 
LN section for CCL21 (green) and ICAM-1 (red). Scale bar represents 200 µm. (C) A peripheral part of a 
LN section was dissected, inverted by 180° and repositioned in close proximity to the remaining part of 
the section. Left panel: Bright-field image of the manipulated section. Right panel: Migratory course of 
mature DCs on this section. Different time points were colorized in graded wavelengths from yellow (1 
hr) to red (4 hr) to show migrating fractions of DCs. Dotted line: outline of the section. Scale bar. Data 
represent one out of four independent experiments. Scale bar represents 250 µm. ***P<0.001, ns: not 
significant (taken from: Schumann et al., 2010). 
 
4.1.3 Response patterns to CCL21  
In order to investigate how the soluble chemotactic gradient is generated, I further simplified 
the migration assay. The experiments with Ccr7-/- and plt/plt DCs on cryosections indicated a 
central role of CCL21 (Figure 17 A), thus I assayed DC migration in the exclusive presence 
of recombinant CCL21. 
CCL21 was dropped onto the bottom of a polystyrene cell culture dish within a circular area 
of about 1 mm diameter and incubated at 37°C to enhance chemokine binding to the 
surface. Non-immobilized CCL21 was thoroughly washed away with PBS. Mature DCs were 
added and the coated area and its surrounding observed by time laps video microscopy 
(Figure 18 A). DCs directly settling onto the coated area showed rapid spreading, followed 
by increased random migration. In addition, 10 minutes after the onset of migration, DCs 
outside but adjacent to the coated area began a co-ordinate migration towards the coated 
area. During the following 15 hr, DCs continuously migrated in a directed manner towards 
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the CCL21 spot from regions of up to 1 mm away from the margins of the coated area, 
resulting in a dense aggregation of DCs on the coated area (Figure 18 C; Movie S4). When 
the cells reached the CCL21 spot, they also showed an increased random migration. Ccr7-/- 
DC showed no response to immobilized CCL21 (Figure 18 B). Previous work in the Sixt lab 
has shown that CCL19 spotted onto cell culture dishes induces some random motility in 
mature DCs, which are in direct contact with the chemokine, but no directional migration 
from the periphery to the chemokine spot (M. Sixt).  
 
 
Figure 18: Migration of DCs towards immobilized CCL21. CCL21 was plated on cell culture plastic 
(coated area marked by dotted circle). (A) Distribution of DCs on CCL21 coated area after 2 min (left 
panel) and 15 hr (right panel). Data show one representative out of >30 independent experiments. (B) 
Ccr7
-/- 
DC distribution after 15 hr. (C) Single cell tracking of migrating WT DCs. Each track represents the 
pathway of a single cell over 30 min. Migration is directed towards the CCL21 coated area (arrow) and is 
observed in uncoated areas up to 1 mm from the coated area (taken from: Schumann et al., 2010). 
 
These observations suggest that immobilized CCL21 has three different effects on mature 
DCs that appear in a distinct order:  
1)  rapid spreading 
2)  random migration 
3)  release of a soluble chemoattractant that leads to a positive feedback event attracting 
more DCs.  
I continued to dissect these individual responses with reductionist in vitro approaches.  
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4.1.4 DCs turn immobilized CCL21 into soluble CCL21 that resembles 
CCL19 
To further analyze the nature of the soluble attractant, I performed under-agarose migration 
assays, which allow the spatial separation of migrating DCs from the place where the 
chemotactic factor is released. Three holes were punched into an agarose/medium-layer. In 
the hole in the middle, the so-called “responder hole”, DCs were filled, the neighboring 
“attractor holes” contained different mixtures of chemokines, DCs and inhibitors. The 
“attractor holes” allow the establishment of a concentration gradient and potential chemoat-
traction of the cells that can migrate between the agarose and the underlying bottom of the 
culture dish (Figure 17 A). After 15 hr “responder” DCs, which migrated towards one of the 
“attractor holes”, were counted to determine the chemotactic capacity of the mixtures 
administered to the “attractor holes” (Figure 19 B). 
CCL21 triggered only minimal chemotactic response in under-agarose assays. The second 
CCR7 ligand, CCL19, on the other hand induced a vigorous, directed migration in responder 
DCs. These results indicated that CCL19, but not CCL21, is able to establish chemotactic 
concentration gradients. Responder DCs also migrated in a directed manner towards a 
mixture of DCs with CCL21 comparable to the migration towards CCL19. DCs alone did not 
attract other DCs. These results proved the induction of a soluble chemotactic gradient once 
DCs get into contact with CCL21. I observed the same effect when DCs were pre-incubated 
with CCL21 and only the cell supernatant was applied as an attractant.  
To elucidate the nature of the chemoattractant, responder DCs were incubated with 
pertussis toxin (ptx) which resulted in a complete blockade of migration. The outcome 
indicates G-protein coupled receptor (GPCR) αi dependent migration. The next step was to 
analyze if the soluble gradient is still sensed by the GPCR CCR7. Ccr7-/- DC were unable to 
respond to CCL21 alone as well as to a mixture of CCL21 and DCs. Therefore, the cells still 
sense the tactic signal via CCR7, suggesting that either an unknown CCR7 ligand, CCL19 
or a modified variant of CCL21 is released upon contact of DCs with CCL21.  
To test if the release of the chemotactic substance requires a CCR7 dependent signal I 
directly compared Ccr7-/- DCs as well as WT DCs co-incubated with CCL21 and found 
contrastable migration towards both attractor holes. Thus, the emerging soluble chemoat-
tractant is constitutively produced upon direct contact between CCL21 and DCs; previous 
binding of CCL21 to the receptor CCR7 is not necessary to induce the chemoattractant. 
Besides FRCs also some hematopoietic cell subsets like mature DCs secrete CCL19 
(Luther et al., 2000). To exclude CCL19-dependent chemoattraction plt/plt DCs, which 
cannot produce CCL19 (Vassileva et al., 1999; Mori et al., 2001; Nakano & Gunn 2001), and 
WT DCs were incubated with CCL21 and the chemotactic response of the WT responder 
DCs were directly compared. In both cases comparable chemotaxis was observed (Figure 
19 B). To rule out the third option, the release of an unknown chemoattractant by DCs after 
contact with CCL21, DCs where incubated with CCL21 in the absence or presence of 
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brefeldinA. BrefeldinA inhibits Golgi export and thereby protein secretion (Low et al., 1992). 
Application of BrefeldinA did not change the chemotactic potential of CCL21 incubated with 
DCs (personal communication M. Sixt). DCs do not release an unknown chemotactic factor 
after contact with CCL21. Together these results argue for a modified variant of CCL21 itself 
that is produced upon direct contact between DCs and CCL21. Modified CCL21 is able to 
establish chemotactic concentration gradients and induces CCR7-dependent chemotaxis. 
 
 
Figure 19: DCs modify CCL21. (A) Scheme of the under-agarose assay. The “responder hole” in the 
middle was filled with DCs, the “attractor holes” outside were filled with DCs and/or chemokine or 
inhibitor, allowing the establishment of a concentration gradient. When the cells sense a chemotactic 
gradient, they migrate out of the “responder hole”. (B) Number of cells that migrated out of the 
“responder hole” after 15 hr. Ptx: Pertussis toxin. Apr: Aprotinin. Sup: Cell supernatant. CCL21 trunc.: 
CCL21 with truncated C-terminus. If not indicated in red, WT DCs were applied as “responder cells”. 
Error bars represent mean ± SEM, n = 4-8, ***P<0.001, ns: not significant. (B) taken from: Schumann et 
al., 2010. 
 
To test for modifications after contact of CCL21 with DCs I performed Western blot analysis 
of CCL21 before and after incubation with DCs (Figure 20 A). With increasing incubation 
times a CCL21 fragment of reduced size (approximately 8 to 9 kDa) appeared, implicating 
proteolytic processing. In approximately 20% of the experiment two CCL21 fragments 
slightly differing in size appeared (Figure 20 A; red arrows). With 150 µM Aprotinin, a serine 
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protease inhibitor, the cleavage reaction could be blocked completely. Additionally Aprotinin 
was applied to the described under-agarose assay. DCs did not migrate towards cell 
supernatants of DCs pre-incubated with CCL21 and Aprotinin. Thus, the enzyme catalyzing 
the cleavage reaction belongs to the family of serine proteases. Besides that, I also 
examined if other cell population of the LN can process CCL21 (Figure 20 B). Incubation 
with T cells and B cells, respectively, lead to low, inefficient cleavage. The low amounts of 
CCL21 fragments also differ in size in comparison to the CCL21 fragment generated by 
DCs. Mouse embryonic fibroblasts, as an example of stromal cells, did not cleavage CCL21 
(Figure 20 C).  
Next, I wanted to test if the in vitro CCL21 cleavage recapitulates a physiological process. 
Therefore, peripheral LNs of WT mice were isolated, lysed and a CCL21 “pull-down” 
performed. With this technique full-length CCL21 as well as a CCL21 fragment of similar 
size as observed in vitro could be detected. Therefore, CCL21 cleavage clearly reflects an in 
vivo process. To test if the in vivo CCL21 cleavage reaction is influenced by LN inflamma-
tion, for example by the increasing number of mature DCs in the LN, pull-downs out of 
inflamed LNs were performed. In inflamed LNs the amount of mature DCs is higher in the 
tissue. 36 h before harvesting the popliteal draining LNs DCs were injected into the foot 
pads of mice. The isolated popliteal LNs were clearly enlarged – a sign for inflammation. 
However, in the pull-down only a faint band of the CCL21 fragment could be detected 
(Figure 20 D). Under inflammatory conditions the amount of cleaved CCL21 is reduced in 
LNs.  
The main difference between CCL21 and CCL19 is the C-terminal extension of CCL21 that 
is highly charged and binds to anionic surfaces as for example heparan sulfate residues 
(Hirose et al., 2001; Hirose et al., 2002; Ueno et al., 2002; Uchimura et al., 2006). To map 
the cleavage site I expressed recombinant CCL21 carrying an N-terminal Flag and a C-
terminal His tag in the yeast Pichia pastoris and detected on Western-blots the chemokine 
as well as the two tags after exposure to DCs (Figure 20 E, F). Mature DCs were able to 
process the recombinant, tagged CCL21 protein. In the αCCL21 and the αFlag-tag Western-
blots full-length chemokine as well as CCL21 fragment were clearly detectable. But by 
detecting the His-tag only the unprocessed CCL21 could be observed (Figure 20 E, F). This 
result together with the difference in size between processed and full-length CCL21 proved 
the complete loss of the immobilizing C-terminus. This result is emphasized by the 
comparison of CCL19 and CCL21 in under agarose assays, where CCL19 in contrast to 
CCL21 induces directional migration that cannot be enhanced by co-incubation with DCs 
(Figure 19 B). Moreover, a truncated version of CCL21 without heparan sulfate binding C-
terminus triggered vigorous directional DC migration without incubation with DCs (Figure 19 
B). These findings demonstrate that upon contact with mature DCs CCL21 is proteolytically 
processed into a variant that lacks the heparan sulfate binding C-terminus. The CCL21 
fragment diffuses and acts as a chemoattractant which functionally resembles unprocessed 
CCL19. 






Figure 20: DCs turn immobilized CCL21 into soluble CCL21: (A) CCL21 was incubated with DCs for up to 
12 hr. Processing of CCL21 was determined by western-blot analysis. Control (-): CCL21 incubated in 
medium without DCs. Red arrows indicate CCL21 fragments slightly differing in size. (B) CCL21 was 
incubated with DCs or with DCs and aprotinin for 15 hr. Control (-): CCL21 incubated in medium without 
DCs. (C) DCs, B cells, T cells and mouse embryonic fibroblasts were co-incubated with CCL21 for 12 hr 
before western-blot analysis of the supernatant. (D) In vitro: CCL21 cleavage after 12 hr co-incubation 
with DCs. In vivo: Pull-down of in vivo cleaved CCL21 out of LN-lysate. To test for CCL21 cleavage under 
inflammatory conditions 36 hr before isolation of popliteal LNs DCs were injected into the foot pads of 
the mice (in vivo + DCs). (E) Scheme of the Pichia pastoris CCL21 construct with N-terminal Strep-tag 
and C-terminal His-tag. (F) Western-blot analysis of tagged CCL21 (detection of CCL21, His- and Flag-
tag) after 15 hr incubation with DCs (+). Control (-): CCL21-incubation in R10 medium without DCs. (A), 
(B), (C), (D) and (F) taken from: Schumann et al., 2010. 
 
4.1.5 Plasmin cleavage of CCL21 
A seminal question arising from the previous findings is which protease cleaves CCL21. 
Using pharmacological inhibitors it could be shown that the sought-after protease belongs to 
the family of serine proteases (Figure 20 B). CCL21 processing is induced upon direct 
contact between chemokine and the DC cell surface. The CCL21 cleaving protease could 
either be produced by DCs themselves and transported to the cell membrane or be recruited 
from the surrounding FCS to the cell surfaces. To test the second hypothesis DCs were 
incubated with CCL21 without FCS or in the presence of FCS that was completely heat-
inactivated at 95°C for 5 min. In both cases no CCL21 processing could be observed (Figure 
21 A). These results were not due to a lack of nutrients in the absence of FCS or nutrient 
degradation in complete heat inactivated FCS; the DCs applied to these cleavage assays 
Results   
77 
 
showed a normal morphology and no increased apoptosis during the experiments. Hence, 
the conclusion was that the cleavage reaction is not a DC autonomous, but a FCS-
dependent process. DCs recruit a serine protease or a co-factor from the applied serum to 
their surface to activate the enzyme, which then cleaves CCL21. 
 
 
Figure 21: CCL21 cleavage in the presence of serum or plasma, respectively, after 15 hr incubation. (A) 
DC-dependent processing of CCL21 with/without (Ø) FCS or completely at 95°C heat-inactivated FCS 
(FCS
HI
). (B) CCL21 processing by non-heat-inactivated mouse plasma (MP) or the combination of MP 
with DCs or p19
ARF-/- 
LN-fibroblasts after 15 hr. 
Next, I replaced FCS with not-heat inactivated mouse plasma (MP), a more physiological 
supplement. Astonishingly CCL21 cleavage can take place in not-heat inactivated MP also 
without additional co-incubation with DCs. But the cleavage could be enhanced by the 
addition of DCs and surprisingly also by the addition of LN-derived p19ARF-/- fibroblasts 
(provided by S. Luther). MP comprehends a serine protease that cleaves CCL21. The 
efficiency of the cleavage reaction is higher in the presence of cells, which probably recruit 
the enzyme to their surface which leads to a fully activated serine protease. This result is 
contrary to previous results derived from co-incubation of mouse embryonic fibroblasts with 
the chemokine in the presence of FCS. In this case no CCL21 cleavage could be detected 
(Figure 20 C). Moreover, in the MP-supplemented CCL21 cleavage assays was the over-all 
amount of CCL21, the processed and unprocessed one, increased upon co-incubation with 
cells, either DCs or p19ARF-/- LN-derived fibroblasts compared to the incubation only with 
plasma, although the same amount of recombinant chemokine was employed to each of the 
cleavage assays (Figure 21 B). Cell surfaces seem to protect full-length as well as cleaved 
CCL21 from further degradation. 




Figure 22: Plasmin cleavage of CCL21. (A) Scheme of the production and degradation of fibrin (taken 
from Schäfer & Werner, 2008). (B) Incubation of DCs and CCL21 with different amounts of the plasmin-
inhibitor VFKck in R10 medium. (C) CCL21 was incubated with 50 nM human plasmin in PBS with 0.1% 
Tween-20. The reaction was stopped by heat-inactivation after different time points. DC control (DC ctrl): 
DC dependent CCL21 cleavage in R10 medium. (D) Different amounts of plasmin were incubated with 
CCL21 in PBS for 1 hr. (E) DC dependent CCL21 cleavage in R10 supplemented with different amounts of 
plasminogen instead of blood serum or plasma, respectively. Mouse plasma control (MP ctrl): CCL21 
incubated with DCs in RPMI supplemented with not heat-inactivated MP. All samples were incubated for 
15 hr. 
Several reaction cascades depending on serine proteases, which bind to cell surfaces upon 
activation, are known, as for example the complement system, the blood coagulation 
cascade and fibrinolysis. Fibrinolysis is the process of disintegrating fibrin clots, the products 
of blood coagulation, by the enzyme plasmin. Plasmin cuts the fibrin network into small 
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fragments that can be transported by the blood circulation and finally be degraded by other 
proteases in kidney and liver. The liver releases the zymogen plasminogen into the blood 
circulation. Plasminogen is converted into the active enzyme by proteolytic processing of 
tissue plasminogen activator, urokinase plasminogen activator or serine proteases of the 
kallikrein family (Figure 22 A). Plasmin has also several non-fibrolytic functions like ECM 
degradation, matrix metalloproteinase- and growth factor activation (Plow & Hoover-Plow, 
2004). It is known that plasmin cleaves several chemokines like CCL1, CCL2 and CXCL8 
(Vakili et al., 2001; Sheehan et al., 2007; Proost et al., 2008). Plasminogen knockout (Plg-/-) 
mice are retarded in growth, have severe defects in mammary gland involution and female 
fertility, monocyte recruitment to inflamed tissue and exhibit fibrin depositions and thrombotic 
lesion in many tissues (Green et al., 2006; Ploplis et al., 1998). These defects result in an 
early mortality. Besides that, plasminogen can also be detected in lymphatic tissues 
(Yamakawa et al., 1991). Because of these reasons plasmin appeared to be a promising 
candidate. 
First, I added the highly selective plasmin inhibitor D-Val-Phe-Lys chlormethyl ketone 
(VFKck, IC50 = 100 pM to human plasmin [Merck]) to the cleavage assay composed of 
mature DCs and CCL21 in R10 medium. When the inhibitor was applied in extremely high 
concentrations of 250 µM only a very faint band of cleaved CCL21 remained (Figure 22 B). 
Moreover, when recombinant CCL21 was incubated with human plasmin two chemokine 
fragments appeared. The fragments exhibit a similar size as the CCL21 cleaved by DCs in 
the presence of FCS (Figure 22 C; DC ctrl). After 2 hr the second, shorter variant of CCL21 
dominates (Figure 22 C). But it was not possible to accumulate cleaved CCL21 in this in 
vitro assay to further characterize the fragments, for example determine the exact cleavage 
site by mass spectrometry. Plasmin degraded the CCL21 fragments (Figure 22 D).  
Plasmin is secreted into the blood circulation as an inactive zymogen, plasminogen. Next, I 
tested if DCs only recruit active plasmin to their surface or if they are also able to recruit 
plasminogen and activate the proenzyme by proteolytic processing. Therefore, DCs were 
incubated in RPMI medium supplemented with mouse plasminogen to replace FCS. Also in 
this experiment two CCL21 fragments could be detected, whereas the shorter CCL21 
fragment accumulated with increasing amounts of added proenzyme. Hence, DCs can turn 
the zymogen plasminogen into its active form, plasmin, which then generates two CCL21 
fragments. 
Because the CCL21 processing can only inhibited in presence of very high concentrations of 
VFKck, blood plasma collected from Plg-/- mice was applied to the cleavage assay and 
compared to WT plasma to further confirm the results. Firstly, CCL21 was incubated with 
RPMI supplemented with either WT or Plg-/- MP. In both cases cleaved CCL21 could be 
detected. However, in the cleavage assay supplemented with WT plasma a higher amount of 
cleaved CCL21 could be detected. Moreover, the CCL21 fragments slightly differed in size 
between the WT and the Plg-/- cleavage assay. In addition to that, the band of cleaved 
CCL21 detected in the WT plasma was thicker and blurred. This band consisted of two 
CCL21 fragments which differed marginally in size. When these cleavage assays were 
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repeated in the presence of DCs, the amount of fragmentized CCL21 was in both cleavage 
assays higher as described before. However, the overall result was the same as observed in 
the absence of DCs: In the cleavage assay with DCs and WT plasma to CCL21 fragments 
appeared only slightly differing in size, whereas in the assay with Plg-/- plasma only the 
smaller band could be detected. When the Plg-/- plasma cleavage assay was rescued with 
purified mouse plasminogen, almost all CCL21 was cleaved and only the second, smaller 
CCL21 fragment could be detected (Figure 23 A). The experiments with Plg-/- plasma reveal 
that plasmin is only one of two or even more serine proteases that can cleave CCL21: Two 
CCL21 fragments could be verified in WT MP and only the second smaller fragment is 
generated by plasmin. When recombinant plasminogen is added the second plasmin-
dependent fragment accumulates over time. 
To confirm these results in a more physiological setting CCL21 was pulled-down from LN-
lysates of WT, Plg+/- and Plg-/- mice. In all three cases processed CCL21 could be isolated. 
In this experiment no difference between WT and Plg-/- could be detected either in the 
amount or the size of the CCL21 fragment. The amount of processed CCL21 was slightly 
increased in the heterozygous LNs (Figure 23 B). Thus, it is unclear if the plasmin cleavage 
of CCL21 is relevant in vivo. I want to mention that the results from these LN pull-down are 
only preliminary and should be repeated. 
 
 
Figure 23: Analysis of CCL21 processing in Plg
-/-
 plasma and LN lysates. (A) Incubation of R10 medium 
supplemented with WT and Plg
-/-
 MP without/with DCs for 12 hr. Rescue with recombinant mouse 
plasminogen is marked in red. Red arrows indicate the size of the two CCL21 fragments. (B) CCL21-






4.1.6 Immobilized but not soluble chemokine triggers integrin activation on 
DCs 
The morphology of migratory DCs on LN cryosection and on immobilized CCL21 point 
towards a central role of adhesion during migration on these substrates. Migratory DCs had 
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a polarized, elongated shape, whereas non-migratory DCs which settled on B cell follicles 
stayed roundish with small dendrites scanning the environment (Figure 24 A; Movie S5). 
Therefore, a possible crosstalk between CCL21 and integrins on DCs was assumed. 
Different integrins knockout DCs were applied to cryosection migration assays, but only β2 
integrin knockout (Itgb2-/-) recapitulated the non-migratory phenotype: Itgb2-/- DCs showed 
significantly less migration on LN cryosections, also in the T cell area. The cells stayed 
roundish and unpolarized. Mature DCs normally carry inactive integrins on their surface 
(Figure 24 B; Movie S6). Hence, only β2 integrin can be activated on LN cryosections. 
 
 
Figure 24: DC migration on LN cryosections is β2 integrin dependent. (A) Morphology of a DC applied to 
a LN section after 0, 2 and 4 hr. Upper panels: Elongated, non-dendritic “amoeboid” shape of a DC 
migrating on a sinus area. Lower panels: Rounded, dendritic-like morphology of a non-migrating DC on a 
B cell follicle. The cell surfaces are highlighted in green. Scale bar represents 10 µm. (B) Accumulation of 
WT and Itgb2
-/-
 DCs on a LN sections. Error bars represent mean ± SEM, n = 3. ***P<0.001.  Adapted from: 
Schumann et al., 2010. 
 
I decided to analyze the chemokine dependent activation of 2 integrin to compare the 
capacity of CCL19 and CCL21 to induce cell spreading. The most important 2 integrin 
ligand in LNs is ICAM-1. Therefore, WT DCs were allowed to settle onto glass cover slips 
coated with a mixture of recombinant ICAM-1 with CCL21, CCL19 or BSA as a negative 
control, respectively. Changes in the 2D cell surface were measured over time.  
DCs showed rapid spreading within minutes after contact with CCL21 plus ICAM-1 (Figure 
25 A). The spreading response was transient and almost immediately followed by random 
polarization and initiation of migration (Figure 25 C). Coated ICAM-1 and BSA did not trigger 
spreading, indicating again a quiescent state of the ICAM-1 binding 2 integrins in mature 
DCs. When DCs were placed on co-coated CCL19 and ICAM-1, almost no spreading 
response could be observed (Figure 25 A). One possible explanation is that CCL19 failed to 
induce spreading because the chemokine is not presented in an appropriate way to the DCs 
due to the missing flexible C-terminus. Possibly CCL19 binding to an ECM molecule induces 
DC spreading. Bax et al. (2009) demonstrated that polysialic acid (PolySia) is a physiologi-
cal platform for the immobilization of CCL21. Cell culture dishes were first coated with a 
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PolySia-solution. Afterwards the PolySia pre-treated dishes were coated with a mixture of 
recombinant ICAM-1 with CCL21, CCL19 or BSA, as described before. Mature DCs applied 
to these different coated surfaces showed the same behaviour as described for glass: Rapid 
spreading on CCL21 and no spreading response to CCL19 or BSA (Figure 25 B). 
 
Figure 25: DC spread on immobilized CCL21. (A) Quantification of the 2D projected cell surface after 
contact with either CCL21/ICAM-1, CCL19/ICAM-1 or BSA/ICAM-1 coated glass surfaces after 1, 5, 10 and 
15 min. Error bars show mean ± SEM, n = 25. (B) 2D projected cell surface of DCs plated on with 
polysialic acid coated glass slides before application of either CCL21/ICAM-1, CCL19/ICAM-1 or 
BSA/ICAM-1 after 1, 5, 10 and 15 min. Error bars show mean ± SEM, n = 25. (C) Outline of a DC polarizing 
on a CCL21/ICAM-1-spot over 13 min. The surface of the DC is highlighted in green. (D) 2D projected 
surface of DCs on ICAM-1 coated glass surfaces after 1, 5, 10 and 15 min incubation with CCL21, CCL19 
or BSA applied to the medium. Scale bar represents 25 µm. Error bars represent mean ± SEM, n = 25. 
Adapted from: Schumann et al., 2010. 




The lack of spreading response on plated CCL19 compared to CCL21 could either be due to 
differential signaling properties or to a lack of surface immobilisation due to the absent 
charged C-terminus. When CCL21 or CCL19 were directly applied to the cell supernatant in 
concentrations that largely overmatch the amounts needed to trigger chemotactic migration 
no spreading response could be observed. Soluble CCL21 or soluble CCL19 cannot 
activate 2 integrins (Figure 25 D). To revise the hypothesis that only the presenting mode 
of the two CCR7 ligands induces the different cell responses CCL19 was artificially 
immobilized. Therefore, glass surfaces were plasma-treated. During plasma treatment the 
glass surface gets electrically charged to enhance the protein loading capacity. The protein 
loading before and after plasma treatment was analyzed by fluorescent measurements 
(Figure 26 A). CCL19 immobilizes on the charged surface to the same amount as CCL21 on 
untreated glass. Indeed, in this setup also CCL19 induced cell spreading similar to CCL21, 
although more transiently and with only 80% of the efficiency of CCL21. When I employed 
Itgb2-/- and Ccr7-/- DCs on CCL21 ICAM-1 co-coated surfaces, no spreading was observed 
(Figure 26 B, Movie S7). These findings indicate that the interaction between CCR7 and 
immobilized CCL21 or artificially immobilized CCL19, but not soluble CCR7 ligands, induces 
inside-out-activation of β2 integrins resulting in cell spreading. 
 
Figure 26: DCs can also spread on artificially immobilized CCL19. (A) Quantification of immobilized 
CCL21 or CCL19 on glass or plasma-treated glass by fluorescence staining. Error bars represent mean ± 




 DCs after contact with a plasma-treated 
and subsequently CCL21/ICAM-1, CCL19/ICAM-1 or BSA/ICAM-1 coated glass surface after 1, 5, 10 and 
15 min. Error bars represent mean ± SEM, n = 25. Adapted from: Schumann et al., 2010. 




4.1.7 Directional steering of haptokinetic movement 
It could be shown that DCs respond to immobilized CCL21 with cell spreading and random 
migration, whereas CCL19 or truncated, soluble CCL21 can induce directed motility. 
Immobilized CCL21 can thereby define a chemokine field, a haptokinetic area with sharp 
boundaries as shown in the “spot-assay”, or also a chemotactic track. Soluble CCR7 ligands 
are able to form chemotactic concentration gradients. These results raise fundamental 
questions. Are DCs able to sense immobilized and soluble CCR7 ligand at the same time? 
Can the cells integrate the different signals and respond to them together?  
To test these considerations in a controlled experimental setup I established a 3D collagen 
gel chemotaxis assays with incorporated protein coated carbon fibers to simulate a 
haptokinetic scaffold. The carbon fibers with a diameter of 5 µm were coated with ICAM-1 
and CCL21, CCL19 or BSA. It was shown by Lämmermann et al. (2008) that DCs can 
respond to chemotactic gradients applied to collagen gels and squeeze themselves through 
the collagen meshwork to migrate towards the chemotactic source. In the 3D collagen gel 
fiber assay DCs are exposed to a chemotactic gradient and a haptokinetic migration scaffold 
at the same time. 
First, I characterized this migration assay without an applied chemotactic gradient. DCs 
incorporated in collagen gels with BSA plus ICAM-1 coated carbon fibers show a random 
migration pattern ignoring the fibers (Figure 27 A, Movie S8). But when DCs get into contact 
with CCL21/ICAM-1 co-coated carbon fibers, the cells adhered to fibers and migrated up 
and down, frequently switching directionality (Figure 27 B, Movie S9). DIC microscopy 
showed adhesion and spreading on the fibers (Figure 27 C). When p19ARF-/- LN-fibroblasts 
isolated out of peripheral LNs, where they form the FRC network, were pre-incubated with 
CCL21 significantly more DCs adhered to the cells than without chemokine treatment 
(Figure 27 D). Hence, chemokine coated carbon fibers can mimic CCL21 decorated FRCs to 
a certain level. These results prove that CCL21 plus ICAM-1 co-coated carbon fibers provide 
a haptokinetic scaffold. 
In the spreading assays described before surface-bound CCL21 induced inside-out 
activation of β2 integrins (Figure 26 B), which results in haptokinetic cell motility. Next I 
wanted to determine if the haptokinetic migration pattern on CCL21 coated carbon fibers 
also relies on β2 integrin activation. WT and Itgb2-/- DCs were incubated in collagen gels 
with incorporated CCL21/ICAM-1 co-coated carbon fibers. After 5 hr of incubation the 
numbers of cells attached to the fibers were determined. The result was that three times 
more WT than Itgb2-/- DCs were attached to the fibers (Figure 27 E). Thus, the haptokinetic 
migration on carbon fibers is again β2 integrin-dependent.  
 




Figure 27: CCL21 plus ICAM-1 co-coated carbon fibers act as haptokinetic scaffold. Three-dimensional 
collagen gel assays with incorporated protein-coated carbon microfibers. (A), (B): Left panels: Bright-
field image of the collagen gel with coated fibers. Right panels: Single cell tracking of DCs. Here, each 
colored track represents the pathway of a single cell. Scale bar represents 100 µm. (A) WT DCs in the 
presence of BSA plus ICAM-1-coated carbon fibers. (B) WT DCs in the presence of CCL21 plus ICAM-1-
coated carbon fibers. (C) Differential interference contrast image of DCs spreading on a CCL21 plus 
ICAM-1-coated fiber. Scale bar represents 100 µm. (D) DC spreading on p19
ARF-/-
 LN-fibroblasts without 
(ctrl) or with CCL21 pre-coating. (E) Quantification of WT and Itgb2
-/-
 DCs associated with CCL21 plus 
ICAM-1-coated fibers after 5 hr incubation. Bars represent mean ± SEM, n = 5. (F) Quantification of WT 
DCs associated with CCL21 plus ICAM-1-coated fibers after 5 hr incubation in a collagen gel with 
different CCL19-gradients applied. Error bars represent mean ± SEM, n = 4. **P<0.01, ***P<0.001. (A), (B), 
(C), (E) and (F) taken from: Schumann et al., 2010. 
Next, I followed DC migration by time laps video microscopy, while the cells were exposed 
to CCL21 /ICAM-1 co-coated fibers and a chemotactic gradient at the same time.  A soluble 
gradient of either CCL19 or truncated CCL21 were applied to the collagen gels containing 
CCL21/ICAM-1 co-coated carbon fibers. Strikingly, chemotactic gradients can steer DCs 
attached to the fibers. Furthermore, once cells contacted a fiber, they preferred to follow its 
surface even if they were distracted from the direct path. Not attached cells move freely 
through the gel towards the gradient (Figure 28 A, B; Movie S10, Movie S11).  
 





Figure 28: Soluble chemokine steers haptokinetic migration. Three-dimensional collagen gel assays with 
incorporated protein-coated carbon microfibers. (A), (B), (C), (D): Left panels: Bright-field image of the 
collagen gel with coated fibers. Right panels: Single cell tracking of DCs. Here, each colored track 
represents the pathway of a single cell. Scale bars represent 100 µm. (A) Directionally biased DCs 
migration on CCL21 plus ICAM-1-coated fibers within a CCL19 gradient. DCs remote from coated fibers 
migrate through the collagen gel towards the CCL19 gradient. (B) WT DCs migrating with a directional 
bias in a collagen gel with CCL21 plus ICAM-1-coated fibers towards a gradient of truncated CCL21. (C) 
Itgb2
-/-
 DCs migrating in a collagen gel with CCL21 plus ICAM-1-coated fibers and applied CCL19-
gradient. (D) WT DCs migrating with a directional bias in a collagen gel with CCL19 plus ICAM-1-coated 
fibers towards a gradient of truncated CCL21. Adapted from: Schumann et al., 2010. 
 




Occasionally DCs detached from the fibers and followed exclusively the soluble gradient. To 
further analyze if strong chemotactic gradients can counteract the haptokinetic scaffold 
CCL19 gradients of different steepness were applied to the described fiber assay and after 5 
hr the number of cells attached to the chemokine coated fibers determined. With increasing 
amounts of CCL19, fewer WT DCs remained attached to the fibers (Figure 27 F). Soluble 
CCL19 gradients can counteract the haptokinetic CCL21 interface. These results suggest 
that the adhesive and the chemotactic signals compete with each other. Itgb2-/- DCs applied 
to the same assay showed in accordance with previous results no interaction with the fibers 
but moved with unimpaired speed and directionality within the gels (Figure 28 C; Movie 
S12). As a further control carbon fibers were coated with CCL19 plus ICAM-1 and combined 
with a gradient of truncated CCL21. In this case DCs followed strictly the soluble gradient of 
truncated CCL21 ignoring the fibers (Figure 28 D; Movie S13). The fiber-bound CCL21 
induces inside-out activation of β2 integrin which induces cell adherence to the fibers. 
CCL19 cannot provide a haptokinetic scaffold. These results showed that DCs can respond 
to a CCL21 field haptokinetically via CCR7 while simultaneously using another fraction of 
CCR7 to sense a soluble gradient that then introduces a directional bias. 
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4.2 Adaptive force transmission in amoeboid cell migration 
The project “Adaptive force transmission in amoeboid cell migration” was carried out in 
cooperation with a master student in the lab, Jörg Renkawitz (Renkawitz et al., 2009). The 
aim of the project was to analyze how DCs can migrate in three-dimensional interstitium 
without transmitting traction forces by integrin transmembrane receptors to the environment 
(Lämmermann et al., 2008). This analysis can potentially also explain how DCs can 
overcome chemotactically biased haptokinesis and follow exclusively a chemotactic 
gradient.  
For this purpose the under-agarose assay (UAA) was combined with TIRF microscopy, 
which allows the visualization of a 200nm thick layer close to the surface. The UAA 
generates a pseudo three-dimensional setting: The cells are squeezed between the bottom 
of a cell culture dish and an agarose-layer without altering the integrin-independency of 
migration. The cells were filmed while they chemotaxed towards a CCL19 gradient (Figure 
29). The cortical actin-cytoskeleton was visualized with the probe Lifeact-GFP. Lifeact-GFP 
is a 17 amino acid peptide, which stains filamentous, assembled actin structures in living 
cells without interfering with actin treadmilling (Riedl et al., 2008; Riedl et al., 2009). 
 
 
Figure 29: Scheme of the under-agarose assay to analyze the actin cortex. Cells were squeezed between 
the bottom of a cell culture dish and an agarose-medium layer generating a confined pseudo three-
dimensional environment. Cells were filled into a hole punched into the agarose layer or in the majority of 
the cases directly injected under the agarose. The chemokine CCL19 was filled into a second hole to 
establish a chemotactic concentration gradient (taken from: Renkawitz et al., 2009). 
4.2.1 Retrograde actin flow in WT and Itg-/- DCs 
First, the described set-up was tested with WT DCs. The cells squeezed under the agarose 
formed a broad lamellipodium with diffusely distributed actin. In the trailing edge thicker actin 
bundles were detected (Figure 30 A; Movie S14). The central axis of the chemotaxing DCs 
was kymographic analyzed. The Kymograph demonstrated that the actin cortex mostly 
remained stationary. At the trailing edge actin started to move forward in relation to the 
substrate (Figure 30 A). In 50% of the examined WT DCs retrograde actin flow from the 
Results   
89 
 
lamellipodium into the cell center was measured. The retrograde actin flow was limited to the 
first 2 to 4 µm of the lamellipodium. The maximum retrograde flow velocity in the 33 
analyzed WT DCs was 4.7 µm/min; the mean retrograde flow velocity amount to 1.23 
µm/min (± 1.48 standard derivation (STDV); Figure 30 C). The fact that almost no retrograde 
flow in WT DCs can be observed indicates force coupling to the substrate (median: 0 
µm/min; Figure 30 C).  
To test if force coupling is facilitated via integrin transmembrane receptors complete integrin 
knockout (Itg-/-) DCs were applied to this assay. In these cells all possible leukocyte integrin 
heterodimers are deleted by the knockout of the β1, β2, β7 and αν subunits. In Itg-/- DCs the 
molecular clutch is genetically uncoupled. Surprisingly, no shape changes could be 
observed in Itg-/- DCs migrating under the agarose layer (Figure 30 B; Movie S15). Besides 
that, the cell reached the same migration speed compared to WT DCs while migrating 
towards CCL19 (Figure 30 D; Renkawitz et al., 2009). These results are consistent with 
previous results that in confined three-dimensional environments integrin-mediated force 
coupling is dispensable for cell movement (Lämmermann et al., 2008). Unimpaired 
protrusion speed and loss of adhesions seems to be contradictory. But the kymographic 
analysis of the actin cortex revealed a massive retrograde flow in Itg-/- DCs with an average 
actin flow velocity of 10.65 µm/min (± 3.9 STDV) and a maximum at 19.8 µm/min (Figure 30 
B, C). The uncoupling of the molecular clutch led to massive retrograde flow, which 
penetrated deeply into the cell center and stopped at in front of the trailing edge. 
Normal cell shape, unaltered cell migration speed and increased retrograde actin flow 
indicated that the actin polymerization rate was enhanced in the absence of integrins. 
Indeed, the actin polymerization rate, the sum of protrusion and retrograde flow velocities, 
increased from a mean value of 9.1 µm/min (± 0.7 STDV) in WT DCs to 17.8 µm/min (± 0.7 
STDV) in Itg-/- DCs (Figure 30 E). The myosin II dependent contractility in these cells was not 
altered, thus an increase in contractility was not the explanation for enhanced retrograde 
actin flow (Renkawitz et al., 2009). DCs seem to compensate the loss of adhesive interac-
tion and of traction force transmission by higher actin dynamics in the leading edge. Hence, 
for DCs locomotion engagement of a molecular clutch is optional but not mandatory. 
Both protrusion speed and retrograde actin flow differed widely among the analyzed WT or 
Itg-/- DCs, respectively (Figure 30 B). By looking at individual DCs it became obvious that fast 
protruding leading edges do not necessarily possess any retrograde actin flow. In growth 
cones and keratocytes the protrusions speed is inversely correlated to retrograde flow 
(Medeiros et al., 2006; Valloton et al., 2006). By plotting protrusion speeds against 
retrograde actin flow velocities of WT as well as Itg-/- DCs, no correlation between retrograde 
actin flow and protrusion speed could be detected (Figure 30 F).  




Figure 30: Actin dynamics in WT and Itg
-/-
 DCs migrating on a glass slide towards a CCL19 gradient. (A) 
Left panel: TIRF image of a migrating Lifeact-GFP- transfected DC. Scale bar represents 10 µm. Right 
panel: Kymograph of the yellow line in the left panel of A. The retrograde actin flow is highlighted with a 
dashed yellow line and an arrowhead. (B) Left panel: TIRF image of a migrating Itg
-/-
 DC transfected with 
Lifeact-GFP. Scale bar: 10 µm. Right panel: Kymographic analysis of the yellow line in (B) left panel. The 
retrograde flow is highlighted with a dashed yellow line. (C) Quantification of retrograde flow velocities 
in WT (n WT = 33) and Itg
-/-
 DCs (n Itg
-/-
 = 29). Numbers represent median values with 25th and 75th 
percentiles in brackets. *P<0.05. (D) Protrusion speed of WT (n WT = 33) and Itg
-/-
 DCs (n Itg
-/- 
= 29). Error 





 = 29). (F) Left: Retrograde actin flow in WT and Itg
-/-
 DCs plotted against the protrusion speed. 
Right: Close-up of WT DCs from boxed region. Error bars represent mean ± SEM. ***P<0.001 (taken from: 
Renkawitz et al., 2009). 
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4.2.2 Flexible actin polymerization in the molecular clutch system 
The previous results strongly implicate that disengagement of force coupling results in 
enhanced retrograde actin flow. But in principle the enhanced retrograde actin flow could be 
the result of altered biochemical properties in Itg-/- DCs like an enhanced actin nucleation for 
example, instead of the disconnection of the molecular clutch by the loss of integrins. To 
exclude this possibility the molecular clutch system was disengaged at the extracellular side. 
The integrin-ligand interaction was inhibited by cell migration on glass passivated with 
polyethylenglycol (PEG), an inert substrate.  
On PEG migrating WT DCs displayed the same shape and protrusion velocities as on glass, 
but the retrograde actin flow was increased (Figure 31 A; Movie S16). The mean retrograde 
flow velocity increased from 1.23 µm/min (± 1.48 STDV) to 4.45 µm/min (± 2.56 STDV). Also 
here, the actin cortex slid back up till it stopped in front of the trailing edge (Figure 31 A, B). 
Even though the molecular clutch was blocked in another position the cells still exhibited 
enhanced retrograde flow. When Itg-/- DCs were placed on PEG, retrograde actin flow 
velocities were comparable to Itg-/- DCs migrating on uncoated glass (Figure 31 C). The 
retrograde actin flow velocities could not be further enhanced by placing Itg-/- DCs on inert 
PEG-substrate. This result indicated that no other force-coupling receptors had an effect in 
the used experimental setup. The comparison of WT and Itg-/- DCs demonstrated that the 
retrograde actin flow was less pronounced in WT DCs migrating on PEG, than in Itg-/- DCs 
chemotaxing on glass or the inert substrate. 
These results showed that the molecular clutch system is of central importance for the 
cortical actin dynamics in migrating DCs. After disconnecting the molecular clutch at 
different positions and thereby enhancing retrograde flow, I tried to heighten the efficiency of 
the molecular clutch to see if the retrograde actin flow decreases under these conditions. In 
the first part of my thesis I showed that immobilized CCL21 leads to inside-out-activation of 
β2 integrins, which results in DC spreading followed by rapid, random cell migration (Figure 
25 C). Thus, I analyzed the retrograde actin flow velocities in WT and Itg-/- DCs migrating on 
CCL21/ICAM-1 co-coated glass slides towards a CCL19 gradient. Surprisingly, retrograde 
actin flow velocities in WT DCs migrating on CCL21/ICAM-1 were enhanced in comparison 
to migration of WT DCs on uncoated glass (Figure 31 B). Whereas in Itg-/- DCs migrating on 
CCL21/ICAM-1 the retrograde actin flow velocities were significantly reduced compared to 
Itg-/- DCs migrating on glass (Figure 31 C).  
 
 




Figure 31: Variable actin polymerization rate in the molecular clutch system. (A) Left panel: TIRF image 
of a with Lifeact-GFP- transfected WT DC migrating on polyethylene glycol (PEG). Scale bar represents 
10 µm. Right panel: Kymograph of the yellow line in the left panel of A. The retrograde actin flow is 
highlighted with a dashed yellow line. (B), (C) Quantitative analysis of WT DCs (B; n glass = 33, n PEG = 40, 
n CCL21 = 25) or Itg
-/-
 DCs (C; n glass = 29, n PEG = 27, n CCL21 = 23) migrating on glass, PEG and with CCL21 
and ICAM-1 co-coated glass, respectively. Numbers represent median values with 25th and 75th 
percentiles in brackets. Ns: not significant. *P<0.05 ((A) taken from; (B), (C) partly adapted from: 
Renkawitz et al., 2009). 
 
4.2.3 Adhesive interaction with CCL21/ICAM-1 
Because of the surprising alterations in retrograde flow velocities in DCs performing 
chemotactically biased haptokinesis on CCL21/ICAM-1 co-coated glass slides, I decided to 
analyze more closely adhesive interactions of chemotaxing DCs with different migration 
substrates. To this end WT DCs were transfected with vinculin-GFP, which accumulates in 
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adhesion sites (Brown et al., 2006), and applied to the already described under-agarose 
migration assays.   
 
 
Figure 32: DCs migrating on uncoated, CCL21/ ICAM-1 co-coated or PEG-passivated glass slides toward 
a CCL19 gradient. Scale bars represent 10 µM. (A), (B), (C): DC transfected with vinculin-GFP migrating 
on glass, PEG or CCL21/ICAM-1 co-coated glass slides. In DCs migrating on glass and CCL21-coated 
glass vinculin-GFP accumulates in little spots in the leading edge and in longer stripes in the trailing 
edge. In DCs migrating on inert PEG vinculin-GFP shows a homogenous distribution. (D), (E): 
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Distribution of CCR7-GFP in DCs migrating on glass or CCL21. In both cases the chemokine receptor is 
homogenously distribute over the whole cell body. 
In with vinculin-GFP transfected DCs migrating on glass little GFP-spots in the leading edge 
and longer stripes in areas of retraction could be observed (Figure 32 A). The spots were 
located approximately 2 µm behind the front of the lamellipodium. This result further proved 
active force coupling in migrating DCs. As a negative control the migration of vinculin-GFP+ 
DCs on PEG was analyzed. As expected no vinculin-GFP accumulations, only a diffuse 
staining of the whole cell could be detected (Figure 32 B). The vinculin spots are therefore 
no artificial protein accumulations; they indeed represent adhesion sites. In DCs migrating 
on CCL21/ICAM-1 co-coated glass no alterations in the localization, form or velocity of with 
vinculin-GFP marked adhesion sites in comparison to migration on uncoated glass could be 
observed (Figure 32 C). 
Possibly also ´non classical´ adhesive interactions exist in DCs migrating on immobilized 
chemokines. In this case the chemokine receptor CCR7 interacts with surface-bound CCL21 
which can also be interpreted as a weak adhesive interaction. I examined the distribution of 
the chemokine receptor CCR7 in towards a CCL19 gradient chemotaxing DCs on untreated 
or on CCL21/ICAM-1 co-coated glass. In contrast to previous observations in T cells (Nieto 
et al., 1997; Gérard et al. 2007; Morley et al., 2010) in DCs migrating under agarose towards 
a CCL19 gradient no CCR7 accumulation in the lamellipodium could be observed. Instead 
small, fast flickering CCR7 spots were homogenously distributed over the whole cell cortex 
(Figure 32 D). On CCL21/ICAM-1 co-coated glass no alterations in the CCR7 distribution 
could be observed in comparison to migration on uncoated glass (Figure 32 E).  
 
4.2.4 Macrophages also adapt their actin polymerization rate 
To test if only DCs can adapt their actin polymerization rate or if other cell types have similar 
capacities, I employed macrophages to the described under-agarose assays. Macrophages 
are amoeboid, haematopoietic cells, which can migrate, but most of the times remain 
stationary. Here, non-migratory cells, which were not exposed to a chemotactic gradient, 
were analyzed.  
On glass as well on PEG the macrophages showed the same morphology: The cells were 
roundish with short protrusions. Also the diameter of the macrophages on the inert substrate 
was not altered. Kymographic analysis of the small protrusions in the two conditions 
displayed a similar behaviour as in DCs. Macrophages placed on glass exhibited no or only 
very low retrograde flow velocity (average retrograde flow velocity: 0.24 µm/min (± 0.42 
STDV; median retrograde flow velocity: 0 µm/min; Figure 33 A, B). Macrophages on inert 
PEG substrate had an average retrograde flow velocity of 1.09 µm/min (± 0.45 STDV) and a 
significantly higher actin polymerization rate (Figure 33 C, D). The adaption of actin 
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Figure 33: Actin polymerization rates in macrophages on uncoated or PEG-coated glass surfaces. 
Lifeact-GFP macrophages were applied to under-agarose assays. (A) Left panel: Lifeact-GFP macro-
phage on serum-coated glass surface. Scale bar: 5 µm. Right panel: Kymographic analysis of the yellow 
line in (A), left panel. The actin flow is marked with a yellow dashed line. (B) Left panel: Lifeact-GFP 
macrophage on PEG-coated glass slide. Scale bar: 5 µm. Right panel: Kymographic analysis of the 
yellow line in (B), left panel. The retrograde actin flow is highlighted with a yellow dashed line. (C) 
Quantification of actin flow velocities in macrophages on glass (n glass = 23) and on PEG (n PEG = 19). 
Numbers in brackets represent median, 25% and 75% percentile. (D) Actin polymerization rates of 
macrophages on serum or PEG slides. Error bars represent mean ± SEM. *P<0.05 (taken from: Renkawitz 
et al., 2009). 
 
4.2.5 Substrate-independent chemotactic DC migration 
The previous results indicate a rapid adaption of the actin cytoskeleton to the adhesive 
properties of the environment in DCs. To test this assumption patterned surfaces were used 
where inert PEG areas alternated with adhesive glass tracks, which were coated with FCS 
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and red fluorescent BSA. When DCs were exposed to these surfaces, they migrated 
towards the CCL19 source without preferences for one of these surfaces (Figure 34 A). 
While DCs crossed an adhesive stripe no change in velocity or cell morphology could be 
observed (Figure 34 B; Renkawitz et al. 2009). Only transient retraction fibers formed at the 
trailing edge while leaving adhesive zones (Figure 34 B). While DCs crossed adhesive 
stripes the retrograde actin flow velocities adapted to the changed adhesive properties of 
the surfaces. Within one cell the retrograde flow was enhanced in the parts of the cell which 
were in contact with the PEG surface in contrast to protrusions expanding on serum-coated 




Figure 34: Chemotactic movement of DCs is substrate-independent. (A) Single cell tracking of DCs 
migrating in an under-agarose assay towards CCL19 on inert PEG-substrate (black) and adhesive tracks 
highlighted with florescent BSA (Alexa-555 BSA, red).  (B) Lifeact-GFP DC migrating over an adhesive 
track in the assay described in (A). Scale bar: 10 µm. (C) Retrograde actin flow velocities in Lifeact-GFP 
DCs simultaneously migrating on Alexa-555 BSA/serum and PEG-coated glass surface. ***P<0.001 (D) 
Left panel: Lifeact-GFP 3T3 fibroblast applied to the assay described in (A). Scale bar: 5 µm. Red lines 
mark the boarder of the Alexa-555 BSA/serum-coated track as shown in the panel in the middle. Right 
panel: Kymographic analysis of the yellow line in the left panel. The retrograde actin flow is marked with 
a dashed yellow line (taken from: Renkawitz et al., 2009). 
As shown before macrophages have the same intrinsic property to adjust their actin 
cytoskeleton to the substrate adhesiveness. But is this a special feature of hematopoietic 
cells or is it a universal mechanism of the cytoskeleton and can for example also be applied 
to mesenchymal cells? Therefore, Lifeact-GFP expressing fibroblasts were exerted to the 
described patterned surfaces. Fibroblasts strictly adapted their shape to the adhesive, BSA-
coated stripes. On the border between inert and adhesive substrate the fibroblast generated 
small, 2-3 µm long protrusions on the PEG (Figure 34 D; Movie S17). Kymographs revealed 
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massive retrograde flow in these protrusions. The retrograde actin flow exactly stopped at 
the border to the adhesive track (Figure 34 D). The ability to locally adapt is therefore a 
general intrinsic property of the cytoskeleton. But only amoeboid cells like DCs can increase 
their actin polymerization rate to an amount that allows the compensation of the loss of 
adhesive interaction. 




5.1 Chemotactically biased haptokinesis 
Chemokines can be bound to GAGs or distribute as soluble molecules; they can be 
homogenously distributed or form a gradient. Depending on their presentation mode 
chemokines can cause random (kinetic), directed (tactic) or adhesive (haptic) cell migration. 
Here, I exemplified how the presenting mode of the chemokines CCL19 and CCL21 can 
influence DC migration. CCL19 and CCL21 are expressed in the T cell areas of SLOs and 
guide naive T cells and mature DCs, which both express the corresponding chemokine 
receptor CCR7 to draining LNs. As such CCR7 and its ligands are responsible for the 
establishment of T cell areas in lymphoid organs. The main difference between the two 
CCR7 ligands is that CCL21 can immobilize to anionic surfaces via its highly charged C-
terminal extension, whereas CCL19 is lacking this C-terminal tail and remains soluble. 
In mature DCs surface-bound CCL21 or artificially immobilized CCL19 induce both inside-
out activation of β2 integrins and cytoskeletal polarization, which results in random, 
haptokinetic migration (Figure 35 C). Soluble CCL19 cannot activate integrins, but leads to 
cytoskeletal polarization. As a consequence CCL19 concentration gradients induce 
directional, chemotactic cell migration. By proteolytically truncating the heparan sulfate 
binding residue of CCL21 DCs generate a soluble variant of CCL21 that functionally 
resembles CCL19 (Figure 35 A). This proteolytic cleavage creates a positive feedback 
phenomenon which leads to the recruitment of further cells from the periphery to the place 
where the truncated CCL21 is released. The result is a self-perpetuating wave of collective 
migration. DCs can furthermore sense immobilized and soluble CCR7 ligands at the same 
time and integrate these different signals. Using the terminology introduced above I call the 
resulting phenomenon “haptokinesis directionally biased by a chemotactic gradient”: CCL21 
defines a track and CCL19 or truncated CCL21 direct the cells on the track. (Figure 35 B). 
Adhesive random migration and directional steering could cooperate to produce dynamic but 
spatially restricted cell migration patterns which closely resemble cellular dynamics 
observed in SLOs by intravital microscopy.   
For the analysis I used reductionistic in vitro approaches because only they allow a detailed, 
controlled dissection of the different cell behaviours. I will discuss here if the resulting model 
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5.1.1 CCL19 and CCL21 are functionally not redundant 
CCR7-/- and plt/plt mice, which lack the expression of CCL19 and CCL21 in SLOs, exhibit to 
a large extend the same phenotype: SLOs with rudimentary T cell areas which lack a clear 
border to the B cell follicles (Förster et al., 1999; Davalos-Misslitz & Rot, 2008; Misslitz et al., 
2004; Nakano et al., 1997; Nakano et al., 1998). These results implicate that CCR7 has only 
two ligands, CCL19 and CCL21, and suggest that these two chemokines, which have both 
similar binding affinities towards CCR7 and similar expression patterns in the LN, act 
redundantly. However, in my thesis I provide evidences suggesting that CCL19 and CCL21 
exhibit non-overlapping functions, and that these non-overlapping functions are mainly 
determined by their presenting mode. 
For each chemokine a dynamic equilibrium between soluble and immobilized molecules 
exists. In the case of CCL21 the dominating form is the immobilized chemokine, because of 
its highly charged C-terminus which mediates linkage to GAGs. For CCL21 diverse 
immobilizing substrates are published like for example heparan sulfates or the proteoglycan 
podoplanin expressed on FRCs (Breiteneder-Geleff et al., 1999; Kriehuber et al., 2001; 
Pegu et al., 2007). The immobilization of CCL21 is the basic prerequisite that CCL21 can 
form homogenous chemokine fields with sharp boundaries. Moreover, immobilized CCL21 
leads to β2 integrin inside-out activation and, therefore, to cell spreading and adhesion. 
Homogenous CCL21 fields lead furthermore to spontaneous cell polarization followed by 
rapid, random migration. CCL19 lacks a highly charged C-terminal tail and has therefore 
only a low affinity towards GAGs - CCL19 remains primarily soluble (Patel et al., 2001). 
Soluble CCL19 cannot activate integrins but is very efficient in concentration gradient 
formation and therefore in directing DCs. In vitro experiments proved that CCL19 is ten 
times more potent than CCL21 in inducing directional migration in DCs (Ricart et al., 2010). 
Additionally, Bao et al. (2010) showed that the binding capacity of CCL19 to lymphatic 
endothelial cells is about half of that of CCL21. The binding affinities of the two CCR7 
ligands towards FRCs, the stromal network in the T cell area, are not determined yet. The 
fact that it is possible to immunostain CCL21 but not CCL19 on LN cryosections implies that 
the binding affinities towards FRCs resemble the one described for lymphatic endothelium. 
Besides that FRCs express GAGs which most likely mediate CCL21 binding, but do not, or 
to a smaller extent, influence CCL19 molecules (Breiteneder-Geleff et al., 1999; Kriehuber 
et al., 2001; Pegu et al., 2007; Patel et al., 2001). 
By interfering with the presenting mode of CCL19 and CCL21 one chemokine can gain the 
functions of the other one. C-terminally truncated, solubilised CCL21 is able to generate 
concentration gradients in under-agarose as well as in carbon fiber migration assays. DCs 
are able to interpret these concentration gradients and respond with directional movement. 
Truncated CCL21 functionally resembles CCL19. Ueno et al. (2002) described a similar 
situation in ex vivo experiments: CCL21 is less efficient in organizing T cells egress from 
explanted thymus slices in comparison to CCL19. But when the C-terminus of CCL21 was 
removed, the chemokine gained the function of CCL19 and promoted T cell egress at the 
same rate.  
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CCL19 can be artificially surface-bound on plasma-treated, highly charged glass surfaces. 
In this experimental setup CCL19 immobilized approximately to the same level as CCL21 on 
untreated glass as shown by fluorescence measurements. Artificially immobilized CCL19 
acted like full-length CCL21: It induced cells spreading facilitated via β2 integrin inside-out 
activation which is followed by rapid, random migration. But the spreading response was 
more transient in comparison to CCL21. One possible explanation for this observation could 
be that the mechanical anchorage of CCL19 is less stable and the cells still internalize a 
certain amount of chemokine. These results implicate that leukocyte behaviour is deter-
mined by the presenting mode of the two CCR7 ligands, not by special signaling sequences 
or differences in the tertiary structure of the molecules. 
 
Figure 35: Schematic representation of chemotactically biased haptokinesis. The scaffold in the big 
panel represents the fibroblastic reticular cell network of secondary lymphoid organs. The scaffold is 
decorated with the integrin ligand ICAM-1 and immobilized CCL21. The soluble chemokine gradient 
(grey; either CCL19 or solubilized CCL21) establishes three principle motility patterns that are depicted 
in panels A-C. (A) Steep gradients of soluble CCR7 ligand lead to detachment of the DCs from the 
haptokinetic scaffold and integrin-independent migration along the gradient. (B) Shallow gradients 
induce directionally biased haptokinesis. Here, immobilized CCL21 induces inside-out activation of β2 
integrins that confine the cells to the scaffold while soluble CCR7 ligand induces the directional bias. (C) 
In the absence of soluble CCR7 ligands, cells perform haptokinetic random migration that is strictly 
confined to the fiber scaffold (taken from: Schumann et al., 2010).     
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Until now it is unclear which signaling events induce the different cell behaviours after 
contact with soluble or surface bound chemokine, respectively. One promising hint is that in 
contrast to CCL21 CCL19 is very efficiently internalized by DCs. CCL19 internalization likely 
enables the cells to adapt to high CCL19 concentrations (Otero, Groettrup & Legler, 2006; 
Byers et al., 2008; Sierra et al., 2010). Possibly, the lack of CCL21 internalization is due to 
the mechanical anchorage to surfaces. These differences potentially lead to the different 
signaling properties of the CCR7 ligands: CCL21 is longer bound to the chemokine receptor 
and not internalized, whereas CCL19 is rapidly endocytosed and degraded (Otero, 
Groettrup & Legler, 2006; Byers et al., 2008), which leads to cell spreading or directed 
migration, respectively. 
 
DCs can establish a positive feedback loop when they migrate on LN cryosections or 
immobilized recombinant CCL21: After several minutes DCs from the adjacent environment 
migrate in a highly synchronized way towards these migration substrates and accumulate 
there. The cells achieve this by actively manipulating the balance between soluble and 
bound CCL21. DCs proteolytically remove the heparan sulfate binding C-terminus of 
CCL21, transform CCL21 in an easily diffusible molecule and thereby establish a chemotac-
tic concentration gradient. In vitro, two CCL21 fragments only slightly differing in size could 
be detected after incubation with DCs. Fragmented CCL21 could also be isolated out of LN 
lysates by pull-down experiments. I also analyzed the amount of cleaved CCL21 in inflamed 
LNs, which contained a high amount of mature DCs. Surprisingly, under inflammatory 
conditions the amount of solubilised CCL21 in LNs is lower, maybe because in reactive LNs 
the lymph flow is enhanced (von Andrian & Mempel, 2003) and fragmented CCL21 rapidly 
washed away.  
 
How the processing of CCL21 influences DC migration in vivo is not analyzed yet. However, 
there are several in vivo observations described, which could potentially be explained by the 
chemokine cleavage. Martin-Fontecha et al. (2003) described a DC migration pattern under 
inflammatory conditions called ´LN conditioning´: When a first cluster of DCs enters the LN, 
these cells “prime” the tissue for following DCs. These following cells arrive faster in the 
draining LN and in higher numbers. The reason for the collective movement could be the 
proteolytic shedding of CCL21 bound on FRCs by the first wave of DCs entering the LN. 
The DCs could thereby generate a stronger chemotactic gradient to recruit further cells, DCs 
and also naïve T cells, and accelerate adaptive immune response. 
Another interesting study demonstrated that in inflamed LNs the borders between T and B 
cell areas become blurred (Okada et al., 2005). Potentially immigrating DCs cut off CCL21 
bound to FRCs and reduce the amount of the homeostatic chemokine in the T cell area. The 
alterations in lymphatic organ architecture in CCR7-/- and plt/plt mice together with the fact 
that CCL19-/- mice have no obvious phenotype implicate that immobilized CCL21 is a 
prerequisite for the establishment for T cell areas with sharp boundaries in SLOs (Förster, 
Davalos-Misslitz & Rot, 2008; Britschgi et al., 2010). By reducing the amount of immobilized 
CCL21 the cells could optionally give rise to indistinct T cell area boundaries.  
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Furthermore, it was shown that stroma cells of reactive LNs down regulate the transcription 
of homeostatic chemokines, probably to regulate the overall cellularity in the organ (Mueller 
et al., 2007). Shedding of CCL21 might act in the same way and also limit the amount of 
leukocytes by reducing the amount of CCL21 bound to FRCs in the T cell area. Thereby the 
retention time of leukocytes in the LN could potentially be decreased. This mechanism could 
act before the transcriptional down-regulation of CCL21 is in effect. I detected truncated 
CCL21 in non-inflamed LNs, which could optionally explain why CCL19-/- mice have no 
gross abnormalities in DC maturation and migration (Link et al., 2007; Britschgi et al., 2010): 
Fragmented CCL21 resembles CCL19 and can therefore probably compensate the loss of 
CCL19 in vivo.  
 
5.1.2 CCL21 is cleaved by serine proteases 
To further characterize the CCL21 cleavage I conducted in vitro cleavage assays. The first 
important result was that the CCL21 cleavage can be blocked completely by the serine 
protease inhibitor Aprotinin. Moreover, DC mediated in vitro cleavage of CCL21 strictly 
depends on the presence of blood serum or plasma, whereas the cleavage was much more 
efficient in the presence of not heat-inactivated mouse plasma than in the presence of FCS. 
Blood plasma is the solvent, cell-free fraction of whole blood, whereas blood serum is 
plasma after blood clotting and removal of the fibrinogen. In the presence of mouse plasma 
CCL21 cleavage could be observed even in the absence of DCs, albeit the observed 
processing is less efficient. Additionally the overall amount of chemokine of processed as 
well as full-length CCL21 was reduced under DC-free conditions. From these results it can 
be concluded that the cleavage of CCL21 is not a cell-autonomous process. DCs potentially 
recruit one or several serine protease from the surrounding blood plasma or serum to their 
cell membranes thereby activating the enzymes and enhancing their cleavage efficiency. At 
the same time the cell surfaces seem to protect fragmented as well as full-length CCL21 
variants from further proteolytical degradation.  
I also tested other cell types found in LNs for their capability to cleave CCL21.  B and T cell 
were able to process the chemokine, although only in very low amounts. These leukocytes 
seem to be less efficient in recruiting or activating serine proteases on their surfaces. These 
results support the idea of a regulated process: Potentially only special cell subsets possess 
the ability to promote cleavage. Furthermore, the CCL21 fragments generated by these two 
cell types differed slightly in size. Perhaps CCL21 processing is carried out by different 
proteases in diverse cell subsets or cell type specific secondary proteases further process 
the cleaved chemokine.  
I also incubated mouse embryonic fibroblasts, as an example for a stromal cell type, in 
medium supplemented with heat-inactivated FCS. In this experimental setup I could not 
observe CCL21 cleavage. However, LN derived fibroblasts cultured in mouse plasma, a 
more physiological experimental setup, can efficiently truncate CCL21. The CCL21 
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fragments generated by DCs or LN fibroblasts possess the same size implicating that both 
cell types might recruit the same enzyme to their surfaces. LN fibroblasts could constitute a 
soluble CCL21 gradient also under homeostatic conditions acting parallel to CCL19 
concentration gradients, which would further explain why CCL19-/- mice have only minor 
defects (Link et al., 2007; Britschgi et al., 2010). 
 
5.1.3 Plasmin cleaves CCL21 in vitro 
Next, I wanted to identify the CCL21 cleaving serine protease. Using in vitro cleavage 
assays plasmin could be identified as one protease truncating CCL21. Plasmin is a serine 
protease which disintegrates fibrin clots and can furthermore also cleave several chemoki-
nes (Schäfer & Werner, 2008; Vakili et al., 2001; Sheehan et al., 2007; Proost et al., 2008). 
The inactive circulating precursor of plasmin is plasminogen. In vitro cleavage assays 
revealed that plasmin generates two soluble CCL21 fragments. The protease database 
MEROPS (http://merops.sanger.ac.uk/) predicted two potential plasmin cleavage sites 
(APGK-QSPG and PGCR-KNRG) resulting in 8.4 kDa and 9 kDa CCL21 fragments in size, 
respectively. These fragments would match the western blot results which showed two 
distinct protein bands between 8 and 9 kDa. With increasing incubation times the smaller 
CCL21 fragment dominated. The same results were achieved by co-incubation of CCL21, 
DCs and the inactive proenzyme of plasmin, plasminogen, under serum-free conditions. 
Hence, DCs have the ability to cleave the corresponding zymogen plasminogen, thus 
generating proteolytically active plasmin. Hence, it is likely that DCs regulate the cleavage 
process. Cell-free in vitro assays, where recombinant plasmin and CCL21 were co-
incubated, showed that plasmin can further disintegrate CCL21 fragments as observed 
before in cleavage assays containing plasma.  
After characterizing the plasmin CCL21 cleavage in vitro, I tried to verify these results in a 
more physiological setting. However, by repeating the in vitro cleavage assays in the 
presence of Plg-/- plasma, I showed that CCL21 can also be cleaved in the absence of 
plasmin. Plasminogen or plasmin, respectively, is not essential for this process. Hence, at 
least one other protease can exert CCL21 cleavage. Moreover, CCL21 pull-downs of LN 
lysates from Plg-/- mice revealed no differences compared to WT LN lysates, either in size or 
amount of cleavage product. In conclusion it remains unclear if plasmin does contribute to 
CCL21 cleavage in vivo. Possibly the plasmin cleavage of CCL21 does take place in vivo, 
but can be fully compensated by other serine proteases in the LN. Another possibility is that 
the influence of plasmin on the amount of fragmented CCL21 only becomes noticeable 
under inflammatory conditions. Besides that, the in vitro cleavage assay has also limitations; 
CCL21 was incubated in the presence of not heat-inactivated mouse plasma that contains 
for example activated serine proteases of the coagulation cascade, the complement system 
and fibrinolysis. Hence, these in vitro cleavage assays did not resemble the in vivo situation 
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in lymphatic organs. Thus, it cannot be ruled out completely that CCL21 is cleaved artificially 
in vitro by non-physiological proteases and plasmin is one of them.   
 
5.1.4 Haptokinetic migration scaffold 
B as well as T cells show rapid swarming behavior in SLOs but the cells remain strictly 
confined to their respective compartments (Miller et al., 2002; Miller et al., 2003; Wei et al., 
2005). Randomly migrating T cells for example turn around once they reach the boarder to 
the B cell follicle (Bajenoff et al., 2006). Besides that, the knockout of CXCL13 or the 
deletion of CCL21 and CCL19 in the SLOs of plt/plt mice are both correlated with massively 
disrupted lymphoid organ architecture: In the absence of these chemokines barriers 
between compartments cannot be established. Hence, immune cell subsets are not 
completely separated anymore (Davalos-Misslitz & Rot, 2008; Förster et al., 1996; Förster et 
al., 1999; Ansel et al., 2000). The fact that these homeostatic chemokines can be detected 
by immunostaining of cryosections of SLO supports the idea that these chemokine 
immobilize to the tissue – soluble proteins would be rapidly washed out during the staining 
procedure.  
Both T cell areas and B cell follicles contain a three-dimensional network of non-
hematopoietic stroma cells; this scaffold is constituted of FRCs in the T cell area and FDCs 
in the B cell area (Mueller & Germain, 2009). Bajenoff et al. (2006) observed by intravital 
microscopy naïve T cells and B cells migrating along “their” respective stromal network in a 
random way. Several research groups identified chemokines as the central factor which 
keeps the cells motile and induces the described migration pattern: Without CCR7 or by 
inhibition of chemokine signaling by pertussis toxin the cells decelerate massively (Asperti-
Boursin et al., 2007; Okada and Cyster, 2007; Worbs et al., 2007). In plt/plt mice T cell 
migration speed is reduced by about 30%, but by intravenously application of CCL21 the 
migration velocity can be restored (Worbs et al., 2007). It was proposed by Bajenoff et al. 
(2006) that CCL21 which is immobilized on FRCs keeps T cells motile. The same basic 
principle is assumed for B cells migrating on CXCL13 coated FDCs (Roozendaal et al., 
2009).  
The carbon fiber migration assay revealed that such a system can be constituted in vitro: 
DCs are able to move along CCL21 coated carbon fibers, which act as an artificial migration 
scaffold. Before leading to rapid migration immobilized CCL21 induces cell adherence by 
integrin β2 activation; a precondition that the cells “do not lose the track” while migrating 
along the fibers. DC adherence was also observed on p19ARF-/- LN-fibroblasts coated with 
CCL21, which resemble more closely the in vivo situation. When both T cells and DCs 
migrate along FRCs, this could lead to more frequent encounters between both cell types 
and therefore to a faster initiation of the adaptive immune response. Spreading of LN 
resident DCs on FRCs potentially also influences the antigen uptake of the DCs from the 
stromal cells or conduits, because of the enhanced interaction surface (Fletcher et al., 2010; 
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Sixt et al., 2005; Hayakawa, Kobayashi & Hoshino, 1988). Migration on the stromal 
backbone as well as on carbon fibers co-coated with CCL21 and ICAM-1 lacked directional 
bias, a phenomenon that was also described as “guided randomness” by Mempel et al. 
(2006). The scenario of a haptokinetic scaffold could potentially explain the swarming 
behavior of leukocytes under homeostatic conditions. Further potential benefits of haptoki-
netic scaffolds are stability against convection forces and mechanical perturbations in vivo. 
 
5.1.5 Chemotactic bias 
The limitations of an immobilized chemokine field become apparent in reactive lymphoid 
tissue: During adaptive immune response leukocytes change their position or accumulate 
within one chemokine field. Thus, leukocytes must sense directional guidance cues. Long 
range gradients of CCL19, CCL21, CXCL13 and CXCL12 could explain cell localization 
under homeostatic and inflammatory conditions in SLOs. These gradients could on one 
hand lead to tactic movement; on the other hand leukocytes could integrate the signals of at 
least two counteracting gradients, which guide the cells then to one defined area, where the 
two gradients are “balanced”. Ricart et al. (2010) demonstrated that such a system is 
operative in vitro. DCs can integrate two opposing concentration gradients and home to an 
area where the signals derived from the different gradients are balanced. When the cells 
reach this region, they show random motility. Thus, cell positioning of DCs, B and T cells in 
SLOs can potentially be correlated with their individual CXCR5, CCR7 and CXCR4 
chemokine receptor expression levels. 
Most data which support these hypotheses derive from static cryosections: Th1 and naïve T 
cells for example exclusively express CCR7 and localize therefore to the CCL21 expressing 
T cell area. Th2 cells on the other hand lack CCR7 and home in close proximity to the B cell 
follicles, potentially because they express very low levels of CXCR5 (Randolph et al., 1999; 
Morita et al., 2011). Dermis-derived migratory DCs expressing high amounts of CXCR5 
localize up to 40% in the CXCL13 rich B cell follicles. Bone marrow derived mature DCs 
displaying 14 times less CXCR5 localize strictly to the T cell zone as well as epidermis-
derived DCs that only express CCR7 (Saeki et al., 2000; Kissenpfennig et al., 2005; Saeki 
et al., 2000; Wu & Hwang, 2002). Anergic B cells have reduces levels of CXCR5 and are 
therefore excluded from CXCL13 expressing follicles (Ekland et al., 2004). To enter 
germinal centers B cells express five to twenty fold more CXCR4 than follicular B cells. At 
the same time they reduce their CCR7 expression levels (Allen et al., 2004). 
In addition to that, data derived from two-photon microscopy experiments in tissue slices or 
living animals, respectively, further support the idea of longer range gradients in SLOs: To 
change their position leukocytes modify their chemokine receptor levels. For follicular 
homing activated T cells up-regulate CXCR5 and simultaneously down regulate CCR7, 
which provides a counteracting signal to retain activated T cells in the T cell area (Ansel et 
al., 1999; Hardtke et al., 2005). Simultaneously activated B cells start to up regulate CCR7 
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and as a consequence move directionally towards the boundary between T and B cell area 
to interact with T helper cells. The area of directed migration involves the region extended 
up to 140 µm away from the boundary, which further supports the idea of longer range 
gradients (Okada et al., 2005). But directed movement was also demonstrated on the single 
cell level. DCs release after successful encounters with CD4+ T cells the chemokines CCL3 
and CCL4 to recruit CD8+ T cells leading to a cell cluster in the T cell area (Castellino et al., 
2006).  
Theoretically immobilized, haptotactic or soluble, chemotactic gradients could guide cells 
within lymphoid organs. Okada et al. (2005) indeed observed on LN cryosections a CCL21 
gradient extending from the T cell zone into the B cell follicles. I observed a similar CCL21 
distribution on LN sections, but it was not correlated with directional DC migration in LN 
cryosection migration assays. DCs clearly follow soluble guidance cues. Until now it is 
unclear, if also a diffusible isoform of CXCL13 is generated. But I showed that chemotactic 
gradients of truncated CCL21 can be generated in vitro, CCL19 concentration gradients are 
well established and also CXCL12 gradients are described (Lämmermann et al., 2008; 
Lämmermann et al., 2009; Ricart et al., 2010). These considerations together with the in 
vitro findings that T cells, B cells and DCs are all capable to migrate towards spatial 
chemokine gradients strongly argue for the presence of soluble chemokine gradients within 
lymphatic organs (Lämmermann et al., 2008). 
In contrast to that, R. Germain and colleagues assumed that locally produced, diffusing 
chemokines directly immobilize on FRCs and thereby generate an immobilized gradient 
(Bajenoff et al., 2007). However, till now no haptotactic gradients could be visualized in 
SLOs. Besides that, immobilized gradients theoretically exhibit several disadvantages: For 
example immobilized gradients are harder to regulate and especially to disintegrate. The 
decomposition of immobilized gradients would presume endocytosis followed by proteolyti-
cal degradation. These processes are more time consuming than the breakdown of soluble 
gradients by convection. But a rapid adaption of tactic guidance cues is essential for quick 
leukocyte encounters during adaptive immunity. Soluble gradients are of course more 
unstable, but also more flexible adjustable during immune response.  
 
5.1.6 Competition between immobilized and soluble CCR7 ligands 
Surface-bound CCL21 induces after binding to CCR7 β2 integrin activation and cell 
adherence. In contrast to that, CCL19 or truncated CCL21 bound to CCR7 induce cell 
polarization and integrin-independent, directional movement. By integrating both signals the 
cells can perform directional migration on a track (Figure 35 B). These results implicate that 
soluble and bound CCR7 ligands bind to different subsets of the chemokine receptor. In a 
steep gradient of CCL19 or truncated CCL21 the chemokine receptor fraction occupied by 
the soluble ligands probably grows. At a certain level the cells can override the adhesive 
signal, disconnect from the fiber and move freely toward the concentration gradients. These 
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results potentially entail important physiological implications: Strong chemotactic guidance 
cues could induce directional cell migration without cell distraction by the extracellular 
infrastructure. This could result in a faster accumulation of effector cells on sites of infection 
or SLOs and could explain why leukocytes can infiltrate almost all tissues. Integrins are 
therefore not essential for interstitial or intranodal leukocyte migration (Lämmermann et al., 
2008), but integrins probably enable DCs to follow pathways on FRCs to efficiently engage 
naïve T cells and mediate close surface contact on conduits. In summary intranodal 
positioning and also dwell times of cell populations within the LN could be influenced by 
steep soluble gradients or sparse CCL21 and integrin ligand or chemokine coating of the 
FRCs.  
 
5.1.7 Cell biological implications  
Kinesis is the result of self-polarization, which is an intrinsic, spontaneous event or can be 
triggered by external stimulation and results in random cell movement. Taxis and spontane-
ous cell polarization were traditionally viewed as contradictory, independent events. But 
Arrieumerlou & Meyer (2005) proposed a model called ´local coupling model for eukaryotic 
chemotaxis´ which connects these two phenomena. In this model the leading edge of a 
polarized cell consists of independent coupling units or cell extensions. Stochastically single 
cell extensions enlarge by spontaneous intrinsic activation of PI3 kinase, which results in 
spontaneous cell polarization and random migration. In cells migrating in a chemotactic 
gradient, the chemokine receptors of one or more coupling units within the lamellipodium 
engage their ligands. The chemokine receptor activation leads in turn to a transient, locally 
restricted activation of PI3 kinase in the respective coupling units and an enlargement of 
these units. These small lamellipodium extensions finally lead to a turn in direction towards 
the steepest increase in local concentration. This model explained conclusively for the first 
time the „directionally biased random walk“ as observed in many migrating cells (Figure 36).  
Chemotactically biased haptokinesis can be considered as an extension of this model. 
Immobilized chemokines induce adhesion and furthermore boost random self-polarization, 
which results in very rapid, undirected migration. The coupling units seem to be more 
“activated”. Soluble chemokine gradients can still induce on top a directional bias leading to 
directed migration. 
 




Figure 36: Local coupling model for eukaryotic chemotaxis. The leading edge of a cell consists of 
independent coupling units (red dots). By sensing a chemotactic gradient (red triangle) coupling units 
on one site of the cell expand leading to a turn in direction and finally in cell migration towards a 
gradient over time (adapted from: Arrieumerlou & Meyer 2005). 
 
5.1.8 Concluding remarks to chemotactically biased haptokinesis 
With the carbon fiber migration assay I could show that mature DCs simultaneously sense 
haptokinetic, immobilized chemokine fields and chemotactic concentration gradients, which 
results in directed migration on a track. The described model chemotactically biased 
haptokinesis might explain the swarming behavior and directional migration of leukocytes in 
lymphoid organs. Moreover, it offers an explanation for the development of the two CCR7 
ligands, CCL21 and CCL19. 
Although the data presented here support the idea of soluble gradients guiding leukocytes in 
lymphoid organs, chemoattraction of leukocytes in peripheral tissues might work differently. 
An example for a haptotactic gradient was described by Massena et al. (2010), where a 
chemotactic gradient sequestered on endothelial heparan sulfates induces directional 
intraluminal crawling of neutrophils. McDonald et al. (2010) could even uncover an 
immobilized CXCL2 gradient in liver sinusoids ranging from 150 to 650 µm of injured areas. 
It is the first time that an intrinsic immobilized gradient could be visualized. However, blood 
vessels provide a relatively plain, rather two-dimensional environment. To establish three-
dimensional immobilized gradients in complex lymphoid organs, whose architecture 
changes rapidly upon inflammation, seems to be very challenging. Soluble gradients that 
only depend on a chemokine source and diffusion are probably easier to realize in SLOs. 
It is unclear till now, if chemotactically biased haptokinesis can only be applied to the 
CCL19/CCL21 system or also to other “chemokine pairs”. There are several “chemokine 
pairs” described, which bind to one chemokine receptor, but differ in their individual affinities 
towards GAGs. The chemokine receptor CXCR8 has also two ligands with different abilities 
to bind to heparan sulfates CXCL1 and CXCL2. CXCL1 is thought to be mainly soluble, 
whereas CXCL2 binds to GAGs, which is indispensable for neutrophil extravasation to 
inflamed skin (Massena et al., 2010; Bao et al., 2010). For the chemokine CXCL12 
expressed for example in germinal centers six different isoforms are published. CXCL12γ 
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consists of a protein core shared by all CXCL12 isoforms, extended by a highly cationic C-
terminal domain containing four heparan sulfate-binding motifs. Only CXCL12γ is the only 
isoform which is able to induce cell accumulations and angiogenesis CXCL12α on the other 
hand has only a low GAG-binding capacity and is assumed to be soluble (Rueda et al., 
2008; Lortat-Jacob, 2009). It will be interesting to see if the described model of chemotacti-
cally biased haptokinesis can also be applied to these chemokines and furthermore if this 
model derived from in vitro assays can be verified in vivo by two-photon microscopy. 
Besides that, it is still unclear which serine proteases cleave CCL21 in vivo, which is 
essential information to elucidate how this process is regulated. 
Our model chemotactically biased haptokinesis can potentially explain leukocyte positioning 
as well as leukocyte migration patterns in SLOs. Up till now immunologists largely ignored 
the presenting mode of chemokines, but it massively influences cell behavior in vitro and in 
all probability also in vivo.  
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5.2 Adaptive force transmission in amoeboid cell migration 
Leukocytes are very rapidly migrating cells and can reach velocities two orders of magnitude 
higher than other cell types. Moreover, migrating leukocytes face diverse environments on 
their trafficking routes. In order to migrate cells have to transmit intracellular forces 
generated by the actomyosin system to their environment; these protrusive and contractile 
forces are transformed into ´traction´, which is a prerequisite for forward movement 
(Renkawitz & Sixt, 2010). In the classical textbook model cellular traction is mediated via the 
integrin family of transmembrane receptors. This model can describe DCs migrating in a 
two-dimensional environment; here, DCs strictly depend on integrins in order to move. But 
against the textbook paradigm of force generation and transmission during cell migration, 
leukocytes are able to migrate in three-dimensional environments without using transmem-
brane receptors of the integrin family (Lämmermann et al., 2008). In three-dimensional 
interstitia leukocytes normally form rounded extensions, also called lobopodia, at their 
leading edge that can intercalate into pores and potentially allow the generation of traction 
force (Friedl et al., 2001).   
To study how the actin cytoskeleton adapts under adhesion-independent conditions we 
established a migration assay in a clearly defined three-dimensional environment: The cells 
were squeezed between a layer of agarose and a cell culture dish while migrating towards a 
CCL19 gradient. The result is a pseudo three-dimensional setup, where the lobopodia are 
flattened to lamellipodia and the actin cortex can easily be analyzed by high-resolution TIRF 
microscopy and the actin probe Lifeact-GFP. 
This study showed, that chemotactic DCs can switch between integrin-dependent and -
independent locomotion and can thereby adapt to the adhesive properties of their environ-
ment. If actin-integrin clutches are active, actin polymerization is entirely converted into 
protrusion. Without a molecular clutch the actin cortex undergoes slippage and retrograde 
flow. But retrograde actin flow can be completely balanced by an enhanced actin polymeri-
zation rate keeping the migration velocity and the cell shape unaltered. Because of the 
adaption of actin polymerization amoeboid cells like DCs can follow soluble guidance cues 
without being distracted by adhesive interactions with tissue components. Mesenchymal 
cells on the other hand strictly depend on adhesive interaction and cannot invade areas 
which lack their respective adhesion ligands.  
 
5.2.1 Amoeboid cells can adapt to different degrees of force coupling via 
actin polymerization 
Efficient cell migration relies on the transmission of the force generated by the actomyosin 
cytoskeleton to the extracellular substrate. Intracellularly this is achieved by the coupling of 
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actin filaments to integrin transmembrane receptors via a protein cluster including vinculin 
and talin (Brown et al., 2006; Hu et al., 2007). The coupling between actin cytoskeleton and 
adhesion receptor has been described as ´molecular clutch´. Without active force coupling 
via the molecular clutch polymerizing actin filaments are pushed backwards into the cell, 
because they experience a counter force by the cell membrane; the result is retrograde actin 
flow of the actin cell cortex (Hu et al., 2007; Giannone, Mège & Thoumine, 2007).  
 
 
Figure 37: Scheme of the adaption of protrusion and retrograde actin flow at different levels of force 
coupling in amoeboid cells. When the actin is coupled to the substrate, actin polymerization is directly 
converted into leading edge protrusion. When integrins cannot bind to a corresponding ligand, slipping, 
an intermediate state of force coupling occurs. By removal of the transmembrane receptors complete 
uncoupling proceeds. Because the protrusion rate always stays constant, during uncoupling the actin 
polymerization rate must be enhanced to compensate for the increased retrograde actin flow (taken 
from: Renkawitz et al., 2009). 
WT DCs show almost no retrograde actin flow while migrating in the described under-
agarose assay on glass slides. In only 50% of the analyzed WT DCs retrograde flow could 
be observed in a small, 2-3 µm wide region at the tip of the leading edge. Thus, the cells 
exhibit an active molecular clutch, which allows the optimal transfer of traction force and the 
conversion of actin polymerization into protrusion. WT DCs migrating on an inert substrate 
like polyethylene glycol (PEG), which eliminates integrin-ligand-interactions, show retro-
grade actin flow. The actin cortex slides backwards because integrins only streak the PEG 
substrate without ligand binding (´slipping´). This actin slippage can be further enhanced by 
applying Itg-/- DCs to glass or PEG slides. Here the coupling between substrate and actin 
filaments is completely abolished (´uncoupling´; Figure 37). But the DCs showed no 
alterations in their cell shape and the same migration and protrusion speed under all three 
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conditions. DCs adapt to the adhesiveness of their migration substrates by regulating their 
actin polymerization rate. Surprisingly, a correlation between protrusion speed and 
retrograde actin flow does not exist in our setup, which is contradictory to data derived from 
keratocytes and growth cones (Valloton et al., 2006; Medeiros et al., 2006). Hence, it follows 
that the molecular clutch system in DCs does not only depend on expanding actin filaments 
and transmembrane receptors, but also on the actin polymerization rate, as a third 
component. 
 
5.2.2 Surface anchoring cells cannot protrude into open space 
Next, I tested if the adaption of actin polymerization is a unique feature of DCs or if it also 
occurs in other cell types. Macrophages, as an example for a resident haematopoietic cell, 
showed exactly the same behaviour as DCs: The cell shape does not change when they are 
placed on PEG or a serum coated glass surface. Macrophages on PEG exhibit an enhanced 
retrograde actin flow.  
 
 
Figure 38: Difference between surface anchoring cells like fibroblasts and the amoeboid cell type 
represented by DCs. (A) DCs can protrude into the open space and compensate the enhanced retrograde 
actin flow. Fibroblasts adapt their shape strictly to adhesive zones (depicted in grey). Red dots represent 
adhesion sites, downwards arrows protrusion direction and upwards arrows retrograde actin flow. Itg-
Lig: integrin ligand (taken from: Renkawitz et al., 2009). (B) Migratory pathways of mesenchymal and 
amoeboid cells. Left panel: Mesenchymal cells depend on adhesive ligands matching to their integrin 
repertoire (marked in red). They strictly follow the track. Right panel: Amoeboid cells migrate towards a 
soluble gradient without being distracted by adhesive paths (adapted from: Renkawitz & Sixt, 2010). 
These results implicate that amoeboid cells can adapt very rapidly to changes in the 
adhesiveness of their environment. To prove this, Lifeact-GFP DCs migrating on a surface 
patterned with alternating inert PEG and adhesive serum coated stripes towards a CCL19 
gradient were analyzed. The DCs strictly followed the gradient and migrated equally well on 
both stripes. Also cell shape and migration velocity were not altered while the DCs migrated 
over the different areas. Therefore, amoeboid cells can rapidly adapt to adhesive substrate 
properties, even within their lamellipodium. When fibroblasts (as a prototypic example for a 
Discussion   
113 
 
mesenchymal, surface anchoring cell) were applied to patterns of inert and adhesive areas, 
they strictly adapted their shape to the adhesive areas (Figure 38 A). Only very short 
protrusions touched the inert areas. These protrusions exhibited massively enhanced 
retrograde actin flow that stopped at the border to the adhesive region. Hence, the adaption 
of the actin polymerization to a varying engagement of the molecular clutch is a common 
mechanism in all cells. But only amoeboid cells can enhance actin polymerization to a level 
which allows them to be independent of adhesive interaction mediated by integrins. 
Therefore, rapid migrating leukocytes can leave adhesive tracks in a strong chemotactic 
gradient (Figure 35) or shuttle to other tissue compartments (Figure 38 B; Luster et al., 2005; 
Massberg et al., 2007). Mesenchymal cells like fibroblasts on the other hand depend on their 
integrin repertoire: They always migrate on adhesive tracks marked by the corresponding 
integrin ligands (Figure 38 B). Because of their strictly haptic movement they cannot invade 
external tissues with diverse ligands. 
 
5.2.3 Immobilized chemokine influences adaptive force transmission 
DCs migrating on glass slides possess no or almost no retrograde actin flow because of 
active force coupling. In the first part of my thesis I demonstrated that immobilized chemo-
kine induces cell spreading and polarization in DCs. Surface-bound CCL21 massively 
affects the shape of the DCs, which is mainly defined by the cytoskeleton. Thus, I analyzed 
how the actin cytoskeleton is influenced by immobilized chemokine. Surprisingly, in DCs 
chemotaxing on glass co-coated with CCL21 and the β2 integrin ligand ICAM-1 towards 
CCL19 more retrograde actin flow could be measured. One explanation for this observation 
could be that CCR7 activates upon ligand binding the small GTPase Rac.  Rac can in turn 
activate the actin elongating and nucleating protein complex Arp2/3. Thereby chemokine 
signaling can enhance the cellular actin polymerization rate (Rot & von Andrian, 2004; 
Thelen & Stein, 2008). Because of the already existing excellent force coupling in DCs 
migrating on uncoated glass, the cells can theoretically convert the additional CCL21-
induced actin polymerization either into an increased migration velocity or into retrograde 
flow. Hence, DCs always move with the same speed irrespectively of the stickiness of their 
environment, they potentially transcribe chemokine-induced polymerization into retrograde 
actin flow.  
To gain more detailed insights into adhesion sites in WT DCs migrating on either glass or 
CCL21 coated surfaces, DCs were transfected with vinculin-GFP. Vinculin acts as a marker 
for adhesive sites, because it is part of the molecular clutch which connects integrins with 
the actin cytoskeleton (Brown et al., 2006). In DCs migrating on glass vinculin-GFP formed 
spots in the leading edge and retraction fibers in the trailing edge, which further confirmed 
active force coupling in DCs. The same protein distribution was observed in DCs migrating 
on CCL21/ICAM-1 coated glass; also the dynamics and the size of the spots were not 
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altered. Immobilized CCL21 has no obvious effects on adhesion sites, but could modify 
signaling and composition of these spots.  
In contrast to that, in Itg-/- DCs performing directional migration towards CCL19 on 
CCL21/ICAM-1 retrograde actin flow slows down in comparison to migration on uncoated 
glass. Optionally CCR7 could act as a surrogate molecular clutch: CCR7 engages surface-
bound CCL21 and could thereby establish weak force coupling. To gain insights into the 
CCR7 dynamics DCs were transfected with CCR7-GFP and the distribution of fluorescent 
protein in the already described setup analyzed. In DCs migrating on glass over the whole 
cell surface small flickering CCR7 spots could be detected. The same was observed in DCs 
migrating on CCL21/ICAM-1 coated glass. CCR7 does not seem to be spatially connected 
to sites of adhesion. However, I cannot rule out weak force coupling distributed over the 
whole cell body. Strikingly, also no CCR7 accumulation on the leading edge was detectable 
in DCs migrating in a CCL19 gradient. This result is contradictory to observation in T cells 
performing directional migration (Nieto et al., 1997; Gérard et al. 2007; Morley et al., 2010). 
   
5.2.4 Concluding remarks to ´adaptive force transmission´ 
The finding that leukocytes can tune their actin polymerization rate depending on the 
extracellular migration substrate suggests a feedback mechanism between force coupling 
and actin polymerization rate. One purely mechanical explanation acts on the assumption 
that the membrane tension always stays constant because of a “force-actin velocity-
relationship” between the plasma membrane and the barbed ends of the actin filaments 
pushing against the membrane. When actin filaments experience a counter force, for 
example by the stiffness of the plasma membrane, the actin polymerization rate slows down 
(Mitchison & Cramer, 1996). There are factors which can decrease membrane tension like a 
massive influx of H2O, which expands the lamellipodium, or a higher availability of plasma 
membrane due to exocytosis (Mitchison, Charras & Mahadevan, 2008; Doherty & McMahon, 
2008). This decrease in tension leads to “more space” between membrane and actin 
filaments and therefore to an increased actin polymerization till the membrane tension is 
balanced again. An inactive molecular clutch could act in a similar way. Because the 
elongating actin filaments are not connected via integrins to extracellular molecules, they 
are less stabilized and can be easily pushed backwards by the plasma membrane. There is 
again a gap between filaments and membrane. However, GTP-actin monomers are 
available in overspill and can be incorporated on the actin filaments: The actin polymeriza-
tion rate increases till the “force-actin velocity-relationship” is intact again.  
This model would also explain why adaptive force transmission is a common cell biological 
phenomenon: All needed components are expressed in all known cell types. But this model 
has also limitations. It is still unclear why only amoeboid cells can increase their actin 
polymerization rate to such high levels. Probably these cells can regulate and initiate actin 
polymerization more efficiently. The next step to explain adaptive force transmission not only 
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mechanically, but also in a more detailed cell biological way is to identify actin initiatory and 
regulatory proteins, which boost actin polymerization in amoeboid cells. Till now it is also 
unclear how and why amoeboid cells adapt their migration velocities always to a somehow 
fixed value. There must be a limiting factor in the actin cytoskeleton. Another unanswered 
question is, which migration mode, an integrin-dependent or –independent one, dominates 
in physiological interstitium. In lymphoid organs with their high density of chemokine and 
integrin ligand coated surfaces most likely the integrin-dependent locomotion outranks.  
In conclusion, we show that amoeboid protrusions unify two seemingly mutually exclusive 
migration models: they can autonomously extend into open space without requiring 
mechanical anchorage, but at the same time they can generate traction by transmitting the 
retrograde force of actin polymerization to a substrate. But how the cells generate traction 
without using integrins has not been analyzed so far and is a question of great interest to 
conclusively explain leukocyte migration in the interstitium. 
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7 Supplementary movie legends 
 
Movie S1. Migration of mature DCs on a LN cryosection (AVI 3090 kb) 
An unfixed cryosection of a murine inguinal LN was fixed on the bottom of a cell culture dish 
and covered with mature DCs. The DCs show a highly synchronized wave of migration from 
the peripheral parts of the section and even from the surrounding of the section towards the 
center of the LN cryosection. The cells enter the LN section along defined segments, 
suggesting migration along preformed tracks. 12-18 hr after the start of migration the cells 
accumulate in the inner part of the LN section. Cell behavior was followed by time-lapse 
video microscopy over 18 hr (103 frames, 15 frames/s).  
 
Movie S2. Migration of immature DCs on a LN cryosection (AVI 1100 kb) 
The experiment descript in Movie S2 was repeated with immature DCs. No migration could 
be observed in this case. Cell migration was recorded by time-lapse video microscopy over 
3 hr (29 frames, 15 frames/s).  
 
Movie S3. Migration of mature DCs on a LN cryosection with a removed and inverted 
peripheral part of the section (AVI 1840 kb) 
A peripheral part of a LN cryosection was cut off and repositioned inverted by 180° in close 
proximity to the remaining section to challenge the possibility of DC migration on immobi-
lized gradients. Applied mature DCs again showed a wave of directed migration, but the 
migration on the small segment was still directed towards the center of the big segment. 
This result implicates the induction of a soluble chemotactic gradient. The DCs were imaged 
over 4 hr (41 frames, 15 frames/s).  
 
Movie S4. DC migration on immobilized CCL21 (AVI 4930 kb) 
In this reductionistic in vitro approach CCL21 was dropped on cell culture plastic and after 
30 min at 37 °C non-immobilized chemokine was washed away with PBS. The coated area 
was then covered with mature DCs. The cells settling directly on the immobilized area 
showed random migration. 5 – 10 min after the onset of migration, DCs near to the coated 
area start directed migration to the center of the spot and accumulate there. DC migration 
was monitored over 15 hr (104 frames, 15 frames/s).  
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Movie S5. DC spreading on different structural parts of a LN cryosection (AVI 295 kb) 
In this time-lapse movie a representative DC migrating on an interfollicular area and a DC 
sitting on a B cell follicle is shown. DC migration was monitored over 1 min (29 frames, 15 
frames/s). 
 
Movie S6. Migration of WT and Itgb2-/- DCs on a LN cryosection (AVI 1360 kb) 
The time-lapse movie over 20 min shows WT (left) and Itgb2-/- (right) DCs crawling on a LN 
cryosection (41 frames, 15 frames/s).  
 
Movie S7. DC spreading on immobilized CCL21 and artificially immobilized CCL19 
(AVI 5100 kb) 
A plasma-treated glass surface was either coated with CCL21/ICAM-1 (left) or 
CCL19/ICAM-1 (right). Mature DCs were applied onto the surface and the cell behavior was 
monitored with differential interference contrast microscopy time-lapse microscopy over 15 
min (150 frames, 30 frames/s).  
 
Movie S8.  WT DCs migrating in a 3D collagen gel with incorporated BSA/ICAM-1- 
coated carbon fibers (AVI 2350 kb) 
DCs migrate in a 3D collagen matrix where BSA/ICAM-1-coated fibers were embedded. 
DCs show unbiased random migration in the collagen matrix. The DCs were recorded over 4 
hr (241 frames, 30 frames/s, without/with cells tracked).  
 
Movie S9. WT DCs migrating in a 3D collagen gel with incorporated CCL21/ICAM-1- 
coated carbon fibers (AVI 2310 kb) 
Time-lapse movie of DCs migrating in a 3D collagen gel with incorporated CCL21/ICAM-1- 
coated carbon fibers. When the cells get into contact with the coated fibers , they adhere , 
and move along the fiber with frequent directional changes. Cell behavior was monitored 
over 4 hr (241 frames, 30 frames/s, without/with cells tracked).  
 
Movie S10. WT DCs migrating in a 3D collagen gel with incorporated CCL21/ICAM-1-
coated carbon fibers towards a CCL19 gradient (AVI 2320 kb) 
DCs migrate in a 3D matrix with embedded CCL21/ICAM-1-coated fibers. An additional 
external CCL19 gradient is applied (highest concentration on top). Once the cells get into 
contact with the fibers, they adhere and move along the fibers with a bias towards the 
CCL19 source. Occasionally, cells detach from the fibers and migrate freely through the gel. 
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This movie shows directional steering of haptokinetic movement. The cells were monitored 
over 4 hr (241 frames, 30 frames/s, without/with cells tracked).  
 
Movie S11. WT DCs migrating in a 3D collagen gel with incorporated CCL21/ICAM-1-
coated carbon fibers towards a gradient of truncated CCL21 (AVI 2340  kb) 
The time-laps movie shows WT DCs crawling in a 3D collagen matrix towards a gradient of 
truncated CCL21 over 4 hr (241 frames, 30 frames/s, without/with cells tracked). The DCs 
show directed migration with a directional bias towards the full-length CCL21 on the fibers. 
The truncated CCL21 resembles the CCL19 gradient in Movie S10. 
 
Movie S12. Itgb2-/- DCs migrating in a 3D collagen gel with incorporated CCL21/ICAM-
1-coated carbon fibers towards a CCL19 gradient (AVI 2370 kb) 
The time-laps movie shows Itgb2-/- DCs crawling in a 3D collagen matrix towards CCL19 
over 4 hr (241 frames, 30 frames/s, without/with cells tracked). The DCs show directed 
migration , but do not interact with the included CCL21/ICAM-1-coated fibers. 
 
Movie S13: WT DCs migrating in a 3D collagen gel with incorporated CCL19/ICAM-1- 
coated carbon fibers towards a of truncated CCL21 (AVI 2350  kb) 
In this movie directed migration of WT DCs in a 3D matrix towards a source of truncated 
CCL21 over 4 hr is shown (241 frames, 30 frames/s, without/with cells tracked). Cellular 
interaction with the CCL19/ICAM-1-coated carbon fibers cannot be observed. Instead, DCs 
chemotaxing towards truncated CCL21 migrate through the collagen matrix. 
 
Movie S14: Lifeact-GFP DC migrating on glass under agarose towards a CCL19 
gradient (AVI  310  kb)  
The DC forms a broad leading edge with a diffusely protruding actin cortex. Only in the 
trailing edge thicker actin bundles can be observed. Time-laps movie over 50 s (30 frame/s), 
TIRF microscopy. The scale bar represents 10 µm. 
 
Movie S15: With Lifeact-GFP transfected Itg-/- DC migrating on glass under agarose 
towards a CCL19 gradient (AVI  392  kb) 
This time-laps movie (70 s; 30 frame/s) shows that the retrograde actin flow in Itg-/- DCs is 
substantially increased in comparison to WT DCs migrating on glass. TIRF microscopy. The 
scale bar represents 10 µm. 
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Movie S16: Lifeact-GFP DC migrating on PEG under agarose towards a CCL19 
gradient (AVI 696 kb) 
The retrograde actin flow can be enhanced in WT DCs by uncoupling of the molecular cluth 
on polyethylene glycol, an inert substrate. Time-laps movie over 150 s (30 frame/s), TIRF 
microscopy. The scale bar represents 10 µm. 
 
Movie S17: Lifeact-GFP 3T3 fibroblasts sitting on patternd surface composed of inert 
PEG substrate and with serum and Alexa555-BSA co-coated adhesive stripes (AVI     
482 kb) 
Left panel: Lifeact-GFP dynamics in 3T3 fibroblasts sitting on the patterned surface. Right 
panel: Alexa555-BSA highlights the serum coated adhesive area. Fibroblasts strictly adapt 
to the adhesive areas. Only short protrusions extend onto the inert PEG substrate, which 
exhibit massive retrograde actin flow. The retrograde actin flow stopps at the border to the 
adhesive substrate. Time-laps movie over 100 s (30 frame/s), TIRF microscopy. The scale 
bar represents 5 µm. 
 
Supplementary statistical analyses   
138 
 
8 Supplementary statistical analyses 
 
Table 5: Statistical analyses. Kruskal-Wallis tests or Mann-Whitney U-test were applied for data which 
does not fulfill the criteria of t-test and ANOVA. 
Figure Test statistic Sample size/ 
degrees of fredom 
P-value Posthoc test 
30 C  Kruskal-Wallis; H=117.18 df=6 P<0.001 Dunns, all pairwise 
30 D t-test; t=0.774 df=60 P=0.442  
30 E t-test; t=8.7 df=60 P<0.001  
30 F Spearman Rank correlation; 
r=0.12 
n=33 P=0.52  
31 B Kruskal-Wallis; H=35.603 df=2 P<0.001 Dunns, all pairwise 
31 C Kruskal-Wallis; H=17.820 df=2 P<0.001 Dunns, all pairwise 





33 D t-test; t=-2.732 df=15 P<0.05  
34 C t-test; t=5 df=12 P<0.001  
 
Table 6: Posthoc tests of Kruskal-Wallis tests in Table 5. The data were compared pairwise with Dunn´s 
method. 
Comparison  P-value 
WT on glass vs Itg
-/-
 on glass P<0.05 
WT on PEG vs WT on glass P<0.05 
WT on PEG vs WT on CCL21/ICAM-1 P<0.05 
WT on CCL21 vs WT on glass P<0.05 
Itg
-/-
 on glass vs  Itg
-/-
 on  CCL21/ICAM-1 P<0.05 
Itg
-/-
 on glass vs  Itg
-/-
 on PEG  P<0.05 
Itg
-/-
 on PEG vs Itg
-/-
 on CCL21/ICAM-1 ns 
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